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Chapter 1. Introduction 
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1. Introduction 
1.1 The synapse 
Already in 1897 Foster and Sherrington introduced the term synapse (from Greek synapsis 
"conjunction", from synaptein "to clasp", from syn- "together" and haptein "to fasten)1 
(WESTFALL et al., 1996). By 1962 the first nervous system, though a simple one, in Phylum 
Cnidaria (corals, anemones, and jellyfish) was defined by Horridge and Mackay. After 
Santiago Ramón y Cajal, the founder of modern neuroscience (LLINÁS, 2003), many scientists 
dedicated themselves in understanding the structure and function of synapses. In 1954 Palade 
and Palay described for the first time the structure of a vertebrate synapse using electron 
microscopy (EM). Since that time our understanding of synapse architecture has deepened, 
facilitated also by enhanced imaging techniques.  
The synapse is an asymmetrical structure composed of a presynaptic terminal, a 
synaptic cleft and a postsynaptic terminal. The presynaptic terminal is important in regulating 
synaptic vesicle docking, priming, fusion and neurotransmitter release into the cleft, where the 
neurotransmitter molecules bind to the postsynaptic terminal’s receptors. In the postsynaptic 
terminal the chemical signal is converted into an electrical one and further propagated within 
the neuron. Several steps of synaptic vesicle (SV) fusion take place at a specialized structure 
in the presynaptic terminal, which contains an electron-dense cytoskeletal matrix, known as 
cytometrix at the active zone (CAZ) (review: SCHOCH and GUNDELFINGER, 2006; review: SÜDHOF, 
2012). 
 
1.2 Cytometrix at the active zone (CAZ) 
1.2.1 Active Zone Ultrastructure  
In a simplistic model the active zone consists of a proximal zone close to the plasma 
membrane, where the docking of synaptic vesicles (SV) takes place and a more distal zone 
where vesicles are tethered. Over the decades electron microscopy and tomography (EM) 
techniques have revealed the existence of an electron-dense structure expanding into the 
cytoplasma. These observed dense projections differ considerably between species (review: 
ZHAI and BELLEN, 2004). At the neuromuscular junction (NMJ) of C.elegans the dense projection 
has been described as a plaque surrounded within 100nm by a subpopulation of vesicles (Fig. 
1.1A; WEIMER et al., 2006); while in D.melanogaster, the dense structure takes the shape of a 
pedestal and a platform (T-bars) enclosed by synaptic vesicles and closely associated with 
calcium channels (Fig. 1.1B; PROKOP and MEINERTZHAGEN, 2006). In vertebrates (frog), the NMJ has 
                                                            
1 ONLINE ETYMOLOGY DICTIONARY: www.etymonline.com 
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assembly and thereby the priming step (BETZ et al., 1997; review: RIZO and SÜDHOF, 2002; STEVENS et 
al., 2005; review: SÜDHOF, 2013).  
After the action potential reaches the presynaptic terminal, voltage gated calcium 
channels open and the calcium concentration builds up in a microdomain near the priming 
complex. The calcium sensor synaptotagmin1 (present on the synaptic vesicle) together with 
the SNARE complex further enables membrane fusion (DAI et al., 2008; CHOI et al., 2010; VRLJIC et 
al., 2010) with the formation of the pore to release the neurotransmitters into the synaptic cleft.  
Following neurotransmitter release SVs are recycled via different routes, like kiss-and-run 
(vesicles undock and recycle locally), clathrin mediated endocytosis (vesicles are reacidified 
and refilled directly or by passing via the endosome compartment) (review: SÜDHOF, 2004) or via 
bulk endocytosis. Activity-dependent bulk endocytosis (ADBE) is the dominant retrieval 
pathway after an elevated stimulation activity (CHEUNG and COUSIN, 2013). 
In accordance with the network’s needs, the amount of SVs ready to release 
neurotransmitter may very as well. SV recycling is tightly regulated by the action of different 
proteins, resident at the AZ. Therefore, fluctuations in the activity of synapses could be 
mediated by the actions of various AZ proteins, as well as by the SVs cycle. These changes 
represent the fundament of presynaptic plasticity.   
 
1.4 Synaptic plasticity 
The concept of synaptic plasticity, which was for the first time formulated by Hebb in 1949, 
refers to the capacity of synapses to react accordingly to the network’s needs either be 
weakening (depression) or strengthening (potentiation) its activity. These types of changes 
may well extend over short periods (short-term plasticity) or long periods of time (long-term 
plasticity). The Hebbian theory is used to describe these synaptic changes as being associative 
and rapidly induced, shortly explained as a positive feedback process (HEBB., 1949). For 
example, upon LTP induction, synapses become more excitable and the entire network 
activity would increase leading to a runaway potentiation. To prevent such extremes, the 
homeostatic process, which hinders the network to reach high levels of activity and preserve 
the stored information, has an important role (review: POZO and GODA, 2010).  
In the active state or basal conditions synaptic transmission is mediated by the release 
of neurotransmitters from presynaptic terminals into the synaptic cleft, followed by the 
activation of different receptors on the postsynaptic terminal. Under increased network 
activity presynaptic neurons decrease their release probability (LTD-long-term depression), 
while the postsynaptic cells decrease the number of their receptors. To offset reduced network 
Chapter 1. Introduction 
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activity, presynaptic neurons enhance the recycling, the number of docked vesicle and the 
release probability (LTP-long-term potentiation) (review: POZO and GODA, 2010; CASTILLO, 2012).  
There are multiple parallel mechanisms responsible for controlling pre- and postsynaptic 
homeostasis, and consequently affecting synapse activity. The molecular mechanisms that 
govern the negative feedback (homeostatic plasticity) rely on the efficiency of different 
intracellular signalling cascades to detect and to respond accordingly to changes in the 
network. These fine-tuned mechanisms include: gene expression induction, protein synthesis 
and degradation. Besides the two major mechanisms: transcription and translation, post-
translational modifications have emerged as an important factor in controlling plasticity 
(review: POZO and GODA., 2010). Several post-translational modifications have been suggested to 
modulate the function of various pre- and postsynaptic proteins, like: palmitoylation (review: 
EL-HUSSEINI and BREDT 2002), myristilation and prenylation (KUTZLEB et al., 1998; O’CALLAGHAN et al., 
2003), SUMOylation (Small Ubiquitin-like Modifier) (GIRACH et al., 2013) and phosphorylation 
(review: BARRIA, 2001). 
 
1.4.1 Presynaptic dormancy 
Presynaptic dormancy is induced as a response to a prolonged strong depolarization or 
increased action potential firing. Dormant synapses display a decrease in neurotransmitter 
release. The molecular mechanism is based on the inhibitory action of G proteins on adenylyl 
cyclase (AC), which causes a decrease in the level of cAMP and thereby directly affects the 
activity of protein kinase A (PKA) (Fig. 1.5). Therefore, presynaptic proteins are less 
phosphorylated and become susceptible to degradation through the proteasome (review: 
CRAWFORD and MENNERICK, 2012). The protein levels of RIM1α and Munc13-1 were shown to be 
decreased upon induction of presynaptic dormancy through the action of the ubiquitin-
proteasome system, while an overexpression of RIM1α in cultured neurons prevented the 
induction of silencing (JIANG et al., 2010). Recently two other presynaptic proteins, Piccolo and 
Bassoon were identified as negative regulators of the E3 ligase Siah1. In the DKO neurons the 
rate of presynaptic protein degradation was increased, leading to the observation that these 
two proteins are important regulators of the protein ubiquitination in the presynaptic terminal, 
therefore maintaining synapse integrity (WAITES et al., 2013).aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
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The sequence between the zinc and PDZ domains contains several amino acid residues 
that have been suggested to be important in modulating RIM’s function (Fig. 1.7). Serine 413 
was identified as a phospho-switch that triggers presynaptic LTP in cultured cerebellar 
granular and Purkinje cell neurons, upon phosphorylation by PKA (LONART et al., 2003). These 
findings however were not confirmed by studies in knockin mice, bearing the S413A 
mutation. The phosphorylation of serine 413, although important in binding 14-3-3 proteins, 
displayed no significant role in presynaptic plasticity or in learning and memory (KAESER et al., 
2008a; YANG and CALAKOS, 2010). Other phosphoserines (Ser241 and Ser287 in RIM1α, and 
Ser335 in RIM2α) were also associated with binding to 14-3-3 proteins, when phosphorylated 
by the Ca2+/calmodulin dependent kinase II (CaMKII). The ability of RIM to bind 14-3-3 
proteins does apparently not impair the binding between RIM-Munc13 and RIM-Rab3A (SUN 
et al., 2003). The same linker region between zinc finger and PDZ domain may also act as a 
substrate for ERK2 kinase, which phosphorylates Ser447, a residue linked to the enhancement 
of glutamatergic transmission in hippocampal CA1 after stimulation with BDNF (SIMSEK-
DURAN and LONART, 2008). 
The central PDZ domain that interacts with the ELKS2/CAST protein (OHTSUKA et al., 
2002; WANG et al., 2002), plays an important role in RIM1’s distribution in cultured neurons; the 
truncated form lacking this domain being diffusely localized (Fig. 1.7; OHTSUKA et al., 2002). 
CAST binds directly not only RIM1, but also Bassoon and Piccolo, and the entire ternary 
complex RIM1-CAST-Bassoon is involved in controlling neurotransmitter release (TAKAO-
RIKITSU et al., 2004). Two reports from 2011 attribute to RIM1/2 a key role in controlling not 
only the number of docked vesicles but also the distribution and/or density of calcium 
channels at the active zone (HAN et al., 2011; KAESER et al., 2011). By generating RIM1/2 floxed 
mouse lines, in which all RIM isoforms containing a PDZ domain can be deleted by cre-
recombinase in vitro, it was shown that the PDZ domain alone was required for the proper 
localization of N- and P/Q type calcium channels (KAESER et al., 2011). 
The α- and β-RIMs contain two C-terminal domains: C2A and C2B that are separated 
by a proline-rich domain and two splice sites (B and C) (Fig. 1.7; WANG and SÜDHOF, 2003). Both 
domains do not contain the consensus calcium binding sites present in synaptotagmin’s C2- 
domains (WANG et al., 2000; DAI et al., 2005). The C2A domain was shown to have affinity in a 
calcium dependent manner for SNAP25 and Synaptotagmin1 (COPPOLA et al., 2001), even though 
NMR studies suggested that there was little binding between these proteins (DAI et al., 2005). 
Very intriguing is a point mutation in human RIM1 (R844H) that was identified in a patient 
with autosomal dominant cone-rod dystrophy-CORD7, characterized by impaired vision due 
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to the reduction in the cone and rod sensitivity (JOHNSON et al., 2003; MICHAELIDES et al., 2005). The 
C2B domain has been shown to interact with several proteins that may have an impact on 
RIM1α function at the active zone, among them Synaptotagmin1, identified to bind with high 
affinity to the C2B domain in biochemical assays (COPPOLA et al., 2001; SCHOCH et al., 2002), 
results not reproduced by NMR studies (GUAN et al., 2007). Other proteins that bind the C2B 
domain are: liprins-α (SCHOCH et al., 2002); the E3 ubiquitin ligase SCRAPPER (YAO et al., 2007) 
that controls RIM1 turn-over, facilitating ubiquitination and degradation; SAD kinase (INOUE et 
al., 2006); and the β4 subunit of voltage gated calcium channels (COPPOLA et al., 2001; KIYONAKA et 
al., 2007). In addition the interaction between RIM1 and the α1 subunit of the N-type calcium 
channel is regulated by cyclin-dependent kinase 5 (Cdk5), which enhances channel opening 
and facilitates neurotransmitters release (SU et al., 2012).  
SUMOylation was recently reported by the group of Hanley to act as a molecular 
switch for RIM1α. SUMOylated RIM1α confers affinity for Cav2.1, therefore promoting 
calcium channel clustering and synchronous synaptic vesicle release, while non-SUMOylated 
form is responsible only for vesicle priming and docking (GIRACH et al., 2013). 
Other proteins that couple RIM1/2 to calcium channels are RIM-BPs. On one hand 
RIM-BP binds the proline-rich domain of RIM1/2 (WANG et al., 2000) and on the other hand 
calcium channels, bringing these proteins in close proximity at the active zone (HIBINO et al., 
2002). 
 
1.5.1.3 RIM function 
1.5.1.3.1 RIM in invertebrates (C.elegans and D.melanogaster) 
Analysis of RIM protein function in C.elegans demonstrated that UNC-10 has a major role in 
coordinating vesicle docking and priming by regulating UNC-13 activity. It has been 
hypothesised that UNC-10/RIM may signal syntaxin, via UNC-13, to change its conformation 
from a closed to an open state. UNC-10 mutants exhibit a decrease in vesicle fusion at release 
sites, an effect suppressed by the expression of the open form of syntaxin (KOUSHIKA et al., 
2001). Furthermore, disruption of the unc-10 gene triggers a depletion of docked synaptic 
vesicles since the normal connections between SVs and dense projection filaments are 
impaired (STIGLOHER et al., 2011). 
D.melanogaster RIM mutants show decreased evoked synaptic transmission as a 
consequence of the reduction in the size of the RRP of SVs and altered Ca2+-channels 
clustering together with a decreased calcium influx. Mutants present a normal cellular 
morphology with no major changes in active zone architecture (GRAF et al., 2012; MÜLLER et al., 
2012).
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1.5.1.3.2 RIM in vertebrates (M.musculus) 
In the recent years several reports have been published, providing new data about the possible 
role of RIMs at the active zone. Different mouse models have been generated, knocking out 
either one or more isoforms, in order to gain new insights into how different variants of RIMs 
influence neurotransmitter release and presynaptic plasticity as well as to understand ability of 
the various isoforms to compensate for each other.  
 
1.5.1.3.2.1 RIM1α knock-out mice 
The first model generated targeted the most abundant isoform in the brain, RIM1α (SCHOCH et 
al., 2002). Homozygous mice were viable and fertile, with no evident structural abnormalities 
or changes in brain architecture. Overall, active zone architecture was comparable to WT 
littermates. Among the AZ proteins, Munc13-1 showed a major decrease of 60% in KOs, 
while several postsynaptic density proteins (SynGAP, PSD95, SHANK) exhibited a moderate 
increase, suggesting a role for RIM1α in synaptic remodelling (SCHOCH et al., 2002). 
Electrophysiological recordings revealed that RIM1α knockout caused a decrease in the size 
of the RRP, with no effect on synaptic vesicle recycling. These data together with findings 
from D.melanogaster and C.elegans suggest a role for RIM1α in vesicle maturation, from 
priming to calcium triggered fusion (KOUSHIKA et al., 2001; SCHOCH et al., 2002; CALAKOS et al., 2004; 
MÜLLER et al., 2012). Additionally, the RIM1α protein seems to be involved both in short-term 
plasticity as well as in presynaptic long-term potentiation (LTP) (review: MITTELSTAEDT et al., 
2010).  
Cryo-electron tomography revealed a series of changes in the AZ with regard to 
vesicle tethering and vesicle concentration in synaptosomes from RIM1α KO mice (40% 
reduction in proximal vesicles compared to control) that may account for the decrease in the 
size of the RRP. Blocking proteasome activity with MG132, the KO phenotype was rescued 
and the treated KO synaptosomes became indistinguishable from WT synaptosomes, 
displaying an increase in the number of vesicles at the AZ. This recent study highlights the 
importance of the ubiquitin-proteasome system (UPS) in the turn-over of RIM proteins, 
emerging as a key factor in controlling presynaptic plasticity (FERNANDEZ-BUSNADIEGO et al., 
2013).  
Besides deficits in synaptic transmission, KO mice display impaired learning and 
memory (POWELL et al., 2004), schizophrenia-like behaviour (BLUNDELL et al., 2010), and a higher 
susceptibility to develop spontaneous seizures after status epilepticus (PITSCH et al., 2012). 
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1.5.1.3.2.2 RIM1αβ double knock-out mice 
Mutant mice lacking both RIM1 isoforms, α and β, display a more severe impairment in 
synaptic transmission and significant changes in the solubility of different active zone 
proteins. Both isoforms are expressed in a similar pattern in the brain, with a slight increase of 
RIM1β levels in the brainstem. During development RIM1β is highly expressed in the early 
postnatal phase in this region, which may account for the lethality of the DKO mice. 
Interestingly, in RIM1α KO mice the level of RIM1β is increased 2 fold, indicating a 
compensatory effect. Among the presynaptic proteins, ELKS1/2, RIM-BP2 and the remaining 
Munc13-1 (reduced to 30% in these mutant mice), showed a higher dissociation rate from the 
insoluble protein matrix, supporting the notion of RIMs acting as scaffolding proteins for 
various AZ proteins. Synaptic transmission is severely impaired in the DKO mice with the 
observation that presynaptic long-term plasticity is not aggravated by this double deletion 
compared to RIM1 KO. Therefore, it has been suggested that RIM1α mediates both long-term 
plasticity via Rab3 as well as short-term plasticity via Munc13, while RIM1β (since it lacks 
the binding motif for Rab3) is involved only in short-term plasticity (KAESER et al., 2008b).  
 
1.5.1.3.2.3 RIM2α knock-out mice 
Since RIM1α and RIM2α, which is much less abundant, display high homology, it was 
expected that the knockout of RIM2α might partially resemble the phenotype of the RIM1α 
KO. However, deletion of the RIM2α gene did not trigger any change in release probability 
compared to the impairment in synaptic transmission and facilitation observed in the RIM1α 
KO mice (CASTILLO et al., 2002; SCHOCH et al., 2002, 2006). RIM2α KO mice were viable and fertile, 
and displayed normal brain morphology (SCHOCH et al., 2006).  
 
1.5.1.3.2.4 RIM1α/RIM2α double knock-out mice 
Deletion of both α isoforms (RIM1 and RIM2) turned out to be lethal, RIM1α/2α DKO mice 
die immediately at birth, not due to changes in brain development but due to breathing 
problems. No obvious alterations in brain morphology were detected by conventional EM. 
Protein composition analysis revealed no additional decrease in the level of Munc13-1 
compared to RIM1α KO mice. Nonetheless, immunostaining analysis of the whole-mount 
diaphragm muscle at E18.5 revealed an increased innervation or expansion of innervation 
with no major changes in the ultrastructure of the NMJ in the DKO mice. These changes were 
accompanied by impairment in synaptic transmission. Spontaneous or Ca2+-dependent 
exocytosis was not abolished, only evoked synaptic transmission (Ca2+- triggering exocytosis) 
was strongly impaired in these mutants (SCHOCH et al., 2006).  
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1.5.1.3.2.5 RIM conditional knockout mice 
As both RIM1α/RIM1β (KAESER et al., 2008b) and RIM1α/RIM2α (SCHOCH et al., 2006) DKO mice 
were lethal, conditional knockouts (floxed mouse lines) were generated to further study the 
consequences of a deficiency of all RIMs isoforms. Deletion of both RIM genes in vitro 
supported the role of RIMs in controlling vesicle priming and neurotransmitter release (KAESER 
et al., 2012). Furthermore, RIMs were shown to be responsible for proper tethering of the Ca2+ 
channels via the PDZ domain (HAN et al., 2011; KAESER et al., 2011).  
Single deletions (RIM1αβ or RIM2αβγ) altered SV priming, while double deletion 
(RIM1αβ/RIM2αβγ) impaired not only the priming but also the calcium responsiveness and 
synchronization of release. In HEK293T cells and in RIM1/2 double deficient neurons, 
RIM2γ wasn’t able to rescue the phenotype, suggesting that the C2 domain alone neither 
contributes to calcium channel activity modulation nor plays an important role in the synaptic 
function of RIM proteins (KAESER et al., 2012). 
 
Taken together, RIM1α plays an important role in synaptic vesicle priming, and in 
both presynaptic short-term and long-term plasticity. Moreover, the level of RIM1α seems to 
be correlated with the synaptic activity.  
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1.5.2.2 SV2A knock-out mice 
In spite of all the data collected until now the exact function of SV2A still remains enigmatic. 
To gain further insights into SV2A function, SV2A deficient mice were generated (CROWDER et 
al., 1999; JANZ et al., 1999). Albeit SV2A KO littermates appeared normal at birth, mice 
experienced severe seizures and died about three weeks after birth. No obvious alterations of 
synaptic density or morphology in the brain of SV2A KO mice were observed (CROWDER et al., 
1999; JANZ et al., 1999).  Therefore, SV2A seems not to be required in embryonic development 
but rather its presence is essential for survival afterwards. Electrophysiological studies further 
revealed that inhibitory (CROWDER et al., 1999; CHANG and SÜDHOF, 2009) as well as excitatory 
(CUSTER et al., 2006) neurotransmission in these mice were impaired. A similar impairment was 
also detected in adrenal chromaffin cells from SV2A KO mice, where the exocytotic burst 
defining the size of the readily releasable pool (RRP) was observed to be decreased with no 
evident alterations in the calcium level (XU and BAJJALIEH, 2001). A role in priming after vesicle 
tethering was suggested by Custer et al. (2006), who observed a similar decrease in RRP in the 
SV2A deficient mice’s brain, with no oscillation in calcium level. 
However, earlier studies using SV2A/SV2B double knockout mice with a phenotype 
resembling SV2A KO, proposed a role in regulating the calcium level during repetitive 
stimulation trains rather than priming (JANZ et al., 1999). The described decrease in the RRP size 
(CUSTER et al., 2006) was not reproduced by Chang (CHANG and SÜDHOF, 2009). A further 
observation that the protein components of SNARE complexe were reduced in SV2A KO 
mice supported the hypotheses that SV2A may have a role in the fusion mechanism (XU and 
BAJJALIEH, 2001). 
 
Taken together, the collected data suggest a role of SV2A in SV priming. Moreover, 
SV2A act as a receptor for the anti-epileptic drug Keppra. It has been suggested that Keppra 
may inhibit inappropriate interactions to occur when SV2A is overexpressed in neuronal cell 
cultures. Neurons with elevated amount of overexpressed SV2A display similar impairments 
in synaptic transmission as neurons from SV2A KO mice (NOWACK et al., 2011). It seems that 
the protein amount plays an important role in maintaining the neuronal function as well. The 
molecular mechanism of action of Keppra on SV2A is not fully elucidated.    
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Aim of the study 
One of the most important properties of the synapse is the capacity to remodel itself in 
response to ongoing activity in its environment. The synapse’s ability to weaken or strengthen 
over time in response to different stimuli is called synaptic plasticity. One way of inducing 
changes in presynaptic plasticity is to modulate SV priming and the protein machinery 
involved in this process, like RIM1α and SV2A proteins. Over the years it has been proposed 
that regulated phosphorylation/dephosphorylation events may play a role in plasticity- 
induced remodelling of established and the assembly of novel active zones.  To date the 
molecular mechanism governing these changes are not understood in detail.  
In this thesis two goals will be pursued: 
1. Examine how phosphorylation events affect RIM1α binding affinities 
RIM1α, a scaffold multi-domain protein residing in the active zone (AZ), has been shown to 
be involved in synaptic vesicle priming and in different forms of presynaptic plasticity. Both 
synaptic abundance and function have been suggested to be regulated by posttranslational 
modifications. However, the precise mechanisms involved in controlling RIM1α protein 
levels and function in the presynaptic terminal are not yet resolved.  
To understand the impact that RIM1α phosphorylation has on active zone 
reorganisation and presynaptic function, we aim at identifying novel phospho-dependent 
binding partners. Combining various stimulation protocols, in order to block or enhance 
kinases activity, different protein complexes binding to RIM1α will be identified by mass-
spectrometry. Next, these newly identified binding partners will be verified by protein-protein 
interaction assays, and the functional role of these new proteins addressed in neuronal cell 
culture. 
2. Identify novel binding partners for SV2A 
The last part of this study will be focused on the synaptic vesicle protein 2A (SV2A) protein, 
whose involvement in vesicle priming or in controlling calcium levels is not yet elucidated. 
Although SV2A is targeted by the antiepileptic drugs Keppra that only acts in case of strong 
pathophysiological activity, its mode of action is still unresolved.  
Therefore, to gain insight into the SV2A function identification of novel binding 
partners will be addressed. Different affinity methods in combination with rAAV injections in 
mice will be applied in order to find the best approach possible to purify the entire complex of 
proteins under native conditions, followed by mass-spectrometry. 
The results of this study will provide new insight into the molecular mechanisms by 
which the functional properties of the presynaptic release machinery might be modulated.   
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2. Materials 
2.1 Equipment  
 Application Model Company 
A 
Acrylamid electrophoresis system Mini-PROTEAN Tetra Cell/ 
Power Pac Basic Power Supply 
BioRad 
Agarose electrophoresis system SUB-CELL GT  BioRad 
Analytical balance JP  Mettler Toledo 
Autoclave Laboklav Steriltechnik AK 
B Balance SBC53  Scaltec 
C 
Capillary Sequencer 3130/xl/Genetic Analyzer Applied Biosystems 
Cell-culture hood  MSC-Advantage Thermo Scientific 
Cell-culture hood  HERA Safe KS Thermo Scientific 
Centrifuge  Rotina 420R Hettich 
Centrifuge  Mikro 200R Hettich 
Centrifuge  - Abimed 
Chamber for MS X Cell SureLock Mini-Cell Life Technologies 
Confocal laser scanning microscope A1/Ti Nikkon 
 Confocal microscope  FV1000 Olympus 
 Controller Micro4 Controller, 4- Channel World Precision Instruments 
G Gel documentation system  AlphaImager Alpha Innotech 
I 
Incubator  HERA Cell 150i Thermo Scientific 
Incubator - Binder 
Incubator Incubator 1000 Heidolph 
Incubator Incubator Mini Shaking VWR 
Infrared imaging system  Odyssey  Li-cor 
Inverse microscope  Axio Observer 1A Zeiss 
Inverse microscope Axiovert 40 CFL Zeiss 
M 
Magnetic Separator - Sigma 
Mass-spectrometer 
 (IBMB, Bonn) 
LTQ OrbitrapVelos/ Thermo 
DionexUlti Mate 3000 RSLCnano 
HPLC 
Thermo Scientific 
MilliQ -Ultra pure water  Advantage A10 Millipore 
Microsyringe pump controller Micro4 World Precision Instruments 
P 
PCR Machine  MY Cycler BioRad 
Peristaltic pump P-1 GE Healthcare 
pH-Meter InLab@ExpertDIN Mettler Toledo 
Potter Potter S B. Braun 
Power Supply PHERO-stab.500 Biotec-Fischer 
Power Supply Power Pack 25 Biometra 
R Rocking Platform  Polymax 1040 Heidolph Rotator SB 3 Stuart 
S 
Shaker  TH 15 Edmund Bühler 
Shaker  TH 30 Edmund Bühler 
Sonicator Labsonic 2000 B. Braun 
Spectrophotometer BIO Eppendorf 
Spectrophotometer  ND 1000  NanoDrop 
Syringe Nanofil World Precision Instruments 
T 
Thermo shaker Compact  Eppendorf 
Thermo shaker MB-102 Bioer 
Transfer System Mighty Small Transphor/ Hoefer 
TE22 
Amersham 
U 
Ultracentrifuge  WX ULTRA Series Thermo Scientific 
Ultracentrifuge Optima L series, S class Beckman Coulter 
Ultrasonicator UP50H Hilscher 
V Vacuum concentrator Concentrator plus Eppendorf Vortex Vortex-Genie 2  Scientific Industries 
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2.2 Chemicals 
Chemicals Company 
A  
Acetic acid Roth 
Acetonitril LC-MS Grade Roth 
Agarose Sigma 
Ammonium hydrogencarbonate Roth 
Ammonium peroxodisulphate Roth 
Ampicillin Roth 
Ampuwa Fresenius 
Antioxidant Agent Life Technologies 
Arginine-HCl Sigma 
  
B  
ß-Marcaptoethanol Roth 
Bensonase Sigma 
BES (N,N, Bis-(2-hydroxyethyl)-
2-amino-ethansulfonic acid) 
Roth 
Bovine serum albumin (BSA) Roth 
  
C  
Calcium chloride (CaCl2) Sigma 
Chlorhidric acid (HCl) Roth 
Chloroform  Roth 
Citric acid Sigma 
ComplexiolLyte114 (CL114)  LogoPharm 
CL114 Dilution Buffer LogoPharm 
Cold Water Fish Gelatine  Sigma 
  
D  
Dimethyl 3,3’-
dithiobispropionimidate-2HCl 
(DTBP) 
Pierce 
Dimethylsulfoxide (DMSO) Roth 
Disodiumhydrogenphosphat Merk 
Dithiobis 
(succinimidylpropionate) (DSP) 
Pierce 
Ditiothreitol (DTT) Roth 
DNA 6 x loading buffer Thermo Scientific 
  
E  
Ethanol Roth 
Ethidium bromide Merck 
EDTA Sigma 
  
G  
Glucose  Roth 
Glycerol Sigma 
Glycine Roth 
  
H  
HEPES Roth 
  
I  
Iodixanol (OptiPrep) Axis-Shield 
Iodoacetamide (IAA) Sigma 
Isofluran Abbott 
Isopropanol Roth 
IPTG Roth 
  
Chemicals Company 
L  
LB-Agar Roth 
LB-Medium Roth 
Laemmli Buffer Life Technologies 
Lysozym Roth 
  
M  
Magnesium chloride (MgCl2) Roth 
Magnesium sulphate (MgSO4) Roth 
Methanol  Roth 
Mowiol 4-88 Roth 
  
N  
n-dodecyl-β-maltoside (DDM) Roth 
Normal goat serum (NGS) Gibco BRL 
NuPAGE MOPS SDS Running 
Buffer 
Life Technologies 
  
P  
Paraformaldehyd (PFA) Merk 
Phenol red Sigma 
Phosphate Buffer Saline (PBS) Biochrom AG 
Potasium chloride (KCl) Roth 
Potasium dihydrogenphosphate Roth 
  
R  
Reduction Agent  Life Technologies 
Roti-Blue Roth 
Roti-Phenol/C/I Roth 
Rotiphorese Gel 30 Roth 
  
S  
Saccharose  Roth 
Sodium acetate Roth 
Sodium carbonate Roth 
Sodium chloride (NaCl) Roth 
Sodium dodecylsulfat (SDS) Roth 
Sodium dihydrogenphosphat Roth 
Sodium hydroxide (NaOH) Roth 
  
T  
TEMED Roth 
Tris-Base Roth 
Tris-chlorhidric acid Roth 
Triton-X-100 Sigma 
Trypan-Blue Life Technologies 
  
V  
Vectashield mounting medium Vectorlabs 
  
X  
Xylene Roth 
  
  
  
  
Chapter 2. Materials
 
20 
 
2.3 Cell culture media 
» B27 supplement (17504) Gibco BRL 
» Basal Medium Eagle (BME) 
(41010) 
Gibco BRL 
» DNaseI (11284932001) Roche 
» Dulbecco’s Modified Eagle 
Medium (DMEM)(41966) 
Gibco BRL 
» Fetal calf serum (FCS)(16170) Life Technologies 
» Hanks’ Balanced Salt Solution 
(HBSS) (14170) 
Gibco BRL 
» Iscove’s Modified Dulbecco’s 
Medium (IMDM) (21980) 
Gibco BRL 
» L-Glutamine (25030) Gibco BRL 
» Minimal Essential Medium Sigma 
Eagle (MEM) (M2279) 
» Neurobasal medium (21103) Gibco BRL 
» Opti-MEM (31985) Gibco BRL 
» Penicillin-Streptomycin 
(15140) 
Gibco BRL 
» Phosphate Buffer Saline (PBS) 
(14190) 
Gibco BRL 
» Poly-D-Lysine (P1149) Sigma 
» Poly-L-Lysine (P1399) Sigma 
» Trypsin  Sigma 
» Trypsin EDTA (25300) Gibco BRL 
  
 
2.4 Kits 
» BigDye Terminator v3.1cycle 
Sequencing kit  
Applied  
Biosystems 
» DNA Clean and Concentration 
kit  
Zymo Research 
» Dynabeads mRNA direct  Life Technologies 
» EndoFree Plasmid Maxi kit  Qiagen 
» First-strand cDNA Synthesis kit 
(K1632)  
Thermo Scientific 
» GeneJET Plasmid Miniprep kit  Thermo Scientific 
» Lipofectamine 2000  Life Technologies 
 
» Trypsin Profile IGD Kit 
(PP0100) 
Sigma 
» QuickChangeII XL Site 
Directed Mutagenesis kit  
Stratagene 
» Pure link Midi kit 
 (DNA purification)  
Life  
Technologies 
» Zymoclean Gel DNA recovery 
kit  
Zymo Research 
 
2.5 Enzymes 
» pfuDNA polymerase 
Thermo 
Scientific 
» Restriction enzymes: 
AvrII, BamHI, BglII, ClaI, EcoRI, 
HindIII, NotI, SalI, XbaI, XhoI 
» Shrimp alkaline phosphatase Thermo 
Scientific » T4 DNA Ligase  » T4 Polynucleotide Kinase 
 
2.6 Inhibitors 
» Calyculin A (208851) Calbiochem 
» Complete Mini EDTA free 
proteinase inhibitors 
Roche 
» Okadaic acid (495604) Calbiochem 
» phosSTOP Roche 
» SRPIN340 Axon Medchem 
» Staurosporine (S5921) Sigma 
 
2.7 Diverse materials  
» Amicon Ultra Centrifigal filters 
(3000 MWCO/100000 MWCO) 
Millipore 
» FLAG-magnetic beads Sigma 
» GFP- magnetic beads Biozol 
» Glutathion-agarose beads Sigma 
» HA- magnetic beads Pierce 
» LoBind Eppendorf tubes Eppendorf 
» NuPAGE 4-12% Bis-Tris Gel Life Technologies 
» Strep-tactin MacroPrep IBA 
» Thinwall Polyallomer 
Centrifuge Tubes (03141)/ 
Sealing Cap Assemblies (52572) 
Sorvall 
» Whatman Protran Nitrocellulose 
Membrane 0.45uM 
Whatman, GE  
Healthcare 
» Vectashield mounting medium 
with DAPI 
Vectorlabs 
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2.8 Cloning primers 
Vector Primer Name Sequence (5’-3’) Restriction 
Enzymes 
AAV-
MCS 
N-TAP Fw gcggaattcaccatggattataaagatgatgatg EcoRI Rev gcgggatcctggtcctggtttctcgaactgcgggtg BamHI 
C-TAP Fw gcgggatcccccggaccctggagccaccctcag BamHI Rev gcggtcgactcatttatcatcatcatctttataatc SalI 
GFP (N) Fw gcggaattcaccatggtgagcaagggcg EcoRI Rev gcgggatccgggtccgggcttgtacagctcgtcc BamHI 
Copine VI Fw gcggaattcaccatgtcggacccagagatg EcoRI Rev gcgggatcctgggctagggctgggag BamHI 
SRPK2 
Fw gcgatcgataccatgtcagttaactctgagaagtc ClaI 
Rev gcgtctagaagaattcaaccaaggatgtcg XbaI 
Fw gcgtctagacccgggccaatgtcagttaactctgagaagtcg XbaI 
Rev gcggtcgactcaagaattcaaccaaggatgccg SalI 
SV2A 
Fw gcgggatccatggaagaaggctttcgag BamHI 
Rev gcgaagctttcactgcagcacctgtcc HindIII 
Fw gcggaattcaccatggaagaaggctttcgag EcoRI 
Rev gcgggatccctgcagcacctgtcc BamHI 
ULK1 Fw gcgtctagaatggagccgggccgc XbaI Rev gcgaagctttcaggcatagacaccactc HindIII 
ULK2 Fw gcgtctagaatggaggtggtgggcg XbaI Rev gcggtcgactcacacagttgcagtgctac SalI 
VAPA Fw gcgtctagaaccatggcgtccgcctccg XbaI Rev gcgaagctttcacaagatgaatttccctagaaag HindIII 
VAPB Fw gcgtctagaatggcgaaggtggaacagg XbaI Rev gcgagatcttcacaaggcaatcttccctataatgac BglII 
CMV-
MCS 
C-TAP 
Fw gcggtcgaccccggaccctggagccaccctcagttc SalI 
Fw gcgcctaggcccggaccctggagccaccctcagttc AvrII 
Rev gcgaagctttcatttatcatcatcatctttataatc HindIII 
C2A 
RIM1α 
Fw gcggaattcaccatgaggccttctatttctgttatttctc EcoRI 
Rev gcgggatcccgggcttcgggaggcatc BamHI 
C2A-C2B 
RIM1α 
Fw gcggaattcaccatgaggccttctatttctgttatttc EcoRI 
Rev gcggtcgactgaccggatgcagggagg SalI 
Zn-PDZ 
RIM1α 
Fw gcggaattctatgtcctcggccgtggg EcoRI 
Rev gcgcctagggatcctggggatgtcacc AvrII 
KD-ULK1 Fw gcgtctagaatggagccgggccgc XbaI Rev gcgaagctttcagaaagggtggtggaaaaattc HindIII 
SPD-ULK1 Fw gcgtctagattggatgccagcaccccc XbaI Rev gcgaagctttcaagcctcgaaggtcacagc HindIII 
CTD-ULK1 Fw gcgtctagacctgacctcccagaggag XbaI Rev gcgaagctttcaggcatagacaccactc HindIII 
KD-ULK2 Fw gcgtctagaatggaggtggtgggcg XbaI Rev gcggtcgactcaaaggaaaggatggctgaaaaatg SalI 
SPD-ULK2 Fw gcgtctagagagcaagttccagttaaaaaatc XbaI Rev gcggtcgactcaggcttcaaaggtgatgagac SalI 
CTD-ULK2 Fw gcgtctagacctgaactaccagaggagac XbaI Rev gcggtcgactcacacagttgcagtgctac SalI 
pGEX 
C2A 
RIM1α 
Fw gcggaattccgaggccttctatttctgttatttc EcoRI 
Rev gcgctcgagtcatggctgaggcagaggtagt XhoI 
SRPK2 Fw gcgcctaggcccgggccaaccatgtcagttaactctgagaagtcg AvrII Rev gcgtcgacctatctagaagaattcaaccaaggatgtcg SalI 
MSP-VAPA Fw gcggaattccggcgaagcacgagcagatc EcoRI Rev gcgaagctttcaaacagctttgctaggttccat HindIII 
CC-VAPA Fw gcggaattccggatatggaacctagcaaagctg EcoRI Rev gcgaagctttcaatctctgaaggacacggctg HindIII 
MSP-CC 
VAPA 
Fw gcggaattccggcgaagcacgagcagatc EcoRI 
Rev gcgaagctttcaatctctgaaggacacggctg HindIII 
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2.9 Sequencing primers 
Vector Primer Name Sequence (5’-3’) 
pGEX Fw gggctggcaagccacgtttggtg Rev ccgggagctgcatgtgtcagagg 
CMV Fw gagtccaaggtaggcccttt 
pAMU6 Fw tacgatacaaggctgttagagag 
 
2.10 Site-directed mutagenesis 
Target gene 
 
Sequence (5’-3’) Amino acid 
Exchange 
C2A (RIM1α) Fw gtctactcacacgtacatcatagagattttcgagagcgaatgttag R844H Rev ctaacattcgctctcgaaaatctctatgatgtacgtgtgagtagac 
ULK1 Fw ggaggtggccgtcagatgcattaacaagaag K46R Rev cttcttgttaatgcatctgacggccacctcc 
ULK2 Fw gggaggtggctattacaagtattaataaaaag K39T Rev ctttttattaatacttgtaatagccacctccc 
 
2.11 Oligonucleotides used for HA-tag cloning  
Vector Primer Name Sequence (5’-3’) Restriction 
Enzymes 
AAV-
MCS HA (N) 
Fw aattcaccatgtacccatacgatgttccagattacgcta EcoRI 
Rev gatctagcgtaatctggaacatcgtatgggtacatggtg BglII 
 
2.12 Oligonucleotides used for shRNA cloning  
Vector Primer Name Sequence (5’-3’) Position Restriction 
Enzymes 
pA
M
U
6 
ULK2 
≠1 
(Xiang et al., 
2007) 
Fw gatctcgtgcctagtattcccagagattcaagagatctctgggaatactaggcatttttta 699-717 
(KD) 
BglII 
Rev agcttaaaaaatgcctagtattcccagagatctcttgaatctctgggaatactaggcacga HindIII 
ULK2 
≠2 
Fw gatctcgggatagaatggactttgaagcttcaagagagcttcaaagtccattctatcctttttta 772-792 
(KD) 
BglII 
Rev agcttaaaaaaggatagaatggactttgaagctctcttgaagcttcaaagtccattctatcccga HindIII 
ULK2 
≠3 
Fw gatctcggctcaccatcttgtcgctttgttcaagagacaaagcgacaagatggtgagctttttta 894-914 
(SPD) 
BglII 
Rev agcttaaaaaagctcaccatcttgtcgctttgtctcttgaacaaagcgacaagatggtgagccga HindIII 
ULK2 
≠4 
Fw gatcttccgcatagaacagaatcttatactcgagtataagattctgttctatgcgtttttggaaa 1235-1255 
(SPD) 
BglII 
Rev agcttttccaaaaacgcatagaacagaatcttatactcgagtataagattctgttctatgcggaa HindIII 
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2.13 Generated constructs 
Plasmids generated and used in this study.  
Vector backbone Insert Plasmid name 
AAV-FLAG/Strep 
(N-terminal/ 
C-terminal) 
ULK1/KD-ULK1 AAV-CMV-FLAG/Strep-ULK1  
AAV-CMV-FLAG/Strep-KD-ULK1  
ULK2/ KD-ULK2 AAV-CMV-FLAG/Strep-ULK2 
AAV-CMV-FLAG/Strep-KD-ULK2 
SV2A AAV-CMV/Synapsin-FLAG/Strep-SV2A 
SV2A AAV-CMV/Synapsin-SV2A-FLAG/Strep 
 - (Negative control) AAV- CMV/Synapsin-FLAG/Strep 
AAV-HA  
(N-terminal/ 
C-terminal) 
Copine VI AAV-CMV-Copine VI-HA 
SRPK2 (WT, DM, ΔSI, ΔNSI) AAV-CMV-HA-SRPK2  
VAPA AAV-CMV-HA-VAPA 
VAPB AAV-CMV-HA-VAPB 
AAV-GFP  
(N-terminal/ 
C-terminal) 
GFP-ULK2 AAV-CMV-GFP-ULK2 
SRPK2-GFP AAV-CMV-SRPK2-GFP 
SV2A- GFP AAV-CMV/Synapsin-SV2A-GFP 
CMV- FLAG/Strep 
(N-terminal/ 
C-terminal) 
Kinase dead-domain (ULK1) CMV-FLAG/Strep-KD-D-ULK1 
Kinase dead-domain (ULK2) CMV-FLAG/Strep-KD-D-ULK2 
Kinase domain (ULK1) CMV-FLAG/Strep-KD-ULK1 
Kinase domain (ULK2) CMV-FLAG/Strep-KD-ULK2 
Serine proline rich domain (ULK1) CMV-FLAG/Strep-SPRD-ULK1 
Serine proline rich domain (ULK2) CMV- FLAG/Strep-SPRD-ULK2 
C-terminal  domain (ULK1) CMV-FLAG/Strep-CTD-ULK1 
C-terminal  domain(ULK2) CMV-FLAG/Strep-CTD-ULK2 
ZF-PDZ (RIM1α) CMV-ZF-PDZ-FLAG/Strep 
C2A (RIM1α) CMV-C2A- FLAG/Strep 
C2A-C2B  (RIM1α) CMV-C2A-C2B-FLAG/Strep 
pGEX 
C2A domain (RIM1α) (WT, R844H, 
T812/814A) 
pGEX-C2A 
C2B domain (RIM1α) pGEX-C2B 
SRPK2 pGEX-SRPK2 
Major sperm protein domain (VAPA) pGEX-MSP-VAPA 
Coil coiled domain (VAPA) pGEX-CC-VAPA 
Major sperm protein domain- Coil 
coiled domain (VAPA) 
pGEX-MSP-CC-VAPA 
pAMU6 shRNA (ULK2)  
 
2.14 Plasmids obtained from other sources and used in this thesis 
Source Plasmid name
Gyorgy Lonart (EVMS, Norfolk, USA) CMV-RIM1α 
Ngo Jacky (Hong Kong, China) SRPK2 (human): WT, DM, ΔSI, ΔNSI 
Open Biosystems – Thermo Scientific 
ULK1 (Image clones-ID:6406755) 
ULK2 (Image clones-ID:5709559) 
VAPA (Image clones-ID:3490082) 
SRPK2 (Image clone-ID: 4507346) 
Copine VI (Image clones-ID:6591063) 
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2.15 Primary and secondary antibodies 
Primary Antibodies 
Antibody Assay Dilution Company 
α-Tubulin DM1A (ab7291) IB 1:1000 Abcam 
Bassoon (clone SAP7F407) IF 1:200 Enzo Life Science 
Copine VI IF 1:100 Ege Kavalali 
FLAG M2 (F1804) IB/IF 1:1000/1:200 Sigma 
GFP (ab290) IB/IHC 1:5000/1:500 Abcam 
HA.11 (Clone 16B12) IB/IF 1:1000/1:100 Convance 
PSD95 (K28/43) IF 1:200 NeuroMab 
RIM1/2 IB/IF 1:1000/1:200 BD Bioscience 
RIM1/2 (115.IT) IB/IF 1:1000/1:600 Frank Schmidt 
SRPK2 (bs-7923R) IF 1:100 Bioss 
SRPK2 (23) IB/IF 1:1000/1:100 Santa Cruz 
SV2A (119002) IB/IF 1:1000/1:200 Synaptic Sytems 
Synapsin 1/2(106004) IF 1:200 Synaptic Sytems 
Synaptotagmin 1 (105011) IB 1:1000 Synaptic Sytems 
ULK1 (ab65056) IF 1:100 Abcam 
ULK1 (OAAB05707) IF 1:100 Aviva 
ULK1 (bs-3602R) IF 1:100 Bioss 
ULK1 (D8H5) IF 1:100 Cell Signalling 
ULK2 (ab97695) IF 1:100 Abcam 
ULK2(PA5-22173) IF 1:100 Pierce 
VAPA (H-20) IB/IF 1:1000/1:100 Santa Cruz 
VAPB (H-20) IF 1:100 Santa Cruz 
    
Secondary Antibodies 
Antibody Assay Dilution Company 
Alexa Fluor 488 goat anti-mouse IF 1:200 Life Technologies 
Alexa Fluor 568 goat anti-rabbit IF 1:200 Life Technologies 
Alexa Fluor 488 goat anti-rabbit IF 1:200 Life Technologies 
Goat anti-guinea pig Cy5 IF 1:400 Jackson immunoreagents Europe Ltd 
Goat anti-mouse Cy5 IF 1:400 Jackson immunoreagents Europe Ltd 
Goat anti-mouse FITC IF 1:400 Jackson immunoreagents Europe Ltd 
Goat anti-rabbit Cy3 IF 1:400 Jackson immunoreagents Europe Ltd 
Goat anti-rabbit FITC IF 1:400 Jackson immunoreagents Europe Ltd 
IRDye goat anti-mouse 800nm IB 1:10000 Li-cor 
IRDye goat anti-rabbit 680nm IB 1:10000 Li-cor 
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3. Methods 
3.1 Molecular Biology 
3.1.1 RNA extraction and cDNA synthesis 
mRNA was extracted from total or from different regions (cortex, hippocampus) of  mouse or 
rat brain using Dynabeads mRNA direct kit (Life Technologies), according to the 
manufacturer’s instructions. 1μg of mRNA was necessary for cDNA synthesis, using oligodT 
(First-strand cDNA Synthesis, Thermo Scientific). The resulting cDNA was used in further 
PCR reactions. 
 
3.1.2 Polymerase chain reaction (PCR) 
The following standard PCR protocol (Table 3.1) and program (Table 3.2) were applied to 
amplify different fragments, which were further used in cloning techniques. The only 
differences resided in the annealing and the strand elongation steps that were adjusted 
according to the product length and primers Tm. PCR primers are listed in section 2.8. 
 
Table 3.1A: PCR protocol 
Final concentration 
1x Buffer with MgSO4  
200µM dNTP 
0.3µM Primer Fw 
0.3µM Primer Rev  
2.5 U pfu DNA polymerase (Thermo Scientific) 
50-500ng DNA 
dH2O to a final volume of 50μl 
 
Table 3.2: PCR program 
Step Temperature Time Cycle 
1- Denaturation 95°C 5 min 1x 
2- Denaturation 95°C 30 sec 
35x 3- Annealing 55°C 40 sec 
4- Elongation 72°C 2min/1kb 
5- Final elongation 72°C 10 min 1x 
 4°C ∞ 1x 
 
3.1.3 Site directed mutagenesis 
Single point mutations were introduced using QuickChangeII XL Site Directed Mutagenesis 
kit (Stratagene). The applied PCR protocol and program were according to the manufacturer’s 
instructions. Primers for site direct mutagenesis are listed in section 2.10. 
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3.1.4 Sequencing 
The sequencing of DNA plasmids was performed using BigDye Terminator v3.1cycle 
sequencing kit (Applied Biosystems) and specific sequencing primers (section 2.9), followed 
by product purification (DNA Clean and Concentration kit, Zymo Research) and analysis 
(capillary sequencer, Applied Biosystems 3130/xl/Genetic Analyser). The sequencing results 
were analysed with BioEdit Sequence Alignment Editor v.7 and with BLAST from NCBI. 
 
3.1.5 Cloning technique 
The PCR products, purified from agarose gels (Zymoclean Gel DNA recovery kit, Zymo 
Research), and the vectors were digested with specific restriction enzymes (section 2.8). 
Subsequent to digestion, both the insert and the dephosphorylated vector backbone were 
cleaned with DNA Clean and Concentration kit and ligated using the T4 DNA Ligase at 
16°C/ON or 22°C for 2-3h. For a complete list of generated constructs see section 2.13. The 
ligation reaction was used to transform chemically competent bacteria; 5-6 colonies from the 
agar plates were picked and incubated in 5ml LB-medium with appropriate antibiotic. 24h 
later DNA was extracted with the GeneJET Plasmid Miniprep kit and the presence of the 
insert was analysed with restriction enzymes followed by sequencing.  
 
3.1.5.1 Oligonucleotides cloning  
Oligonucleotides (sections 2.11 and 2.12) were annealed and phosphorylated at the 5’-end 
using the T4 polynucleotide kinase. Next, the DNA oligonucleotides were extracted using 
phenol-chloroform (Molecular Cloning, Sambrook) and precipitated in the presence of 
sodium acetate (3M) and ethanol (99.9%) at -80°C/ON. After precipitation, DNA was 
pelleted at 14.000rpm/1h/4°C and the pellet washed one time in 70% ethanol and eluted in 
10μl water. For ligation 1μl of annealed oligonucleotides was used in the presence of 
dephosphorylated vector backbone and T4 DNA Ligase. The ligation reaction was performed 
at 16°C/ON. The presence of the insert was verified in the same manner as previously 
described in cloning technique section 3.1.5. 
 
3.2 Cell Culture  
3.2.1 HEK (AAV) 293T cell culture 
Human embryonic kidney-293 cells (HEK293T or AAV293) were maintained in DMEM 
medium supplemented with penicillin/streptomycin (100units/ml penicillin and 100mg/ml 
streptomycin) and 10% FCS (fetal calf serum) in a humidified incubator at 37°C and supplied 
with 5% CO2. Splitting was performed every 3 days.aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
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3.2.2 HEK (AAV) 293T transfection methods  
3.2.2.1 Ca2+-phosphate method 
For transfection, cells were seeded at a density of 1.5 x 106 cells/10cm dish and allowed to 
reach 50-60% confluence. 4h prior to transfection, DMEM medium was exchanged with 
IMDM medium, supplemented with 5% FCS. 2xHEBS (50mM HEPES, 280mM NaCl, 
1.5mM Na2HPO4, pH 7.05) buffer was added to the transfection mixture containing water, 
CaCl2 and DNA (Table 3.3), under vortexing in a drop-wise fashion, and further incubated for 
2 minutes, to allow complex formation. 
 
Table 3.3: Transfection protocol 
Components Amounts 
dH2O  1.1 ml 
CaCl2 (2.5 M) 145 μl 
DNA plasmid 4-5 μg 
2x HEBS (pH 7.05)  1.6 ml 
 
The newly formed precipitate was quickly added drop-wise in a circular motion to the 
cells. After 24h the medium was replaced with fresh DMEM supplemented with 10% FCS 
and Pen/Strep and further incubated at 37°C and 5% CO2. 48h post-transfection the cells were 
ready for harvesting. 
 
3.2.2.2 Lipofectamine method 
For shRNA transfection, the cells were seeded in a 12 well plate at a density of 1.5 x 104 
cells/well. shRNA encoding plasmids and the DNA plasmids were co-transfected in a ratio of 
(µgr) 1:1, 1:3 and 1:6 using Lipofectamine2000 (Life Technologies) according to the 
manufacturer’s instructions. 72h post-transfection, the cells were harvested and prepared for 
SDS-PAGE. 
 
3.2.3 Neuronal primary cell culture 
3.2.3.1 Generation of primary cell culture 
The hippocampal and cortical neurons were prepared from rat and mouse embryos (E18/E19). 
Different brain regions (hippocampus or cortex) were trypsinized in HBSS, using trypsin to a 
final concentration of 0.25% for 20min/37°C. After trypsinization, the tissue was washed 3-5 
times with HBSS and dissociated in 200μl DNaseI, passing the suspension 3-4 times through 
small size needles. Cells were counted (Table 3.4) and platted on poly-D-lysine pretreated 
glass coverslips (24-well plate) or on 6-wells plate in BME medium supplemented with: 1% 
FCS, 1% glucose (45%), 2% B27 and 0.5mM L-glutamine. After 24h the medium was 
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replaced with fresh DMEM medium and the neuronal cell culture incubated at 37°C/5% CO2 
for 2-3 weeks until ready to be used in experiments. 
 
Table 3.4: Counted cells per well 
Plate type Number of cells/ well 
6-well plate 120 000 cells 
24-well plate 30 000-32 000 cells 
 
3.2.3.2 Transfection of neurons 
Primary cortical and hippocampal neurons were transfected at DIV4-6 according to the 
protocol of Köhrmann et al. (1999). Neurons transfection was performed in pre-warmed 
MEM medium, while the original medium was set aside in the incubator. 1.5μg of endofree 
DNA, 30μl CaCl2 (250mM) and 30μl BES (280mM NaCl, 1.5mM Na2HPO4, 50mM BES, pH 
7.11 to 7.14) were vortexted for 20sec. and quickly added to the neurons. The neurons were 
incubated for 30-40min at 2.5% CO2. When the precipitates became visible under the 
microscope, neurons were washed twice with pre-warmed HBS (135mM NaCl, 4mM KCl, 
1mM Na2HPO4, 2mM CaCl2, 1mM MgCl2, 10mM glucose, 20mM HEPES, pH7.35), one 
time with BME and after that the original medium was added. Transfected neurons were kept 
at 37°C and 5% CO2 until DIV14, when they were prepared for immunocytochemistry. 
 
3.2.3.3 Infection of neurons 
Primary cortical neurons (24-well plate) were infected at DIV2-6 with 1-10μl crude viral 
particle extracts (rAAV serotype 1/2) per well. The infected neurons were further maintained 
at 37°C and 5% CO2 until DIV14 or 21, when ready for immunocytochemistry. 
 
3.3 Virus Production 
3.3.1 rAAV serotype 1/2 and 8 production (Ca2+-phosphate method) 
The transfection protocol was based on the Ca2+-phosphate method described above (section 
3.2.2.1), with some small additions, according to the following table 3.5.  
Table 3.5: Transfection mixture amounts: per 10/15 cm dish 
Components Serotype 1/2 
(10 cm dish) 
Serotype 8 
( 15 cm dish) 
dH2O  1.1 ml 2.4 ml 
CaCl2 (2.5 M) 145 μl 330 μl 
AAV plasmid 5.5 μg 5 μg 
pFdelta6- helper virus 11 μg 10 μg 
pNLrep / pRV1- serotype 1 2.75 μg - 
pH21- serotype 2 2.75 μg - 
p5E18-VD2/8 - 5 μg 
2x HEBS - added under vortexing 1.6 ml 2.6 ml  
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48h post-transfection cells were harvested in 1ml DMEM and frozen at -80°C. The 
cells were disrupted by three cycles of freezing-thawing, followed by a short spin to pellet the 
cellular debris. The supernatant containing the viral particles was kept at 4°C until further use. 
 
3.3.2 rAAV serotype 8 purification  
HEK293T cells were transfected using the Ca2+-phosphate method (sections 3.2.2.1 and 3.3.1) 
with p5E18-VD2/8 (AAV2 rep and AAV8 cap), pFdelta6 and the AAV plasmid. After 48h, 
cells were harvested in medium and centrifuged at 1.200rpm/20min. The pellet was 
resuspended in 10ml lysis buffer (150mM NaCl, 50mM Tris-HCl, pH 8.5) and three cycles of 
freezing-thawing were performed. In order to get rid of nucleic acids, 20μl benzonase 
(50U/ml suspension) was added to the lysate and incubated for 30min at 37°C. After the 
incubation, the suspension was centrifuged at 4.000rpm/30min/4°C and the clear suspension 
collected. The purification of the virus was performed using four layer discontinuous 
iodixanol gradients (ZOLOTUKHIN et al., 2002). The gradients were layered (Table 3.6) in 
ultracentrifuge tubes (Sorvall) using a peristaltic pump (P-1).  
 
Table 3.6: Iodixanol gradients 
Components  15% Iodixanol 25% Iodixanol 40% Iodixanol 54% Iodixanol 
PBS 10x 5 ml 5 ml 5 ml 5 ml 
Iodixanol 12.5 ml 20 ml 33.3 ml 45 ml 
NaCl 5M 10 ml - - - 
KCl 2.5M 50 μl 50 μl 50 μl 50 μl 
MgCl2 1M 50 μl 50 μl 50 μl 50 μl 
0.5% Phenol red  75 μl 75 μl - 75 μl 
H2O 22.3 ml 24.9 ml 11.6 ml - 
Volume used for one gradient 
 8-9 ml 5-6 ml 5 ml 2-4 ml 
 
The cellular suspension (8-9ml) was layered on top of the iodixanol gradients; the 
tubes were sealed, and centrifuged at 60.000rpm/2h/4°C (fixed angle rotor T865, Thermo 
Scientific). rAAV particles were recovered from the 40% iodixanol layer and iodixanol was 
removed by several rounds of washing with PBS, using the Amicon centrifugal filters. The 
purity of the virus was determined by SDS-PAGE and Coomassie staining.  
 
3.3.3 P0-P3 animal injection 
New-born C57/BL6 mice were anesthetized for 30-40sec. on ice, followed by injection of 1µl 
purified rAAV, serotype8 in each hemisphere (2µl/brain). Injection was performed using a 
10µl Hamilton syringe at a rate of 451nl/sec. After two to four weeks, mice were anesthetized 
with Isofluran and brains extracted and used for crude synaptosome preparation (section
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 3.4.1). All experiments were performed in agreement with the regulations of the University 
of Bonn Medical Centre Animal Care Committee.  
 
3.4 Biochemistry  
3.4.1 Preparation of crude synaptosomes  
The preparation was performed at 4°C using detergent free equipment and buffers 
supplemented with proteinase inhibitors (Roche). C57/BL6 mice (6-8 weeks old) were 
euthanized with Isoflorane, decapitated and the brains extracted. The cerebellum together with 
the most of the white matter was removed. Both hemisphere were homogenized in ice-cold 
homogenization buffer (0.32M sucrose, 50mM EDTA, 2mM HEPES, pH 7.4), supplemented 
with proteinase inhibitor (Roche) in a Teflon-glass homogenizer (7strokes, 900rpm), followed 
by centrifugation at 3.000g/15min/4°C. The pellet (P1-nuclear fraction) was removed and the 
supernatant (S1-crude synaptosomal fraction) transferred into 2ml eppendorf tubes and 
centrifuged at 14.000rpm/25min/4°C. The synaptosomal cytosol fraction (S2) was discarded 
and the pellet (P2-crude synaptosomes) resuspended in either 500μl lysis buffer (CL114 
detergent, Logopharm) or 100μl equilibration Krebs-Henseleit-HEPES buffer (118mM NaCl, 
3.5mM KCl, 1.25mM CaCl2, 1.2 mM MgSO4, 1.2mM KH2PO4, 25mM NaHCO3, 11.5mM 
glucose and  5mM HEPES-NaOH, pH 7.4).  
In the case of SV2A protein purification, P0-P3 mice were injected with purified 
rAAV (serotype 8) and after several weeks crude synaptosomes were prepared as described 
above. The P2 fraction was resuspended in lysis buffer (50mM Tris-HCl, 150mM NaCl, pH 
7.5) supplemented with proteinase, phosphatase inhibitors and 3.9mM n-dodecyl-β-maltoside 
(DDM, specific detergent for SV2A) as previously described by Lambeng et al. (2006). After 
1h incubation at 4°C the solution was clarified by centrifugation and the supernatant used for 
immunoprecipitation (section 3.4.2.4) or TAP purification (section 3.5.2). 
 
3.4.2 Protein-protein interaction assays 
3.4.2.1 Protein induction and purification from BL21 bacteria 
pGEX plasmids encoding for the protein of interest were retransformed in Escherichia coli 
BL21 (DE3). At an optic density (OD) of 0.6-0.8 of the bacterial culture, the expression of the 
GST-fusion proteins was induced by addition of IPTG (1mM) for 3-4h, under constant 
shaking at 37°C. After a centrifugation step at 4.500rpm/30min/4°C the bacterial pellet was 
resuspended in PBS supplemented with proteinase inhibitor (Roche) and lysozym (1mg/ml) 
and lysed on ice for 20min, followed by sonication and centrifugation at 4.500rpm/1h/4°C. To 
capture the protein of interest the clear supernatant was incubated for 1h with prewashed 
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Glutathion-agarose beads. Beads were extensively washed and resuspended in 1ml of PBS 
supplemented with proteinase inhibitors to reach 50% slurry, further used in GST-pull down 
assay (section 3.4.2.2). In order to check the efficiency of protein induction a small aliquot 
was analyzed by Coomassie staining. 
 
3.4.2.2 GST-pull down assay 
To analyse the binding of different GST-fusion proteins to native or overexpressed proteins, 
GST-pull down assays were performed with crude synaptosomes (section 3.4.1), primary 
cortical neurons and with transfected HEK293T cells by the Ca2+-phosphate method (section 
3.2.2.1). HEK293T cells were lysed for 1h in ice-cold lysis buffer (50mM HEPES pH 7.4, 
150mM NaCl, 1% Triton X-100, Complete Protease Inhibitor Cocktail Tablets), spun at 
14.000rpm/10 min/4°C and the resulting clear supernatant was incubated for 1-2h with GST 
and GST-fusion proteins. Beads were washed five times with PBS-0.5% Triton X-100 
washing buffer, boiled at 95°C/5min in Laemmli buffer with β-ME and resolved in SDS-
PAGE gel. GST and GST-fusion proteins were incubated also with lysed crude synaptosomes 
or lysed cortical neurons for 2-4h. Bound protein complexes were washed with either CL-114 
dilution buffer or PBS-0.5% Triton X-100, boiled in Laemmli buffer with β-ME at 95°C/5 
min and resolved in SDS-PAGE gel. 
 
3.4.2.3 Co-immunoprecipitation (co-IP) 
HEK293T cells were co-transfected with DNA plasmids containing the sequence encoding for 
the proteins of interest using the Ca2+-phosphate method as described in section 3.2.2.1. 48h 
post-transfection the medium was discarded and the cells harvested in ice-cold lysis buffer 
(50mM HEPES pH 7.4, 150mM NaCl, 1% Triton X-100, Complete Protease Inhibitor 
Cocktail Tablets) and lysed on ice for 1h, followed by a short centrifugation step at 
14.000rpm/10min/4°C. The supernatant was incubated at 4°C with pre-washed (in PBS) 
magnetic beads for 1h (FLAG M2 beads) or for 2-3h (HA- or GFP-magnetic beads) on a 
rotator. After the incubation time, the beads containing the protein complexes were washed 
with PBS-0.5% Triton X-100 buffer. The beads were boiled in Laemmli buffer with β-ME at 
95°C/5 min and proteins resolved in SDS-PAGE gel (8% or 10%). 
 
3.4.2.4 Immunoprecipitation (IP) 
The P0-3 C57/BL6 mice were injected into the hemisphere with 2µl of purified virus (rAAV-
SV2A-GFP, serotype 8) and two weeks after the injection crude synaptosomes were prepared 
(section 3.4.1). After the P2 fraction was solubilised, the clear supernatant was mixed for 2-3h 
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with anti-GFP antibodies (abcam 290). The antibodies were collected overnight by incubation 
with protein A/G-agarose beads (Santa Cruz). The A/G-agarose beads were collected by 
centrifugation at low speed (2.000 rpm/5 min), washed five times in PBS and boiled in 
Laemmli buffer with β-ME at 95°C/5 min. 
 
3.4.3 Protein concentration determination 
The protein concentration was determined by measuring the optical density at 260nm using 
NanoDrop. For shRNA testing, the protein concentration of all samples was adjusted to the 
lowest one, before analysing by WB. In binding assays the protein concentration of the crude 
synaptosomes was adjusted to 3-5mg/ml/reaction. 
 
3.4.4 Western Blotting (WB) 
Prior to WB, samples were resolved in 8% or 10% SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) and separated by size. The separated proteins were transferred to nitrocellulose 
membrane, followed by protein detection. The membranes were blocked with 3% cold water 
fish gelatin in PBS for 1h, incubated with primary antibodies in blocking buffer for 2h, 
washed three times/15min with PBS-0.1% Tween 20 and further incubated with secondary 
antibodies (IRDye-1:10000, section 2.15) for 40min. The detection was achieved with an 
infrared imaging system (Odyssey, Li-cor). 
 
3.5 Identification of novel binding partners by tandem-affinity purification (TAP) 
3.5.1 Protein cross-linking 
Cultured cortical neurons (DIV2) obtained from wild-type (WT), SV2A +/- and SV2A -/- 
mice were infected with crude viral particles, serotype 1/2, expressing N- or C-TAP-tagged 
SV2A. At DIV14 neurons were washed one time with PBS and proteins were cross-linked 
using three different cross-linkers (Table 3.7): 1% formaldehyde (VASILESCU et al., 2004; 
KLOCKENBUSCH and KAST, 2010), 5mM DSP (dithiobis(succinimidylpropionate), Pierce), 5mM 
DTBP (dimethyl 3,3’-dithiobispropionimidate-2HCl, Pierce). The protein cross-linking was 
performed at room temperature or at 37°C/30-60 min, followed by quenching the reaction 
with 50mM Tris, pH 7.5 or 2.5mM glycine for 5-15min. Cells were lysed either in HEPES 
buffer (50mM HEPES, 150mM NaCl, pH 7.4) or in Tris-HCl buffer (50mM Tris-HCl, 
150mM NaCl, pH 7.4) supplemented with proteinase, phosphatase inhibitors and 3.9mM n-
dodecyl-β-maltoside (DDM) for 1h/4°C. The clear supernatant was subject to either one-step 
or tandem purification as described below (section 3.5.2), with only one difference: the 
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elution was performed by boiling the beads in the presence of β-ME reducing agent at 95°C/5 
min before SDS-PAGE. 
 
Table 3.7: Cross-linkers 
Cross-linker Functional 
group 
targeted 
Cleavable Solubility Permeability Arm 
length 
Formaldehyde 
Amine to 
amine 
Yes /95°C Water soluble 
Membrane 
permeable 
2 Å 
DSP Yes/ β-ME/95°C 
thiol-cleavable  
Organic 
solvents 12 Å 
DTBP Yes/DTT/37°C 
thiol-cleavable  
Water soluble 11.9 Å 
 
3.5.2 Strep/FLAG tandem affinity purification  
Tandem affinity purification (Fig.3.1) is based on the protocol previously described by 
Glockner, C.J., et al. (Current Protocols in Protein Science, Unit 19.20, 2009). Briefly, crude 
synaptosomes (section 3.4.1) or infected neurons (section 3.2.3.3) were lysed under native 
conditions using cold lysis buffer (50mM Tris-HCl, 150mM NaCl, pH 7.5) supplemented 
with proteinase inhibitors and/or phosSTOP (Roche), and 3.9mM n-dodecyl-β-maltoside 
(DDM). Clear supernatant was applied directly to the Strep-Tactin MacroPrep columns (IBA). 
After the adsorption, the column was washed five times with buffer W (100mM Tris-HCl, pH 
8.0, 150mM NaCl, 1mM EDTA) and elution performed with buffer E (100mM Tris-HCl, pH 
8.0, 150mM NaCl, 1mM EDTA, and 2.5mM desthiobiotin). From each collected fraction a 
small aliquot was kept for further analysis by WB. All operations were performed either at 
4°C or at room temperature.  
In the case of two-step purification all elution fractions were pooled and mixed with 
anti-FLAG M2 affinity gel (A2220, Sigma) or anti-FLAG M2 magnetic beads (M8823, 
Sigma) for 1h/4°C. Beads were washed several times with TBS (Tris buffered saline) 
supplemented with DDM and elution was performed with: (a) 200µg/ml FLAG peptide 
(F3290, Sigma) in TBS for 10-30min; (b) 1M Arg-HCl pH 3.5 in TBS (FUTATSUMORI-SUGAI et 
al., 2009)  or (c) SDS-PAGE sample buffer and boiled at 95°C/5 min.  
In one-step FLAG purification, the clear supernatant resulted from neurons’ lysis was directly 
incubated for 1h with anti-FLAG M2 beads, followed by the same washing and elution steps 
as described above.  
For sample concentration, Amicon Ultra Centrifigal filters (Milipore, MWCO, 3000) 
were used (optional step). Proteins were separated in SDS-PAGE and the gel stained with 
Coomassie Colloidal Blue according to the manufacturer’s instructions (Carl Roth). 
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3.5.3 Protein purification from HEK293T cells 
HEK293T cells transfected with the FLAG/Strep-tagged truncated form of RIM1α (ZF-PDZ 
and C2A-C2B domains) were lysed for 1h in ice-cold lysis buffer (50mM HEPES, pH 7.4, 
150mM NaCl, 1% Triton X-100, Complete Protease Inhibitor Cocktail Tablets), centrifuged 
at 14.000rpm/10min/4°C and the resulted supernatant was incubated for 1h with pre-washed 
FLAG-M2 magnetic beads. The beads were washed five times with lysis buffer and incubated 
with lysed crude synaptosomes. 
 
3.5.4 Binding assays between the different regions of RIM1α and crude synaptosomes 
Crude synaptosomes prepared as previously described (section 3.4.1) were pre-equilibrated 
for 10min/37°C in Krebs-Henseleit-HEPES buffer (118mM NaCl, 3.5mM KCl, 1.25mM 
CaCl2, 1.2mM MgSO4, 1.2mM KH2PO4, 25mM NaHCO3, 11.5mM glucose and 5mM 
HEPES-NaOH, pH 7.4) and studied under three treatment conditions for 15min/37°C: 
methanol control, Staurosporine (1μM) and 1xphosSTOP (Roche). After kinase or 
phosphatase inhibition, crude synaptosomes were lysed 1h/4°C in CL114 detergent (in the 
presence of the corresponding inhibitors), spun at 14.000rpm/20min/4°C and the supernatant 
incubated for 3-4h with purified ZF-PDZ and C2A-C2B domains of RIM1α, coupled to 
FLAG-magnetic beads. Subsequent to incubation, the magnetic beads were washed five times 
in CL114 dilution buffer and proteins denaturated at 95°C in 1x loading buffer (Life 
Technologies). Samples were separate by size in pre-cast NuPAGE4-12% Bis-Tris Gel, 
according to the manufacturer’s instruction (Life Technologies) and stained with Coomassie 
Colloidal Blue (CCB). 
 
3.5.5 Sample preparation for mass spectrometer analysis  
Bands were excised with a cleaned scalpel, placed in 0.5ml LoBind Eppendorf tubes and 
destained using destaining solution, containing 200mM ammonium hydrogencarbonate and 
40% acetonitrile (according to Sigma Protocol IGD profile kit). Gel pieces were dried using 
the vacuum concentrator for 30-40min/RT. For the maximum recovery of proteins, disulfuric 
bridges were reduced with 20mM DL-Dithiothreitol (DTT) in 100mM ammonium 
hydrogencarbonate for 30min/55°C and, the generated thiol groups were alkylated in the 
presence of 40mM iodoacetamide (IAA) in 100mM ammonium hydrogencarbonate for 
30min/RT/in the dark (aminocarboxymethylation). The solution was removed and the gel 
pieces were incubated 5min with 100mM ammonium hydrogencarbonate, further dehydrated 
two times (5min each) with 50% acetonitrile and one time (5min) with 100% acetonitrile, and 
completely dried in the vacuum concentrator. In the tryptic digestion step, performed 
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3.6 Immunochemical methods 
3.6.1 Pre-treatment of primary neurons with various inhibitors 
Rat primary cortical neurons were stimulated at DIV19-21 with different phosphatase 
inhibitors and at DIV12-14 with a specific inhibitor for SRPKs (table 3.8). As control the 
equivalent amount of methanol was used for Calyculin A and okadaic acid, DMSO for 
SRPIN340, while for phosSTOP, PBS was added to control cells (1 tablet of phosSTOP in 
1ml PBS to obtain a concentration of 10x).  
 
Table 3.8: Phosphatase and kinase inhibitors 
 Inhibitor Target Concentration Inhibition time 
Phosphatase 
Inhibitors 
Calyculin A  PP1, PP2A 2nM 30 min 
Okadaic acid  PP1, PP2A 10nM 60 min 
phosSTOP all 0.1x 60 min 
SRPK 
inhibitor 
SRPIN340 SRPK1 
SRPK2 
10µM 12-16h 
 
After the incubation time, neurons were washed 1x with PBS and fixed in 4% 
paraformaldehyde for 5min, followed by immunofluorescence (section 3.6.2). 
 
3.6.2 Immunofluorescence (IF) 
Transfected or infected neuronal cultures were fixed for 5min in 4% paraformaldehyde and  
4% glucose in PBS, permeabilised with 0.3% Triton X-100 and blocked for 1h/RT in 
blocking solution (10% BSA, 1% NGS, 0.1 Triton X-100 in PBS). Neurons were incubated 
with primary antibodies at 4°C/ON. Following the incubation, cells were washed three times 
with PBS and incubated with the secondary antibodies (section 2.15) for 40min/RT/in dark. 
Subsequently to PBS washing, cover-slips were mounted in Mowiol (Sigma) and let to dry 
O.N.  
 
3.6.3 Immunohistochemistry (IHC)  
Brains were fixed in 4% paraformaldehyde and embedded in paraffin blocks. 4µm brain slices 
were deparaffinised in xylene and rehydrated in a series of ethanol baths (100%, 95% 70% 
and 50% in PBS) for 2min each. Heat mediated antigen retrieval was performed in citric 
buffer (10mM citric acid, pH 6.0), microwaved for 10min and cooled for 30min/RT. Slices 
were blocked in PBS with normal goat serum (1:100 to 1:200) and 10% fetal calf serum for 
2h in a humidified chamber, followed by incubation with anti-GFP (ab290, 1:100), anti-
FLAG (1:100, Sigma) and anti-SV2A (1:200, 119002 SySy) primary antibodies overnight. 
After several washings with PBS, secondary antibodies goat anti-mouse FITC and goat anti-
rabbit Cy3 (Jackson ImmunoResearch) were applied at a concentration of 1:400 and
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incubated for 2h in the dark. Several washing steps with PBS were followed by mounting the 
samples with Vectashield mounting medium containing DAPI (Vectorlabs).  
 
3.7 Imaging 
Images were acquired with a laser scanning Nikon A1/Ti confocal microscope using a CFI 
Plan APO IR 60x WI objective (NA 1.27), Nikon NIS-Elements 4.0 acquisition software or 
by using a confocal microscope Olympus FV1000, UPLS Apo60X WUIS2, 1.2 NA objective. 
IHC pictures were taken using a Zeiss Axio Observer A1 inverted microscope with a Plan-
Apochromat 20x NA 0.8 air objective. 
 
3.8 Quantifications and statistical analysis  
3.8.1 Image quantification 
Bouton size quantification was performed in ImageJ program. The maximal brightness was 
determined by subtracting the background (rolling ball radius of 1/3 of the pixel width of the 
image). A 30% threshold value was applied to all compared pictures, and the number of 
synapses counted. The pixel number, obtained for each synapse, was multiplied with the pixel 
size to obtain the area of each bouton. Obtained values were binned in 0.2- steps ranging from 
0.2 to 2-2.5µm2. Co-localization analysis was performed using the JACOp plug-in in ImageJ, 
and measuring Pearson’s coefficient. Statistical analysis was performed either in Excel or in 
GraphPad Prism 6.  
 
3.8.2 WB quantification 
Images of the WB were quantified using the ImageJ program. Statistical analysis was 
performed in GraphPad Prism 6.  
 
3.9 Programmes and URLs 
ImageJ  
GraphPad Prism 6 
BioEdit v.7.1.3.0 
Seqbuilder v.8.0.2 
http://www.uniprot.org 
http://www.ncbi.nlm.nih.gov 
http://www.matrixscience.com 
http://www.insilico.uni-duesseldorf.de (Ligation calculator) 
http://www.bioinformatics.org/primerx (Designing primers for point mutations) 
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4. Results 
4.1 Impact of phosphorylation status on the properties of RIM1α  
It has been proposed that regulated phosphorylation/dephosphorylation events may play a role 
in plasticity- induced remodelling of established active zones, as well as in the assembly of 
new ones. The active zone protein RIM1α, a scaffolding multidomain protein, has been shown 
to be the substrate of two kinases, ERK2 (SIMSEK-DURAN and LONART, 2008) and PKA (LONART et 
al., 2003) and contains a large number of yet uncharacterized potential phosphorylation sites. 
Nevertheless, the impact of RIM1α phosphorylation on active zone reorganisation and 
function is not well understood. Moreover, such posttranslational events may impact the 
binding affinity of RIM1α to some of its binding partners, and subsequently trigger, directly 
or indirectly, a cascade of events culminating in the reorganization of active zone architecture 
and changes in synaptic activity.  
4.1.1 Distribution of RIM1α in synaptic boutons is altered by hyperphosphorylation events 
Both the UPS-system (JIANG et al., 2010) and the transcriptional/translational machinery 
(LAZAREVIC et al., 2011) have been suggested to control the level of RIM1α at the active zone. In 
addition, phosphorylation events may as well affect RIM1α’s activity (Fig. 4.1).  
 
Figure 4.1: Regulation of RIM1α interactions by phosphorylation and dephosphorylation. In vivo, under 
normal physiological conditions, the activity of the cell dictates the phosphorylation state of RIM1α. 
Phosphorylation of various amino acid residues may have a direct influence on the affinity of protein interactions 
of RIM1α. In a simplified model, RIM1α is phosphorylated and binds certain proteins (Y, blue). By applying a 
phosphatase inhibitor, the equilibrium is moved toward a hyperphosphorylated state and RIM1α may interact 
with additional proteins (Z, pink). By blocking kinase activity, RIM1α may lose some of its binding partners and 
bind new ones (X, violet). For the simplicity of the model, the influence of other posttranslational modifications 
has not been taken into the account.   
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followed by affinity purification and LC-MS/MS. Four independent experiments were 
performed, and each resulted in similar band pattern after Coomassie Colloidal Blue (CCB) 
staining (Fig. 4.5).  
 
Figure 4.4: Experimental approach to identify phospho-dependent binding partners for RIM1α. The N- 
and C-terminal regions of RIM1α, fused to a FLAG/Strep-affinity tag and the respective control (tag alone) were 
overexpressed in HEK293T cells. After purification proteins were incubated with lysed mouse crude 
synaptosomes, in the presence of  1μM staurosporine, 1x phosSTOP, and the equivalent amount of methanol, as 
negative control. Samples were separated by SDS-PAGE. Bands were excised from the gel, digested with 
trypsine O.N. and peptides analysed by LC-MS/MS. 
 
 
 
Figure 4.5: Separation by SDS-PAGE of protein complexes from crude synaptosomes bound to either the 
N-terminal region (N) or C-terminal region (C) of RIM1α. After elution, co-immunoprecipitated proteins 
were separated in NuPAGE 4-12% Bis-Tris and visualized by Coomassie Colloidal Blue (CCB) staining. Each 
lane was cut in 8 small pieces and prepared for mass spectrometry according to the protocol (n=4). 
 
4.1.2.1 Identification of protein complexes associated with the C-terminal region of RIM1α 
Four independent experiments were performed using lysed crude synaptosomes and the C2A-
C2B region of RIM1α, overexpressed and purified from HEK293T cells. Immunopurified 
protein complexes were separated by SDS-PAGE and identified by mass-spectrometry. Three 
groups were analysed: control, staurosporine and phosSTOP. As negative control for 
unspecific binding, the FLAG-tag sequence alone was purified with FLAG magnetic beads.  
The MS scores of treated samples were divided by the scores of negative samples 
(protein X – sample/protein X- control). Proteins with a ratio above 2- fold enrichment were 
considered to specifically bind RIM1α and not to the FLAG sequence or the magnetic beads. 
The remaining proteins were classified in five groups, according to their subcellular 
localization independent of the pharmacological treatment (Fig. 4.6A). A significant 
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Table 4.1: Identification of proteins interacting with the RIM1α C2A-C2B region. Proteins identified with a 
high score under different conditions are summarized in the table. Proteins were sorted according to their 
subcellular localization or function. *: best score from four independent measurements. Proteins of interest for 
this work are marked in bold italic. RIM1α, representing the input, is marked in italic. Proteins common for all 
three groups are marked in green, for staurosporine and phosSTOP in orange, control and phosSTOP in lila. 
  
Protein name Control* Staurosporine* phosSTOP* Function/Localization 
14-3-3 protein beta/alpha  3788 3634 4952 
 
Signalling cascades 
14-3-3 protein epsilon  7724 7543 8543 
14-3-3 protein eta  4456 4405 5467 
14-3-3 protein gamma 5111 4811 6860 
14-3-3 protein theta  5775 4945 5607 
14-3-3 protein zeta/delta  6153 5327 6806 
Calcineurin subunit B type 1 1371 1686 2307 
Calcium/calmodulin-dependent protein kinase type 
II subunit alpha 
419 2729 1028 
Calcium/calmodulin-dependent protein kinase type 
II subunit beta 
 1666 572 
Calcium/calmodulin-dependent protein kinase type 
II subunit delta 
 1445 560 
Calmodulin  154  
Casein kinase II subunit alpha 1343 1215 989 
Casein kinase II subunit alpha' 810 557 417 
Casein kinase II subunit beta 617 630 355 
Creatine kinase B-type 417 769 713 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
99 149 145 
RasGTPase-activating protein SynGAP  58 57 
Serine/threonine-protein phosphatase 2A catalytic 
subunit beta isoform 
166   
Serine/threonine-protein phosphatase 2B catalytic 
subunit alpha isoform 
3437 4129 4420 
Serine/threonine-protein phosphatase 2B catalytic 
subunit beta isoform 
2575 2576 3082 
Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform 
316 278 256 
SRSF protein kinase 2 169 71 266 
Rab GDP dissociation inhibitor alpha 101  58 
Septin-5 71  101 
AP-2 complex subunit alpha-2 191   
Synaptic vesicles 
AP-2 complex subunit beta 74 95 90 
Alpha-enolase 213  300 
Dynamin-1 144 109 403 
Gamma-enolase 201 405 337 
Ras-related protein Rab-3A  174 85 
Phosphoglycerate kinase 1 49  70 
Phosphoglyceratemutase 1  82 117 
Synapsin-1  124  
Synapsin-2   82 
Vesicle-associated membrane protein-associated 
protein A 
127 105 36 
V-type proton ATPase subunit B, brain isoform  156 124 
V-type proton ATPase subunit D  124 73 
Copine-6 747 574 423
  
A
ctive Z
one/ 
 
Plasm
a m
em
brane 
 
Excitatory amino acid transporter 1 381   
Excitatory amino acid transporter 2 382   
ERC protein 2  360  
Neuronal membrane glycoprotein M6-a  300 128 
Protein bassoon 395 782 623 
Protein piccolo 33 290 117 
Regulating synaptic membrane exocytosis protein 
1 (Input) 
11054 91764 114517 
Regulating synaptic membrane exocytosis protein 
2 
13665 3302 10679 
RIMS-binding protein 2 819 453 697 
Synaptosomal-associated protein 25  146 116 
Syntaxin-1A   141 
Syntaxin-1B  302  
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4.1.2.3 Analysis of the protein complexes co-purified with the overexpressed C-terminal 
region of RIM1α in primary cultured neurons  
In the previous MS data, obtained with crude synaptosomes, we identified several proteins as 
potential novel binding partners for RIM1α (Table 4.1 and 4.2, protein names are marked in 
bold italic). Therefore, to confirm these results, rat primary cortical neurons were further 
used. Primary neuronal cultures were chosen because the detection of endogenous proteins 
binding the overexpressed C-terminal region of RIM1α was more reliable.    
Rat primary cortical neurons were infected at DIV2 with rAAV (recombinant adeno 
associated virus) expressing only the C-terminal part of RIM1α and the FLAG-tag. Two 
weeks later C2A-C2B region was purified via FLAG-magnetic beads and bound protein 
complexes analysed by mass-spectrometry. The data was analysed as previously described in 
chapters 4.1.2.1 and 4.1.2.2. The highest number of proteins was found in the 
kinase/signalling group (26%) and in the CAZ (22%), excluding the group of others (Fig. 
4.8A; Table 4.3).  
Protein name Control* Staurosporine* phosSTOP* Function/Localization 
14-3-3 protein beta/alpha  3747 6375 4148 
Signalling cascades 
 
14-3-3 protein epsilon  8247 11102 8344 
14-3-3 protein eta  4243 6636 4681 
14-3-3 protein gamma 6227 9722 6737 
14-3-3 protein theta  3740 7859 5630 
14-3-3 protein zeta/delta  5091 8209 5650 
Calcium/calmodulin-dependent protein kinase 
type II subunit alpha 
1447 2421 1080 
Calcium/calmodulin-dependent protein kinase 
type II subunit beta 
684 1349 572 
Casein kinase II subunit alpha 2480 1974 1210 
Casein kinase II subunit alpha' 1242 1231 725 
Casein kinase II subunit beta 560 1161 527 
Guanine nucleotide-binding protein G(o) 
subunit alpha 
 435  
RasGTPase-activating protein SynGAP 125 495 92 
Serine/threonine-protein phosphatase 2A 
catalytic subunit alpha isoform 
186 240 252 
Alpha-enolase  213  Synaptic 
vesicle 
Ras-related protein Rab-15  80  
Synaptotagmin-1 73   
Vesicle-fusing ATPase 263 398  
V-type proton ATPase 116 kDa subunit a 
isoform 1 
 54  
V-type proton ATPase subunit E 1  224  
V-type proton ATPase catalytic subunit A 446  106 
ELKS/Rab6-interacting/CAST family member 
1 
1114 1349 1047 Plasm
a m
em
brane/ 
A
ctive Z
one (A
Z
) 
ERC protein 2 3179 5108 3790 
Protein piccolo 287 532 135 
Protein bassoon 1044 2078 783 
Protein unc-13 homolog A 175 558 174 
Regulating synaptic membrane exocytosis 
protein 2 
1764 2861 2175 
Sodium/potassium-transporting ATPase 
subunit alpha-3 
366   
Sodium/potassium-transporting ATPase 
subunit beta-1 
147   
Voltage-dependent anion-selective channel 
protein 2 
73 358  
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Table 4.3: Identification of binding proteins binding to the RIM1α C2A-C2B domain overexpressed and 
purified from rat primary cortical neurons. Proteins were grouped according to their subcellular localization 
or function. Proteins of interest for this work are marked in bold italic. In bold lila known binding partners for 
RIM1α are marked. 
 
Protein name Score Coverage Localization/Function 
14-3-3 protein beta/alpha 1450 31,71 
Signalling cascades 
14-3-3 protein epsilon 4005 63,53 
14-3-3 protein eta 2665 50,41 
14-3-3 protein gamma 2504 46,96 
14-3-3 protein theta 1561 42,86 
14-3-3 protein zeta/delta 2750 47,76 
Calcium/calmodulin-dependent protein kinase type II subunit alpha 655 18,2 
Calcium/calmodulin-dependent protein kinase type II subunit beta 565 24,17 
Calmodulin 84 30,87 
Casein kinase II subunit alpha 739 43,48 
Casein kinase II subunit alpha' 224 23,14 
Casein kinase II subunit beta 318 29,77 
Creatine kinase B-type 101 13,65 
Serine/threonine-protein kinase 38 101 6,88 
Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha 
isoform 
436 21,22 
Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform 179 12,94 
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform 2601 59,69 
Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform 3306 67,43 
SRSF protein kinase 2 92 6,75 
Alpha-enolase 359 13,82 
Synaptic vesicle 
Clathrin heavy chain 1 62 2,69 
Phosphoglyceratemutase 1 118 10,63 
Pyruvate kinase isozymes M1/M2 74 5,08 
Ras-related protein Rab-6A 85 10,58 
Triosephosphateisomerase 225 9,36 
Vesicle-associated membrane protein-associated protein A 636 41,37 
V-type proton ATPase catalytic subunit A 209 9,56 
V-type proton ATPase subunit B, brain isoform 243 21,72 
V-type proton ATPase subunit E 1 194 11,95 
Adenylyl cyclase-associated protein 1 41 7,59 Plasm
a m
em
brane/ A
ctive 
Z
one (A
Z
) 
Contactin-1 112 5,1 
Copine-6 682 26,39 
Liprin-alpha-2 583 10,1 
Liprin-alpha-3 296 8,53 
Neuromodulin 48 9,25 
Regulating synaptic membrane exocytosis protein 2 5325 3,01 
RIMS-binding protein 2 1018 31,06 
Synaptosomal-associated protein 25 229 21,36 
Syntaxin-1B 100 12,85 
Voltage-dependent anion-selective channel protein 1 279 7,09 
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4.1.3 Validation of the newly identified RIM1α binding proteins  
All filtered proteins were analysed by screening the uniprot4 and pubmed5 databases, for their 
possible functions/involvement in CAZ architecture. Based on this analysis, four candidate 
proteins were chosen to be further tested: two kinases (ULKs, SRPKs) involved in controlling 
active zone assembly in invertebrates (JOHNSON et al., 2009; NIERATSCHKER et al., 2009; WAIRKAR et 
al., 2009); VAPA/VAPB, proteins associated with bouton formation (PENNETTA et al., 2002), and 
Copine VI, whose function in synaptic plasticity has not been yet elucidated. 
 
4.1.3.1 Unc-51-like kinase (ULK) 
ULK1 and ULK2 that were the first time described in mouse by Yan et al. (YAN et al., 1998, 
1999), are protein kinases with a major role in autophagy (review: ALERS et al., 2012). Besides 
macroautophagy, ULKs play an important role in neurite outgrowth in cerebellar granular 
neurons (TOMODA et al., 1999).  
In invertebrates (C.elegans) the function of Unc-51 in axon guidance is tightly 
regulated by protein phosphatase 2A, which dephosphorylates proteins phosphorylated by this 
kinase (OGURA et al., 2010). Moreover, Unc-51 acts in presynaptic motorneurons in D. 
melanogaster, where it regulates the localization of Bruchpilot opposite to glutamate 
receptors. In its absence a decrease in synaptic density, accompanied by abnormal active zone 
composition and impaired neurotransmitters release was detected (WAIRKAR et al., 2009).  
So far, AZ protein substrates for ULK kinases have not been identified yet. In 
addition, the role of these kinases in the presynaptic terminal has not been fully elucidated. 
 
4.1.3.1.1 ULK proteins bind RIM1α 
Chromatography affinity coupled to MS analysis identified ULK2 to bind the biotin tagged 
C2 domain of RIM1α (Table 4.4). Although the score and the number of unique peptides were 
low, its association with CAZ and especially, with RIM1α protein was investigated, due to its 
involvement in controlling the assembly of the AZ in D. melanogaster (WAIRKAR et al., 2009). 
 
Table 4.4: ULK2 protein was identified to bind with C2A-C2B domain of RIM1α. The biotin tagged RIM1α 
C2-region was incubated with whole brain lysate and co-immunoprecipitated proteins were analysed by MS. 
Identification of ULK2 was performed using the human databank (international protein index). The generated 
score and the unique peptides are listed in table. 
  
                                                            
4 http://www.uniprot.org/ 
5 http://www.ncbi.nlm.nih.gov/pubmed 
Accession Number 
(UniProtKB) 
Gene name Score Unique 
peptides 
Type of experiments Description 
O75385 ULK2-Human 45 2 Co-IP (Biotin) unc-51-like kinase 2 
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To measure the degree of co-localization between the ULK kinases and the pre- and 
postsynaptic markers, pictures were analysed using the JACOp plug-in in the ImageJ software 
(BOLTE and CORDELIERS, 2006). The calculated Pearson’s coefficient indicated a high degree of 
co-localization between ULK1/2 kinases and the presynaptic proteins, Bassoon and RIM1/2. 
In addition, ULK1/2 seems to be present, even in higher amounts, in the postsynaptic site. 
This is suggested by a higher degree of co-localization between ULK1/2 and the postsynaptic 
marker, PSD95 (Fig. 4.14).  
 
 
 
Figure 4.14: Quantitative analysis of the co-localization of ULK1/2 with different synaptic markers. 
Pictures were analysed in ImageJ, measuring the Pearson’s coefficient (JACOp plug-in). Values in bars indicate 
the number of cells analysed. Statistical analysis was performed in GraphPad Prism6, performing one-way 
ANOVA (Kruskal-Wallis test), followed by Dunn’s multiple comparisons test. Bars show mean ± SEM. 
*p<0.05. 
 
4.1.3.1.4 Generation of a short-hairpin RNA against ULK2 
Biochemistry, as well immunofluorecence data suggest an interaction between RIM1α and 
ULK kinases. Therefore, to study the functional relevance of this interaction, shRNAs against 
ULK1 and ULK2, respectively, were designed and tested in HEK293T cells (Fig.4.15A). All 
four chosen shRNA efficiently knock-downed overexpressed FLAG-tagged ULK2. Three of 
these pairs had no effect on ULK1 protein levels, while pair no.4 reduced slightly the level of 
the ULK1 protein (Fig. 4.15B). Furthermore, these results were also confirmed by 
immunofluorescence using HEK293T cells (Fig. 4.15C). Overexpression of GFP-tagged 
ULK2 in HEK293T cells was accompanied by cells rounding up and detaching. These effects 
were abolished by shRNA-mediated knock-down of FLAG-tagged ULK2. 
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4.1.3.2.1 SRPK2 targets RIM1α 
The analysis of our mass-spec data revealed that SRPK2 kinase associated exclusively with 
the C2A-C2B region of RIM1α, under all experimental conditions (Table 4.5).  
In addition, co-immunoprecipitation of overexpressed FLAG-tagged RIM1α C2A-
C2B from rat primary cortical neurons followed by MS, also revealed its association with 
SRPK2 protein (MS score: 92,24).  
Experiments performed with crude synaptosomes showed the same affinity between 
the C2A-C2B domains of RIM1α and SRPK2 kinase, under all pharmacological treatments. 
However, in comparison to control and staurosporine conditions, application of phosSTOP 
increased the amount of the detected kinase. Therefore, the MS scores as well as the sequence 
coverage and the number of unique peptides were increased when phosphatase inhibitor was 
applied to mouse crude synaptosomes (Table 4.6, phosSTOP; Fig. 4.16A). RIM1α ZF-PDZ 
did not bind SRPK2 kinase. Therefore, this supports the specificity of the SRPK2 binding to 
the C2-domains of RIM1α.  
 
Table 4.5: Detection of the SRPK2 kinase as RIM1α binding protein by mass-spec under different 
experimental conditions. Mass scores are listed in correlation to various experimental conditions. Five 
independent experiments were performed.  
 
Accession 
Number 
(UniProtKB) 
Gene 
name 
Score Sequence 
coverage 
Unique 
peptides 
Type of experiments Description 
O54781 
SR
PK
2-
M
O
U
SE
 
92,24 6,75 4 Co-IP from neurons  
SRSF protein kinase 2 
32 4,41 2 
Control 
169,47 7,49 4 
59,05 6,02 3 Staurosporine 
175,72 
129 
9,54 
9,1 
5 
4 
phosSTOP 
175,63 
266,65 
7,93 
10,57 
4 
6 
 
Because the kinase SRPK2 was identified with high scores in MS to bind to the C2A-
C2B domains of RIM1α, the direct interaction between these proteins was further 
investigated. Thus, GST-constructs containing either the C2A- or C2B-domain of RIM1α 
were used to examine the binding to endogenous SRPK2 from mouse brain or rat cortical 
neurons. GST-fusion proteins were incubated for several hours with either lysed crude 
synaptosomes or lysed rat primary cortical neurons, followed by SRPK2 detection by 
immunoblotting. In all cases, only the C2A-domain pulled down the native SRPK2, while the 
C2B domain did not bind the SRPK2 kinase (Fig. 4.16B, control panels).  
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Figure 4.24: SRPIN340 treatment induces a 
slight increase in co-localization of endogenous 
SRPK2 and RIM1/2 in primary cortical 
neurons. At DIV14 rat cortical neurons were 
incubated with 10μM SRPK2 inhibitor (SRPIN340, 
Axon Medchem) for 16h, followed by fixation in 
paraformaldehyde and staining for the endogenous 
SRPK2 (Santa Cruz, 23) and RIM1/2. Co-
localization was calculated using the Pearson’s 
coefficient, part of the JACOp plug-in (ImageJ). 
Statistical analysis was performed in GraphPad 
Prism 6 using Man-Whitney test (two-tailed) 
(N=2). N, number of independent experiments. 
 
4.1.3.3 Vesicle-associated membrane protein (VAMP) associated-protein A/B 
(VAPA/VAPB)  
The first report on VAPA dates back to 1995 when, by using yeast two hybrid system, VAP-
33 was identified in Aplysia californica to bind synaptobrevin-2/VAMP-2 and to play a role 
in synaptic transmission (SKEHEL et al., 1995). Several years later the mammalian homologs 
VAPA, VAPB and VAPC were characterized and their role in vesicle fusion and trafficking 
was suggested (WEIR et al., 1998; NISHIMURA et al., 1999). In accordance with the function of the 
Aplysia californica VAP-33, the D.melanogaster homologue DVAP-33 was reported to 
control synaptic bouton formation at the NMJ (PENNETTA et al., 2002) and to traffic proteins to 
axonal processes (YANG et al., 2012). VAPB protein was identified to contribute to normal 
dendrite morphology by taking part in ER-to-Golgi transport (KUIJPERS et al., 2013). A mutation 
in VAPB (P56S) was described to be the cause of a motor neuron disease (amyotrophic lateral 
sclerosis type 8-ALS8) (NISHIMURA et al., 2004). The role of VAP protein family in maintaining 
the AZ architecture has not been fully elucidated. 
 
4.1.3.3.1 VAPA/VAPB binds RIM1α 
The MS data revealed the VAPA protein as another possible candidate to bind the C2-
domains of RIM1α (Table 4.7). The VAPA protein was identified, with a similar sequence 
coverage and number of unique peptides, in all three experimental conditions using crude 
synaptosomes. Analysis of the protein complexes co-immunoprecipitated with overexpressed 
RIM1α C2A-C2B domains in primary cortical neurons identified the VAPA protein with an 
even higher score (636, 10) and percentage of sequence coverage (40%).  
 
  
Table
correl
 
A
(
 
Altho
intera
VAP
GST
overe
only 
using
doma
gene
trunca
 4.7: Identifi
ation to vario
ccession 
Number 
UniProtKB) 
Q9WV55 
The VA
ugh VAPB
ction with 
Next, in
A or VAP
-fusion pro
xpressed in
the C2A-d
 either who
Addition
ins were s
rated GST-
ted form of R
cation of VA
us experimen
Gene 
name 
Sco
V
A
PA
-M
O
U
SE
 
636
119
127
47,
53,
105
36,
31,
P protein 
 was not id
RIM1α wa
 vitro bind
B/C could 
teins (GST
 HEK293T
omain of R
le mouse b
ally, to ide
eparated an
 fusion pr
IM1α (n=4). 
PA as a no
tal conditions
re Sequen
coverag
,10 41,37
,63 
,37 
12,05
12,05
79 13,25
88 
,10 
12,05
17,67
84 
27 
12,05
12,05
family inc
entified in 
s examined
ing assays
bind RIM1
-RIM1α C2
 cells. Imm
IM1α. Th
rain or prim
ntify which
d cloned in
oteins were
N, number of
64
vel RIM1α b
. Five indepen
ce 
e 
Unique 
peptides
 9 
 
 
2 
2 
 2 
 
 
2 
3 
 
 
2 
2 
ludes besid
the MS scr
, due to its 
 were em
α. GST-pu
A, GST-R
unoblottin
ese results 
ary rat cor
 part of VA
to vectors 
 incubated
containin
FLAG- t
showed t
associated
domains 
 
Figure 4.25
RIM1α. (A
the individu
GST-pull d
with VAPA
HEK293T 
endogenou
VAPA ant
protein dom
 independent 
inding prote
dent experim
Type of e
Co-IP – rat c
Co
Stauro
phos
es VAPA 
een for nov
high sequen
ployed to 
ll down ex
IM1α C2B)
g revealed t
were furth
tical neuron
PA was m
containing 
 for sever
g overexp
agged C2A
hat only th
 with RIM
(Fig. 4.25C
: Both VAP
) Schematic 
al domains f
owns showin
 from mouse
lysates (N=8
s or overexpre
ibody (K15, 
ain of VAP
experiments; 
in by MS. M
ents were per
xperiments 
ortical neurons 
ntrol 
 
sporine 
 
STOP 
 
(vap33) a
el RIM1α i
ce homolo
investigate 
periments 
 and VAPA
hat VAP pr
er validated
s (Fig. 4.2
ediating thi
the GST s
al hours w
ressed fu
-C2B dom
e major s
1α, as w
). 
A and VAPB
representation
used to GST. 
g the RIM1α
brain (N=3), 
) and VAPB
sed VAPA w
Santa Cruz)
A binds both
IB, immunob
Chapte
ascot scores
formed.  
Descrip
Vesicle-ass
membrane 
associated p
lso VAPB
nteraction p
gy with VA
whether e
were perfo
 and VAP
oteins bou
 by GST-
5B).  
s interactio
equence. T
ith HEK29
ll-length R
ains. Bind
perm prote
ell as wit
 bind the C2
 of full-lengt
(B) Immunob
 C2A-domain
rat cortical ne
 (N=2). Det
as performed
.  (C) The 
 full-length a
lotting. 
r 4. Results
 are listed in
tion 
ociated 
protein-
rotein A 
/C protein.
artners, its
PA. 
ndogenous
rmed with
B proteins
nd strongly
pull downs
n, different
hese newly
3T lysates
IM1α or
ing assays
in domain
h the C2-
A-domain of
h VAPA and
lotting of the
 to associate
urons (N=1),
ection of the
 with an anti-
major sperm
s well as the
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
4.1.3
In ou
was 
phos
An i
comp
bindi
or ph
RIM
pre-t
immu
same
obser
 
during
and t
immu
 
.3.2 Kinase
r mass-spe
blocked. A
STOP score
ncrease in 
ared to pho
To test w
ng affinity,
osSTOP i
1α C2B) w
reated wit
noblotting
 amount of
Compare
ved in sam
 the binding 
he endogeno
noblotting. 
 inhibition
ctrometry 
fter the M
s (treatmen
detected V
sphatase in
hether the 
 GST-pull 
nhibitors. T
ere incubat
h 1μM s
 and detect
 staurospor
d to the ph
ples pre-tre
assays. Staur
us VAPA co
 strengthe
analysis, an
S scores
t vs. contr
APA prot
hibition (F
same treatm
down exper
o this end
ed with cru
taurosporin
ion of VAP
ine or phosS
osSTOP an
ated with th
osporine trea
mpared to c
65
ns the VAP
 increase i
 of contro
ol), the obt
ein was ob
ig. 4.26A). 
ent applied
iments wer
, GST-fus
de synapto
e (30min)
A protein.
TOP inhib
d control co
e kinase in
tment enhanc
ontrol or ph
A-RIM1α
n VAPA w
ls were d
ained value
served wh
   
 to crude s
e performe
ion protein
somes or l
 or 1x 
 The bindin
itors.  
nditions, a
hibitor (Fig
ed the associ
osSTOP con
 interaction
as detected
educed fro
s were plot
en kinase 
ynaptosom
d in the pre
s (GST-RI
ysed primar
phosSTOP 
g reaction 
n increase i
. 4.26B).  
Figu
trea
RIM
was 
scor
inhib
appl
repr
inde
is p
(N=4
and 
incu
syna
or 
corti
follo
imm
para
with
phos
ation between
ditions. N, n
Chapte
  
 when kina
m staurosp
ted relative
activity wa
es had an e
sence of sta
M1α C2A 
y rat cortic
(1h), fo
contained 
n binding a
re 4.26: S
tment enhan
1α binding
detected 
es in the MS
ition by 
ication. 
esents the m
pendent expe
lotted relativ
). (B) GST-
GST-RIM1α
bated with 
ptosomes (m
with lysed 
cal neurons 
wed by SD
unoblotting 
llel samples 
 staurosporin
STOP (1x) 
 the RIM1α 
umber of re
r 4. Results
se activity
orine and
 to control.
s inhibited
ffect on the
urosporine
and GST-
al neurons
llowed by
as well the
ffinity was
taurosporine
ced VAPA-
. (A) VAPA
with higher
, after kinase
stauroporine
The data
ean of four
riments, and
e to control
RIM1α C2A
 C2B were
lysed crude
ouse brain)
primary rat
for 2h/4°C,
S-PAGE and
(N=4). In
were treated
e (1µM) or
before and
C2A-domain
petitions; IB,
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
4.1.3
VAP
Beca
doma
previ
respo
More
poten
kinas
lysed
muta
while
 
4.1.3
GST
overe
C2A
bead
was a
C). 
.3.3 The T
A 
use the bin
in and VA
ous report
nsible for 
over, usin
tial targets
e A, were m
GST-pul
 crude syn
tions in the
 the R844H
.3.4 VAP p
-pull down
xpressing 
-C2B, were
s.  
Full-leng
lso validat
812/814A 
ding assay
P proteins,
 described 
the autosom
g bioinfor
 for kinase
utated and
l down exp
aptosomes 
 RIM1α C
 mutation 
roteins bin
 results w
HA-tagged 
 subjected 
th untagge
ed when on
point muta
s clearly i
 several RI
a point m
al domina
matical too
s. Two am
 tested in th
eriments w
or mouse 
2A-domain
did not hav
d RIM1α 
ere furthe
VAPA or V
to co-imm
d RIM1α w
ly the trunc
66
tions in th
ndicated a
M1α C2A 
utation in
nt cone-rod
ls, severa
ino acids, 
e binding 
ere perform
whole brai
 impaired 
e any influe
in co-IP as
r confirme
APB and 
unoprecipit
as precipita
ated form, 
e RIM1α 
 direct bin
mutants w
 the RIM1
e dystroph
l amino ac
predicted 
assay.  
ed with ly
n. In all th
the binding
nce on the 
says 
d by co-I
full-length
ations usin
ted by both
RIM1α C2
C2A-doma
ding betwe
ere tested i
α C2A-do
y in human
id residue
to be phos
sed rat prim
ree cases, 
 to VAPA
binding aff
 
 
Figure 4.2
RIM1α 
VAPA bin
of the ful
the WT-C
domains 
used in th
(B) The T
RIM1α C
recognition
binding to
(N=3). N
experimen
 
P experime
RIM1α or 
g either HA
 VAPA an
A-C2B was
Chapte
in impair 
en the RIM
n GST-pul
main (R84
s (JOHNSON 
s were id
phorylated 
ary cortic
the T812/8
 protein (F
inity.   
7: Point mut
C2A-doma
ding. (A) R
l-length untag
2A and the 
(R884H and
e GST-pull 
812/814A mu
2A-domain, 
 motif for PK
 the endoge
, number of
ts. 
nts. HEK
FLAG-tagg
- or FLAG
d VAPB. T
 used (Fig.
r 4. Results
binding to
1α C2A-
l downs. A
4H) to be
et al., 2003).
entified as
by protein
al neurons,
14A point
ig. 4.27B),
ations in the
in impair
epresentation
ged RIM1α,
mutant C2A-
 T812/814A)
down assays.
tations in the
affecting the
A, impaired
nous VAPA
independent
293T cells
ed RIM1α
-magnetic
he binding
 4.28B and
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
4.1.3
cultu
Beca
and V
neuro
fixati
and V
4.30,
mislo
DIV
the p
local
4.30,
prote
.3.5 Co-lo
re 
use the bio
AP protein
To study
ns were tr
on and stai
APB show
 upper p
calization,
14, neurons
rotein was 
ization was
 lower pan
ins and the
calisation 
chemistry 
s, co-local
 the co-loc
ansfected w
ning agains
ed co-loc
anel). Bec
 staining of
 were fixed
high in the 
 observed b
el). A low
 presynapti
of VAP p
data sugges
ization stud
alization o
ith full-len
t endogeno
alization w
ause prote
 the endoge
, stained, a
soma and v
etween RIM
 degree of
c marker, B
67
roteins wi
ted, so far
ies in prim
f VAPA or
gth HA-tag
us RIM1α 
ith endoge
in overexp
nous VAPA
nd imaged
ery weak i
1/2 and V
 co-localiz
assoon (Fig
th endoge
, the possib
ary cell cult
 VAPB/C w
ged constru
and the HA
nous RIM1
ression m
 and VAP
 for native
n neurites. 
APA or VA
ation was 
. 4.31). 
 
Figure 4.28
bind RIM
representatio
length VA
RIM1α. (B)
cells trans
RIM1α (or 
and either H
were subject
magnetic be
incubated 
magnetic be
were washe
Laemmlli b
PAGE. Inpu
analyzed by
RIM1α and 
(C) A fusion
the C2-doma
full-length V
independent 
immunoblott
immunoprec
 
 
 
nous RIM
ility of bin
ure were pe
ith RIM1
cts, follow
-tag. Both 
/2 (Fig. 4.
ight lead 
B/C was pe
 VAPA and
Neverthele
PB (Fig. 4
also observ
Chapte
: Both VAPA
1α. (A) 
n of the HA
PA and th
 Extracts o
iently trans
RIM1α C2A
A-VAPA o
ed to co-IP 
ads. Co-IP re
for 2h/4°C 
ads. Subsequ
d and boil
uffer follow
t and prec
 immunoblo
FLAG antibo
 protein cons
ins of RIM1
APA (N=3). 
experim
ing; 
ipitations. 
1/2 in neu
ding betwe
rformed. 
α, rat prima
ed two wee
overexpres
29, upper p
to aggreg
rformed. T
 VAPB. T
ss, some de
.29, lower 
ed betwee
r 4. Results
 and VAPB
Schematic
-tagged full-
e untagged
f HEK293T
fected with
-C2B-FLAG)
r HA-VAPB
with anti-HA
actions were
with HA-
ently, beads
ed in SDS-
ed by SDS-
ipitates were
t (IB) using
dies (N=2-5).
isting of only
α bound also
N, number of
ents; IB,
IP,
ronal cell
en RIM1α
ry cortical
ks later by
sed VAPA
anel; Fig.
ation and
herefore, at
he level of
gree of co-
panel; Fig.
n the VAP
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
calcu
softw
Bass
 
Figur
synap
weeks
endog
endog
scann
protei
The co-l
lated using
are. The d
oon or RIM
e 4.29: Imm
ses. (Upper p
 post-transfec
enous RIM1/
enous VAPA
ing confocal 
ns: RIM1α an
ocalization
 the Pearso
egree of c
1/2 was sim
unofluoresc
anel) At DIV
tion neurons 
2 (Frank Sch
 (H-40, Sant
microscope 
d VAPA. Sca
 between V
n’s coeffici
o-localizati
ilar (Fig. 4
ence labeling
3 primary ra
were fixed an
mitz). (Lowe
a Cruz), and
(Nikon A1/T
le bar: 20µm
68
AP prote
ent, using 
on between
.32). 
 reveals a 
t cortical neu
d stained aga
r panel) DIV
 RIM1/2 (BD
i). Yellow 
 (overview); 1
ins and di
the JACOp
 VAP prot
partial co-lo
rons were tr
inst the HA-t
14 rat cortic
 Bioscience)
arrows indica
0µm (insets)
fferent pres
 plug-in, in
eins and th
calisation of
ansfected wit
ag (HA.11 C
al neurons w
. Images we
te co-localiz
. 
Chapte
ynaptic pr
tegrated in 
e presynap
 RIM1α wi
h HA-tagged
lone 16B12, C
ere fixed an
re acquired u
ation betwee
r 4. Results
oteins was
the ImageJ
tic protein
th VAPA at
VAPA. Two
ovance) and
d stained for
sing a laser-
n these two
 
 
 
 
 
 
 
 
 
 
  
Figur
cortic
staine
panel)
RIM1
Yellow
e 4.30: Parti
al neurons we
d against HA
 DIV14 rat 
/2 (BD Biosc
 arrows indi
al co-localisa
re transfected
-tag (HA.11
cortical neur
ience). Imag
cate co-locali
tion of RIM
 with HA-tag
 Clone 16B1
ons were fix
es were acqu
zation betwee
69
1α with VAP
ged VAPB. 
2, Covance) 
ed and stain
ired using a 
n RIM1α and
B at synaps
Two weeks p
and endogen
ed for endog
laser-scannin
 VAPB. Sca
es. (Upper pa
ost-transfectio
ous RIM1/2 
enous VAPB
g confocal m
le bar: 20µm 
Chapte
nel) At DIV
n neurons w
(Frank Schm
 (H-40, Sant
icroscope (N
(overview); 1
r 4. Results
3 primary rat
ere fixed and
itz). (Lower
a Cruz), and
ikon A1/Ti).
0µm (insets).
 
 
 
 
 
 
  
Figur
cortic
Cruz)
endog
bar: 2
 
Figur
prima
Pearso
observ
e 4.31: Imm
al neurons we
, and the act
enous protein
0µm (overvie
e 4.32: Quan
ry cortical ne
n’s coefficie
ed between d
unofluoresce
re fixed and 
ive zone pro
s. Images w
w); 10µm (in
0.0
0.2
0.4
0.6
Pe
ar
so
n'
s 
co
ef
fic
ie
nt
tification of 
urons were s
nt was used fo
ifferent VAP
nce labeling
stained for en
tein Bassoon
ere acquired u
sets). 
Bassoon RI
V
VAPA
the co-localiz
tained agains
r correlation 
 proteins and 
70
 of VAPA, 
dogenous VA
 (Covance). 
sing a laser-
M1/2 Bassoo
AP proteins
V
ation of VA
t the endogen
analysis (JAC
RIM1/2 or B
VAPB/C and
PA (A) (H-4
The yellow a
scanning con
n RIM1/2
APB
P proteins w
ous proteins
Op plug-in, I
assoon. 
 Bassoon at
0, Santa Cruz
rrows mark 
focal microsc
Bassoon
RIM1/2
Bassoon
RIM1/2
ith different 
: VAPA, VA
mageJ). No s
Chapte
 synapses. A
), VAPB (B)
boutons posi
ope (Nikon 
 
presynaptic 
PB, Bassoon 
ignificant dif
r 4. Results
 
t DIV14 rat
 (H-40, Santa
tive for both
A1/Ti). Scale
markers. Rat
and RIM1/2.
ferences were
 
 
 
 
 
 
 
 
  
4.1.3
High
Copi
kaina
(E16
mitra
VI in
 
4.1.3
A les
Copi
RIM
level
 
Table
indep
 
A
 
assay
C2A
revea
pull d
of ind
.4 Copine V
ly expresse
ne N, is a
te stimulat
.5), the mR
l cells in th
 the presyn
.4.1 Copin
s studied p
ne VI was 
1α C2A-C2
 of detected
 4.8: Copine
endent experi
ccession Numb
(UniProtKB) 
Q9Z140 
To inves
s were em
 or RIM1α 
led a stron
own assay rev
ependent exp
I 
d in the o
 calcium b
ion and L
NA and the
e olfactory
aptic termin
e VI binds 
rotein, Cop
identified 
B domain
 Copine VI
 VI. Mascot
ments were p
er Gene 
name 
C
PN
E
6-
M
O
U
SE
 
tigate the 
ployed. GS
C2B) and H
g interactio
ealed that Co
eriments; IB, 
lfactory bu
inding pro
TP (NAKAYA
 protein ex
 bulb (YAM
al has not 
RIM1α 
ine VI, wa
with high s
s in rat cor
 by MS wa
 scores are l
erformed.  
Score 
682,45 
747,06 
139,28 
306,17 
574 
191,33 
226,42 
423,02 
397,20 
89,75 
121,64 
direct bind
T-pull dow
A-tagged f
n between t
4.
 
Fi
Sc
do
W
pine VI has a
immunoblotti
71
lb and in t
tein, whose
MA et al., 1
pression is 
ATANI et al., 
yet been fu
s detected 
cores both
tical neuro
s similar be
isted in corre
Sequence 
coverage p
26,39 
33,93 
6,82 
9,16 
19,39 
6,82 
9,16 
16,34 
12,21 
3,59 
9,34 
ing betwee
n assays w
ull-length 
he calcium
33B). RIM
gure 4.33: C
hematic repr
mains (C2A
illebrand fact
 stronger affi
ng. 
he hippoca
 gene exp
998, 1999). 
up-regulate
2010). At th
lly investig
in MS to a
 in co-IP e
ns, as well
tween diffe
lation to the
Unique 
eptides 
T
11 
15 
2 
5 
9 
2 
5 
8 
4 
2 
5 
n RIM1α a
ith differe
Copine VI 
 sensor and
1α C2A-do
opine VI bi
esentation of 
 and C2B) 
or type A-dom
nity for the C
mpus Copi
ression lev
During em
d in the ax
e present, t
ated. 
ssociate wit
xperiments
 as in crud
rent pharm
 various expe
ype of experimen
Neurons 
Control 
 
Staurosporine 
 
phosSTOP 
 
nd Copine
nt GST-fu
overexpress
 the C2B-d
main did no
nds the C2B
full-length Co
in the N-te
ain in the C
2B-domain of
Chapte
ne VI, kno
el is up-re
bryonic de
onal projec
he function
h RIM1α (
, using ove
e synaptos
acological 
rimental con
ts Desc
Cop
 VI, differe
sion protei
ed in HEK
omain of R
t bind the C
-domain of 
pine VI, with
rminal regio
-terminal regi
 RIM1α (N=3
r 4. Results
wn also as
gulated by
velopment
tions of the
 of Copine
Table 4.8).
rexpressed
omes. The
treatments. 
ditions. Five
ription 
ine-6 
nt binding
ns (RIM1α
293T cells,
IM1α (Fig.
opine VI.
RIM1α. (A)
 the two C2-
n, and von
on. (B) GST-
). N, number
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
4.1.3
Give
al., 1
immu
agen
  
impa
comp
affin
4.1.3
Beca
local
were
4.35)
arrow
micro
.4.2 The C
n that prev
998, 1999),
noprecipit
t, EGTA. 
In the pr
ired (Fig.4
ared to un
ity for the H
.4.3 Copin
use of the 
ization of th
 fixed at DI
. 
s mark the p
scope (Nikon
opine VI-R
ious studies
 the requi
ations were
esence of 
.34B). The 
treated co
A-tagged C
e VI and R
direct bind
ese two pr
V14 and th
ositive bouto
 A1/Ti). Scale
IM1α inte
 have show
rement of 
 carried ou
EGTA the 
addition of 
ntrol. The 
opine VI (
IM1/2 co-l
ing betwee
oteins was 
e endogeno
ns for both 
 bar: 20µm (o
72
raction is c
n copines 
calcium 
t in the ab
binding be
calcium di
truncated 
Fig. 4.34C
 
Fig
dep
tagg
Ove
HA
(1.2
inte
FLA
N, 
imm
 
 
 
ocalized at
n RIM1α a
studied in p
us RIM1/2
proteins. Ima
verview); 10
alcium dep
to be calciu
in this bin
sence or p
tween RIM
d not have 
form of R
). 
ure 4.34: C
endent. (A/C
ed full-leng
rexpressed p
-magnetic be
mM) or E
raction betw
G-tagged RI
number 
unoblotting;
 a subset o
nd the cal
rimary rat 
 and Copin
ges were ac
µm (insets). 
endent 
m-binding 
ding was 
resence of 
1α and Co
any effect o
IM1α (C2
opine VI-RI
) Schematic 
th Copine V
roteins were
ads in the p
GTA (2mM)
een Copine V
M1α C2A-C2
of indepen
 IP, immunop
f synapses 
cium senso
cortical neu
e VI protei
quired using 
Chapte
proteins (N
assessed. 
the calcium
pine VI w
n the bind
A-C2B) al
M1α bindin
representatio
I and the 
 subject to 
resence of e
. EGTA w
I and RIM1
B binds Cop
dent exper
recipitations. 
 
r, Copine 
rons. Prima
ns were lab
Figure 
Immuno
labelling
and Co
synapses
rat cort
were fixe
for 
proteins: 
Bioscienc
Copine 
Kavalali)
a laser-scann
r 4. Results
AKAYAMA et
Thus, co-
 chelating
as strongly
ing affinity
so showed
g is calcium
n of the HA-
RIM1α. (B)
co-IPs using
ither calcium
eakened the
α (N=4). (D)
ine VI (N=3).
iments; IB,
VI, the co-
ry cultures
elled (Fig.
4.35:
fluorescence
 of RIM1/2
pine VI at
. At DIV14
ical neurons
d and stained
endogenous
RIM1 (BD
e) and
VI (Ege
. The yellow
ing confocal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
4.2 S
SV2A
al., 20
the a
et al.
deter
synap
1996)
apply
mass
 
4.2.1
To p
chrom
for p
(TAP
termi
(Fig.
trans
fusio
immu
Syna
the a
the t
V2A 
 is a trans
06), in regu
mount and 
, 2010). How
mined. Th
totagmin1
. Therefore
ing tandem
 spectrome
 Generatio
urify SV2A
atography
roper expre
Full-leng
) tag, com
nal positio
4.36A). Ra
duced with
n proteins, 
nofluoresc
psin1/2. Th
xons and a 
agged SV
membrane 
lating the c
the co-traf
ever, up 
is might 
, only few 
, one majo
 affinity p
try.  
n and char
 under nat
 techniques
ssion and c
th SV2A f
posed of o
n. Furtherm
t cortical n
 crude vira
at DIV2-5 
ence using
e TAP and
co-localisat
2A was co
synaptic ve
alcium lev
ficking of s
to date its
have been
binding pa
r goal of th
urification 
acterisation
ive conditi
, the overe
ellular loca
rom mouse
ne FLAG-
ore, SV2A
eurons we
l particles 
(day in vitro
 antibodie
 GFP-tagge
ion with th
nfirmed b
fo
F
m
IP
d
F
cu
co
S
by
73
sicle protei
el at the ac
ynaptotagm
 precise m
 in part 
rtners for 
is thesis is
and to iden
 of the TA
ons from m
xpression c
lization. 
 was clone
and two S
 was fuse
re transfec
(rAAV ser
). Two we
s against S
d SV2A sh
e synapsin1
y immuno
llowed by
LAG-tag. 
olecular w
 using an 
id not give 
igure 4.36: 
ltured neu
nstructs. (B
V2A-C-TAP 
 WB w
n with a su
tive zone (J
in1 in neu
ode of act
hampered 
SV2A hav
 to purify S
tify the po
P-tagged S
ouse brain
onstructs h
d with a s
trep-sequen
d in the C
ted with th
otype 1/2), 
eks later ne
V2A, FLA
owed a pu
/2 marker 
precipitatio
 immunob
The resulti
eight aroun
anti-GFP an
positive ba
Testing for
rons. (A) 
) Overexpre
in neuronal c
ith antibod
ggested rol
ANZ et al., 19
rons (CHANG
ion has no
by the f
e been iden
V2A unde
tential nov
V2A constr
 or neuron
ad to be fir
hort tandem
ces, both i
-terminal 
e newly g
expressing
urons were
G and th
nctate syna
(Fig.4.37A;
n using F
lotting ag
ng bands 
d 100-130
tibody cou
nds in the im
 SV2A ove
Schematic r
ssion of SV
ell culture. C
ies against
Chapte
e in primin
99), and in 
 and SÜDHO
t been une
act that, 
tified (SCH
r native co
el binding 
ucts  
al cells us
st designed
 affinity p
n N- as we
position al
enerated p
 the above
 fixed and a
e presynap
ptic distrib
 B). The ex
LAG-magn
ainst SV2A
showed th
kDa (Fig.4
pled to aga
munoblot
rexpression 
epresentation
2A-GFP, S
ell lysates w
 SV2A a
r 4. Results
g (CUSTER et
controlling
F, 2009; YAO
quivocally
except for
IVELL et al.,
nditions by
partners by
ing affinity
 and tested
urification
ll as in C-
so to GFP
lasmids or
mentioned
nalysed by
tic marker
ution along
pression of
etic beads
 and the
e expected
.36B). The
rose beads
ting. 
in primary
 of SV2A
V2A-N-TAP,
ere analysed
nd FLAG.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figur
transf
antibo
expre
(Niko
 
 
 
e 4.37: Anal
ected at DIV
dies against 
ssing N- and 
n A1/Ti). Sca
ysis of SV2A
4 with SV2
SV2A and FL
C-TAP-tagg
le bar: 20µm.
 overexpress
A-GFP, SV2
AG. (B) At D
ed SV2A. Pic
 
74
 
ion in cultur
A-N- and -C
IV2-3 rat co
tures were a
ed primary 
-TAP, and 
rtical neurons
cquired using
neurons. (A)
analysed by 
 were infecte
 a laser-scan
Chapte
 Rat cortical 
immunofluor
d with rAAV
ning confoca
r 4. Results
neurons were
escence with
 serotype 1/2
l microscope
 
 
 
 
 
 
Chapter 4. Results 
 
75 
 
4.2.2 Optimization of SV2A protein purification from primary rat cortical neurons 
To test and optimze the affinity purification of SV2A, primary rat cortical neurons were 
transduced with viral particles (rAAV serotype 1/2) expressing SV2A with the TAP-tag either 
in the N- or C-terminal position. Two weeks after the transduction the cells were harvested, 
lysed in cold ice lysis buffer containing 3.9mM DDM (n-Dodecyl-ß-maltoside) and subjected 
to either a one- or two-step purification procedure.  
 
4.2.2.1 One-step purification yields good recovery of TAP-tagged SV2A 
Strep purification was based on the ability of the Strep-tactin matrices (streptavidin) to bind 
with high selectively to the strep sequence of the TAP-tag, allowing the purification of SV2A 
in one single step and in a column modus. To determine the purification efficiency, a small 
aliquot was kept after each purification step for further analysis by WB. The Strep purification 
alone showed a good recovery of the recombinant protein, since little material was lost during 
the procedure and the entire material was recovered after the 3rd and 4th elution steps. The 
disadvantage of this procedure was the limited binding capacity of the columns (50 to 
100nmol/ml recombinant proteins), which were therefore unable to capture the entire applied 
tagged-SV2A protein. The bands present in the flow fraction and the first two washing steps 
may indicate that the column was over-saturated with the fusion protein (Fig.4.38B). 
The capacity of the monoclonal M2-FLAG antibodies, covalently attached to the 
agarose beads, to recognise the octapeptide (DVKDDDDK) present in the TAP-tag allowed 
for the protein purification using the FLAG-tag (Batch modus). As in the case of the Strep 
purification, the column binding capacity was the limiting factor in capturing the whole 
amount of recombinant protein. However, the elution step performed with competitive FLAG 
peptides showed a sufficiently high recovery of the targeted protein (Fig.4.38C).  
Since the purpose of these procedures was to purify proteins maintaining their native 
configuration, it was mandatory to control for SV2A structural integrity. For this purpose 
Synaptotagmin1 (Syt1) was chosen because it is one of the proteins known to bind to SV2A 
(SCHIVELL et al., 1996; PYLE et al., 2000). The immunoblotting experiments showed that a 
significant amount of Synaptotagmin1 was co-eluted in the Strep purification and to a lesser 
degree in the FLAG purification procedure, indicating that the recovered SV2A protein 
retained to a certain degree its native structure (Fig.4.38). 
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5. Discussion 
Synaptic plasticity denotes the ability of neurons to respond to the ongoing network activity, 
by weakening or strengthening their activity. These adaptive changes can take place both at 
the pre- and postsynaptic terminals. Whereas the molecular mechanisms underlying 
postsynaptic plasticity have been studied in great detail, the cellular events mediating 
presynaptic plasticity are not as well understood. It has been hypothesized that presynaptic 
plasticity may involve the posttranslational modification of proteins. One of these 
modifications is the phosphorylation of proteins, which plays a role in the plasticity-induced 
remodelling of established AZs or in the assembly of novel active zones.  
Two presynaptic proteins, the AZ protein RIM1α and the SV protein SV2A have been 
shown to be important in presynaptic plasticity, by modulating the function and properties of 
the presynaptic release machinery, e.g. SV priming. However, their precise mode of action is 
still unresolved. Thus, to gain a better understanding the following goals were pursued in this 
thesis:  
(5.1) The effect of hyperphosphorylation on RIM1α at synapses.  
(5.2) The identification of novel potential phospho-dependent binding partners for RIM1α.  
(5.3) To gain insight into the enigmatic function of SV2A, we aimed to purify and analyse 
novel SV2A binding partners. 
 
5.1 Hyperphosphorylation alters the distribution of the presynaptic protein RIM1α at 
synapses 
Presynaptic plasticity involves the structural remodelling of the CAZ, which in turn engages 
dynamic changes in protein turnover and protein interactions. At the D.melanogaster NMJs 
an increase in the amount of the active zone protein Bruchpilot (Brp) and an enlargement of 
the presynaptic cytometrix structure was detected after the rapid induction of presynaptic 
strengthening. Moreover, the fast recruitment of Brp to the AZ led to an increase in the 
number of SVs and calcium channels at synapses (WEYHERSMÜLLER et al., 2011). The structural 
remodelling of the CAZ on a timescale of minutes was further supported by studies in 
hippocampal neurons using a fluorescently labelled Bassoon. The local redistribution of the 
AZ component led to rapid changes in the size of the AZ, which correlated with modifications 
in the RRP and the release probability (MATZ et al., 2010). Prolonged silencing of excitatory 
neurons caused a down-regulation of cellular expression levels of distinct presynaptic 
proteins, including RIM1α (LAZAREVIC et al., 2011). Interestingly, the decrease in the amount of 
RIM1α was not caused by UPS-dependent degradation but rather dependent on other 
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mechanisms, like the regulation of transcription and/or translation. Whereas the number of 
synapses labelled by RIM1α was decreased after silencing, the remaining positive puncta 
showed an increase in the level of RIM1α. This suggested a redistribution of RIM1α after 
prolonged activity deprivation (LAZAREVIC et al., 2011). 
Even though the precise molecular mechanisms controlling synaptic adaptation are not 
well understood, protein phosphorylation has been postulated to contribute to the underlying 
synapse remodelling and plasticity. For example, ERK kinase, which can integrate a variety 
of signals, exerts many downstream effects, like, dendritic spine stabilization, modulation of 
ion channels or receptor insertion (review: SWEATT, 2004). Cdk5 was shown to be involved in 
LTP and LTD, acting as a homeostatic regulator of synaptic plasticity (review: SHAH and LAHIRI, 
2014). One of the central enzymes actively involved in presynaptic plasticity is PKA, e.g. 
essential for mossy fiber (MF)-LTP (review: CASTILLO, 2012).  
It has been shown that the presynaptic protein RIM1α acts as substrate for several 
kinases: PKA (LONART et al., 2003), ERK2 (SIMSEK-DURAN and LONART, 2008), CaMKII (SUN et al., 
2003) and SAD-B (INOUE et al., 2006). Whereas the phosphorylation of the amino acid residue 
S413in RIM1α by PKA was required for the induction of presynaptic LTP in cultured 
cerebellar granular and Purkinje cell neurons (LONART et al., 2003), studies in mice expressing  
mutations in this position were not able to confirm this (KAESER et al., 2008a; YANG and CALAKOS, 
2010). Although RIM1α has been shown to be phosphorylated by a variety of kinases, the 
functional implications of phosphorylation/dephosphorylation of RIM proteins are not well 
understood. However, such posttranslational modifications regulated by synaptic activity, 
may directly impact RIM1α’s properties, like its binding affinity to other proteins or its 
stability.  
To test if the increased phosphorylation status of RIM1α affects its level or its 
association with the AZ, neuronal cell cultures were incubated with various phosphatase 
inhibitors. At different time intervals the neuronal cultures were fixed, endogenous RIM1/2 
was labelled and the area of the bouton marked by RIM1α determined. Our results show, that 
by shifting the equilibrium to a hyperphosphorylated state, RIM1α distribution at synapses is 
altered. Application of phosSTOP led to a significant increase in the number of boutons with 
smaller RIM1α marked areas in comparison to control conditions. By blocking only the PP1 
and PP2A phosphatases using either 10nM okadaic acid or 2nM Calyculin A, a non-
significant increase in the number of RIM1/2 labelled boutons with smaller sizes compared to 
DMSO control conditions was detected.  
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High level of protein phosphorylation may affect RIM1α turn-over by either 
increasing or decreasing its stability. Computer-based simulations have described proteins to 
become more degradable if more sites are phosphorylated (multi-site phosphorylation). Such 
phosphorylation-dependent degradation processes are important for proteins involved in 
regulating the cell cycle (VAREDI et al., 2010). Because RIM1α is a protein with multiple 
phosphorylation sites, high kinase activity might trigger a degradation process. However, the 
total intensity of RIM1/2 labelling was not changed after phosSTOP treatment compared to 
the control condition. Therefore, these results do not suggest that a degradation mechanism 
might be induced by phosphorylation of RIM1α. On the other hand, phosphorylation may as 
well protect proteins from degradation, by blocking for example either the binding of E3 
ubiquitin ligase to the substrate or by impairing its interaction with E2 ubiquitin-conjugation 
enzymes. It was hypothesised that RIM1α phosphorylation by PKA, may provide resistance to 
the degradation by the proteasome (CROWFORD and MENNERICK, 2012). However, to date there is 
no experimental evidence supporting this hypothesis. 
In addition to protein stability, phosphorylation events may impact the association of 
RIM1α with the CAZ. It has been shown that certain phosphorylation events of CAZ 
components induce protein solubilisation by interfering with their intermolecular interactions. 
Binding of the 14-3-3 adapter protein to phosphorylated Bassoon (S2845) decreased the 
attachment of Bassoon to the AZ (SCHRÖDER et al., 2013). Moreover, treatment of neuronal 
cultures with the phosphatase inhibitor okadaic acid inhibitor further induced solubilisation 
and diffusion of Bassoon, CAST and RIM proteins (SCHRÖDER et al., 2013). Accordingly, our 
experiments may indicate that hyperphosphorylated RIM1/2 protein becomes more soluble 
and diffuses away from the AZ and the bouton.  
Prolonged exposure to okadaic acid has been shown to have cytotoxic effects on a 
variety of cells and to mediate neurodegenerative mechanisms by blocking PP2A phosphatase 
activity. The impairment of PP2A activity stimulates a large group of kinases, like ERK2, 
CaMKII, PKA (review: KAMAT et al., 2013). In our experiments, 1h stimulation did not induce 
neurotoxicity and moreover, the observed changes in the distribution of RIM1α may be a 
direct consequence of the interplay between multiple kinases that act at synapses. 
However, in interpreting the functional relevance of our observation, it has to be 
considered that hyperphosphorylation of proteins induced by various pharmacological 
treatments is not physiological, but rather pushes the system to one side of the equilibrium. 
Secondly, our approach, immunocytochemistry, does not allow capturing the dynamic nature 
of phosphorylation events. In summary, our analysis revealed that the distribution of the 
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RIM1/2 protein is influenced by kinase activity and that hyperphosphorylation may affect the 
association of RIM1α with the CAZ.  
 
5.2 Identification of novel phosphorylation-dependent RIM1α binding proteins  
Over the years proteomics has emerged as an important tool to identify and characterize 
components of the pre- and postsynaptic terminals. Over 1000 proteins were identified in 
synaptosomes from whole mouse brain, representing the first inventory of the synaptic 
proteome (SCHRIMPF et al., 2005). Nevertheless the interactome of presynaptic proteins is not yet 
fully characterized, especially, when considering posttranslational modifications or transitory 
protein interactions. 
To identify novel potential binding partners for the N- and C-terminal region of 
RIM1α we performed affinity purifications and mass spectrometry (MS). By using this 
approach more than 100 proteins were identified to associate with either the RIM1α ZF-PDZ 
or the RIM1α C2A-C2B domains. These proteins were classified in five categories: signaling 
cascades/kinases (SC), synaptic vesicles (SV), plasma membrane/active zone (AZ), 
cytoskeleton (C) and others (O). Of these, the proteins of the signalling cascades/kinases and 
plasma membrane/active zone group accounted for nearly half of the total identified proteins. 
Another large class was the others group, which included mitochondrial proteins or proteins 
whose localizations and functions were not well known.  
In a recent study, the immunopurification and MS analysis of the presynaptic AZ 
resulted in the identification of 485 proteins, data that suggests the AZ to be enriched in 
proteins involved not only in neurotransmitter release but also in other cellular activities 
(WEINGARTEN et al., 2014). On the other hand, a comparison of the proteome of glutamatergic and 
GABA-ergic synapses showed no major differences between proteins involved in SV docking 
and release. Besides SV and AZ proteins, ion channels and transporters were also identified 
(BOYKEN et al., 2013). In accordance with Weingarten et al., we detected an overlap between our 
identified proteins and the purified AZ-proteins from their study. Similar proteins were 
presented in the SV group (vATPase subunit A, C1 and E1; synapsin-1, Rab-3A, 
phosphoglycerate kinase 1, peroxiredoxin-6, alpha-enolase, pyruvate kinase isozymes 
M1/M2, malate dehydrogenase, AP-2 subunit alpha-2, dynamin-1-like protein, clathrin light 
chain A and B); the AZ group (GLAST-1, synatxin-1B, EAAT2, SNAP-25, Thy-1, neuronal 
membrane glycoprotein M6-a, paralemmin-1, copine, thioredoxin-related transmembrane 
protein); the SC group (heat shock proteins, G proteins, 14-3-3 proteins, septin-5, 
calcineurin); the C group (tubulins, actin, septin-11, septin-6, cofilin-1, profilin-1). 
Chapter 5. Discussion 
 
90 
 
In addition to these, the known binding partners of RIM1α were purified from mouse 
crude synaptosomes and rat primary cortical neurons: 14-3-3 proteins, ELKS2/CAST, RIM-
BP, liprins. Other putative interacting proteins, like Munc13 or voltage-gated calcium 
channels, were not identified, probably due to a technical problem or due to the transitory 
nature of the interaction. The combination of buffer stringency and incubation time may be a 
limiting factor in analysing proteins that display transitory or weak interactions with RIM1α. 
Boyken et al. did also not identify Munc13 by MS, even though it was detected by WB in the 
same preparation (BOYKEN et al., 2013).  
Whereas in the previous attempts at identifying novel RIM1α binding partners the 
posttranslational modifications were not taken into account, in this new experimental design 
we analysed the phosphorylation-dependent binding affinities between RIM1α and various 
proteins as well. Kinase and phosphatase blockade triggered changes in the phosphorylation 
status of RIM1α that were accountable for increasing or decreasing its binding affinity (Table 
5.1). In this respect, RIM1α binding to certain proteins appeared to be phosphorylation 
dependent. This was, for example the case for SRPK2 (up-regulation with phosSTOP) and 
VAP proteins (up-regulation with staurosporine).  
 
Table 5.1: The number of proteins binding the different regions of RIM1α under various pharmacological 
treatments. The values represent the number of proteins binding RIM1α in only one condition. Four 
independent measurements were performed with the RIM1α C2A-C2B region, and two with the RIM1α ZF-PDZ 
region.    
  
Region (RIM1α) Staurosporine treatment phosSTOP treatment 
ZF-PDZ 18 3 
C2A-C2B 29 25 
 
 Several proteins were chosen to be further investigated in biochemical assays, due to 
their direct involvement in AZ assembly. In this study we focused in particular, on four novel 
binding partners for RIM1α: two kinases (ULK and SRPK), trafficking proteins (VAPA, 
VAPB) and a calcium binding protein (copine VI).  
 
5.2.1 Two novel potential kinases associate with RIM1α protein  
The analysis of the protein complexes bound to the C2-domains of RIM1α identified two 
classes of kinases: serine/threonine kinases (ULK family) and serine/arginine kinases (SRPK 
family), which have been recently described as novel potential regulators of AZ assembly 
during synaptic plasticity and synaptogenesis (JOHNSON et al., 2009; NIERATSCHKER et al., 2009; 
WAIRKAR et al., 2009). To date nothing is known about the mammalian homologs with regard to
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AZ function. Here, we report the direct binding between the presynaptic protein RIM1α and 
the members of the ULK and the SRPK family, respectively.   
 
5.2.1.1 Unc-51-like kinase (ULK) binds the C2-domains of RIM1α 
In our MS data, ULK2 was only identified with a low score. However, due to its suggested 
role in AZ assembly, the potential interaction with the presynaptic protein RIM1α was 
investigated. Using several independent biochemical approaches we found: (1) both ULK1 
and ULK2 bind both C2-domains of RIM1α; (2) the interaction with RIM1α is mediated by 
their kinase domains; (3) inactivation of the catalytic activity of ULKs, by impairing the ATP 
binding site (K46R in ULK1, K39T in ULK2) (TOMODA et al., 1999; YAN et al., 1999), completely 
abolished its binding affinity for RIM1α. The presence of a lysine residue in the ATP pocket 
site ensures the autophosphorylation of the ULK1/2-spacer region that positively regulates 
kinase activity (TOMODA et al., 1999; YAN et al., 1999). It’s believed that once autophosphorylation 
is impaired, the binding affinity of ULK1 and ULK2 for other substrates, like RIM1α protein, 
will decrease. Such is the case for fibroblast growth factor receptor substrate 2/3 that acts as 
substrate for WT-ULK1 and ULK2. In the presence of the kinase deficient form of ULK2 
(K39T) the FRS2/3 is no longer bound and phosphorylated (AVERY et al., 2007). 
Besides autophosphorylation, the activity of ULK1/2 is also under the control of other 
kinases. AMPK kinase for example, phosphorylates S555 of ULK1, thereby promoting the 
binding of ULK1 to 14-3-3 adapter proteins (BACH et al., 2011). 14-3-3 proteins are conserved 
regulatory molecules, able to bind a multitude of proteins, like S413 phosphorylated RIM1α 
(KAESER et al., 2008a) or S2845 phosphorylated Bassoon (SCHRÖDER et al., 2013). Thus, ULK kinases 
may act either directly, binding and phosphorylating RIM1α protein, or indirectly by 
modulating the function of other classes of proteins, such as adapter proteins. 
ULK kinases have an unique phosphorylation recognition motif characterized by 
hydrophobic residues at multiple positions. According to peptide arrays the amino acids M, L 
and S are preferred in position -3; F, V, I and Y in positions +1 and +2; while L can be found 
at position +2 as well (PAPINSKI et al., 2014). Phosphorylation sites encompassing all these 
criteria were not found in RIM1α; however, this does not exclude phosphorylation at 
unconventional sites. 
The positive interactions between ULKs and RIM1α were further supported by co-
localization experiments in primary neuronal cultures. Both ULK kinases showed co-
distribution with both the presynaptic proteins Bassoon and RIM1α, and the postsynaptic 
marker PSD-95. However, the degree of overlap with the presynaptic proteins was smaller 
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than with the postsynaptic marker. Studies in embryonic sensory neurons indicated that both 
ULK1 and ULK2 were present in axons and in growth cones, where punctuate structures were 
observed (ZHOU et al., 2007). 
In all our biochemical studies RIM1α was able to bind both ULK1 and ULK2. This 
could be explained by the fact that both ULK1 and ULK2 have a high sequence homology 
(TOMODA et al., 1999). The mRNA expression profiles of ULK1 and ULK2 in adult mice indicate 
that the level of ULK1 in the cortex and hippocampus are much lower compared to ULK2 
(Allen Brain Atlas7). Therefore, it remains to be elucidated if both isoforms or only one of 
them plays any significant role in the presynaptic compartment.  
The ULK family, part of the serine/threonine kinase group, comprises five members, 
of which only two, ULK1 and ULK2, were shown to be expressed in brain (TOMODA et al., 
1999). Whereas the role of ULK proteins in autophagy is documented (review: ALERS et al., 2012), 
their involvement in maintaining the CAZ is less well understood. ULK kinases have been 
linked to various processes from neurite outgrowth (TOMODA et al., 2004; ZHOU et al., 2007; OGURA 
et al., 2010) to the assembly of the AZ ultrastructure in D.melanogaster (WAIRKAR et al., 2009).  
ULK kinase regulates axon formation in cerebellar neurons via the SynGAP-ULK-
Syntenin-1 complex (TOMODA et al., 1999). Moreover, Syntenin-1 co-localizes within the 
presynaptic terminal with ELKS, contributing to the organization of the AZ (KO et al., 2006). 
ELKS, on the other hand, interacts with the PDZ-domain of RIM1α, possibly controlling 
either its distribution in cultured neurons (OHTSUKA et al., 2002; WANG et al., 2002) or inhibiting 
Ca2+-channel binding to RIM1α and attenuating neurotransmitter release (KAESER et al., 2011). 
Via ELKS-Syntenin-1, ULK kinases might act on RIM1α and on other presynaptic proteins 
promoting changes in AZ architecture. Additionally, ULK may regulate the interaction 
between RIM1α-ELKS or RIM1α-Ca2+-channels as well, which could have a direct impact on 
AZ ultrastructure or on the release machinery.    
The postulated role of ULKs proteins in controlling AZ density and composition is 
based on studies in D.melanogaster, where ULKs regulate the localization of Bruchpilot 
(ELKS homolog) protein opposite to the glutamate receptors at synapses. The mechanism of 
action relies on the inactivation of ERK2 kinase by ULK, thereby promoting synapse 
development. Unc-51/ULK mutants displayed increased ERK2 kinase activity, while 
Bruchpilot was absent from many synapses (WAIRKAR et al., 2009). Since in mammalian cells 
RIM1α is a substrate for ERK2 kinase (SIMSEK-DURAN and LONART, 2008), it is tempting to 
speculate that ULK kinase may indirectly influence RIM1α phosphorylation level and in
                                                            
7 http://mouse.brain-map.org 
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NIERATSCHKER et al., 2009) may indicate that other presynaptic proteins could act as mediators 
between SRPK79D and Brp.  
One such protein could be RIM1α. The following data favours the idea that RIM1α 
could act as a possible substrate for SRPK2: (1) the high affinity of SRPK2 for the C2A-
domain of RIM1α; (2) bioinformatical identification of RS dipeptides in the RIM1α sequence. 
Thus, SRPK2 could directly associate with RIM1α and phosphorylate it. Besides the RS 
dipeptides, SRPK2 may also phosphorylate unconventional sites in RIM1α, like the one 
previously described in Tau proteins-‘PSLP’ (HONG et al., 2012). Analysis of the RIM1α binding 
in the presence of a docking grove mutant (SRPK2-DM) revealed only a slight decrease in the 
RIM1α binding affinity compared to SRPK2-WT control. Moreover, deletion of both, the N-
terminal region, important for the kinase activity, and the linker region, triggered as well a 
decrease in RIM1α binding affinity. Because in the presence of these truncated proteins, the 
binding to RIM1α was not completely abolished, the only regions from SRPK2 that could 
directly mediate these affinities are the catalytic domains. In consequence it remains to be 
elucidated, which kinase domain is directly involved in this interaction.  
  Up to date, only two proteins, SNAP25 and Syt1, were identified to bind the C2A-
domain of RIM1α (COPPOLA et al., 2001). However, NMR studies were not able to confirm these 
findings (DAI et al., 2005). Identification of SRPK2 may represent the first specific binding 
partner for the RIM1α C2A-domain. The exact role of the C2A-domain in RIM proteins has 
not been fully elucidated. One point mutation in the C2A-domain of RIM1α (R844H) was 
linked to the autosomal dominant cone-rod dystrophy-CORD7, characterized by impaired 
vision due to the reduction in the cone and rod sensitivity (JOHNSON et al., 2003; MICHAELIDES et al., 
2005). Individuals with such mutations display enhanced cognitive functions in at least the 
verbal and executive domains (SISODIYA et al., 2007). 
IF studies support the co-localization of SRPK2 and RIM1α in the presynaptic 
compartment, despite the fact that the detected level of SRPK2 at synapses was significantly 
lower than at the soma. However, this is in agreement with the previous report of Nieratschker 
et al. (2009), where they could show that the expression level of SRPK79D was low and not 
well detected by the antisera raised against this protein. According to the Allen Brain Atlas, 
the mRNA expression level of SRPK2 in adult mouse brains seems to be low in the cortex 
compared to hippocampus. Because all our immunohistochemistry was performed with 
cortical neurons, a further investigation of the co-localization of SRPK2 and RIM1α in 
hippocampal neurons should be conducted as well.  
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Whereas studies in D.melanogaster suggested an important role for SRPK2 in 
preventing the ectopic formation of AZs within the axons (JOHNSON et al., 2009; NIERATSCHKER et 
al., 2009), the role of SRPKs in mammalian neurons, in particular in AZ formation, has not 
been fully addressed. The molecular mechanism by which SRPK79D prevents the unspecific 
accumulation of Brp at unconventional sites is not understood. However, it could be 
hypothesised that in mammalian cells SRPK2 might act in a similar way, regulating the 
assembly of AZ as well. Phosphorylation of RIM1α by SRPK2 may protect RIM1α against an 
unspecific accumulation/aggregation in different parts of the cell preventing in this way a 
premature assembly of the AZ. Once RIM1α reaches the correct destination (synaptic 
bouton), phosphatases could remove some of the phosphate groups promoting protein-protein 
interactions to occur. Additionally, certain functions of presynaptic proteins may be directly 
regulated by SRPK2 kinase activity. In this respect, the amount of SRPK2 present in the 
presynaptic terminal may be critical. Intriguingly, our IF data revealed that by blocking the 
activity of SRPK1 and SRPK2, a slight increase in the co-localization of SRPK2 with RIM1α 
was detected in the boutons. Because no sufficient data is available regarding the 
irreversibility of the inhibitor SRPIN340, we cannot conclude whether this presynaptic 
accumulation of SRPK2 represents active or inactive kinase.  
Besides affecting the functions of presynaptic proteins, SRPK2 might promote 
changes in AZ architecture, by targeting the cytoskeleton as well. It has been reported that 
SRPK2 binds and phosphorylates Tau proteins (tau proteins stabilize the microtubules) 
impairing tau-dependent microtubule polymerization and neurite outgrowth (HONG et al., 2012). 
Hong et al. (2012) also showed that the knockdown of SRPK2 in the hippocampus of the 
Alzheimer’s disease mouse model (APP/PS1) impact presynaptic functions. The amplitude of 
pair pulse facilitation (PPF), an indicator of presynaptic activity, was elevated in APP/PS1 
mice, in which SRPK2 levels were decreased by injecting a lentivirus expressing a specific 
shRNA against this kinase (LV-shSRPK2), compared to WT. Unfortunately no 
electrophysiological data comparing the WT versus WT LV-shSRPK2 mice was presented. 
An increased in PPF was also measured in RIM1α KO mice, consistent with a reduced release 
probability (SCHOCH et al., 2002; PITSCH et al., 2012). Thus, it can be hypothesized that SRPK2 by 
phosphorylating various substrates may impact proper synaptic transmission. In 
D.melanogaster the deletion of SRPK79D does not induce any significant changes in the 
synaptic transmission at the NMJs (NIERATSCHKER et al., 2009). However, an overexpression of 
this kinase impaired synaptic transmission, probably by disrupting either the assembly of T-
bars or the AZ organization (JOHNSON et al., 2009). Due to multiple effects this kinase might 
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have on various presynaptic proteins, further experimental data are necessary to explain 
whether SRPK2 acts as a negative regulator of AZ assembly, similar to D.melanogaster, or 
has a more subtle role in controlling diverse aspects in synaptic transmission.  
 
5.2.2 VAPA/B proteins bind specifically the C2A-domain of RIM1α  
The protein VAPA was identified with relative high scores in our MS analysis with both 
crude synaptosomes and neuronal cultures. In addition, the treatment of mouse crude 
synaptosomes with a kinase inhibitor (staurosporine) increased the level of VAPA detected by 
MS compared to the phosSTOP or control samples. These results corroborated with GST-pull 
down assays, in which kinase blockade increased not only the endogenous level of VAPA but 
also the binding affinity to the C2A-domain of RIM1α. Thus, a global kinase inhibition seems 
to favour the binding between RIM1α and VAPA. 
The VAP protein family includes two highly homologous members: VAPA and 
VAPB/C (NISHIMURA et al., 1999). Both VAPA and VABP were identified to bind exclusively 
the C2A-domain of RIM1α in various biochemical assays, potencially due to their high degree 
of sequence homology. However, in our MS data we only detected VAPA, even though 
VAPB is expressed more abundantly in the brain (Allan Brain Atlas), indicating a preferential 
binding of VAPA to RIM1α.  
Interestingly, the mutation of two threonine residues (T812/814A) in the RIM1α C2A-
domain completely abolished the binding of RIM1α to VAPA. Bioinformatics predicts these 
threonines to be part of a PKA recognition motif. Either these threonine residues are 
necessary to mediate the direct binding of the RIM1α C2A-domain to VAPA or the 
phosphorylation status of these amino acid residues could impact the binding.   
Taken together, this study shows that: (1) VAP proteins, and especially VAPA, bind 
specifically the RIM1α C2A-domain; (2) this association seems to be mediated by the 
threonine residues in the RIM1α C2A-domain. 
Even though, Teuling et al. reported that VAPB did not co-distribute with presynaptic 
proteins, we observed that in rat cortical neurons these proteins were present in the same 
presynaptic compartment. The highest VAPA/B signal was detected, as previously published, 
in the soma, where the ER compartment is located (TEULING et al., 2007). However, IF analysis 
revealed that both VAP proteins showed a weak co-localization with endogenous RIM1α and 
Bassoon at the synapse. Because VAPs are actively involved in trafficking, their steady-state 
levels at synapses might be low. 
Initially, VAP proteins were associated with plasma membrane fusion events in 
neuronal cells, via their interaction with Synaptobrevin/VAMP-2 protein (SKEHEL et al., 1995; 
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WEIR et al., 1998). However, later studies have shown that VAPA was not directly involved in 
SVs exocytosis but rather involved in regulating the organization of the ER (AMARILIO et al., 
2005) and in ER-Golgi trafficking (KUIJPERS et al., 2013). Moreover, it was hypothesised that 
VAPA might play a role in trafficking or chaperoning vesicular components such as VAMP-2 
through the ER to the presynaptic compartment (SKEHEL et al., 2000). The hypothesis of VAP 
proteins being actively involved in protein trafficking is supported by the fact that the 
D.melanogaster homolog, DVAP-33A was identified to selectively transport proteins to 
axonal processes (YANG et al., 2012). A reduction in the presynaptic DVAP-33A induced 
structural changes, like the disruption of synaptic microtubules and the accumulation of 
clusters of proteins and SVs along the axons (FORREST et al., 2013). In mouse cortical neurons 
VAPA is transported, through its interaction with protruding via KIF5, from the soma to 
neurites (MATSUZAKI et al., 2011). All these data could suggest a potential role of VAP proteins in 
assisting the selective transport of various axonal proteins, such as RIM1α, to either nascent 
or mature AZs. Therefore, we may speculate that besides VAMP-2, RIM1α could also be 
trafficked to the synaptic bouton via VAP proteins, a transport dependent on the 
phosphorylation status of both proteins. Future experiments will try to decipher the role of 
phosphorylation events in controlling the traffic of RIM1α. 
Moreover, studies on DVAP-33A provide evidence of its importance in bouton 
formation by mediating the interaction between microtubules and presynaptic membranes 
(PENNETTA et al., 2002). DVAP-33 overexpression in presynaptic terminals induced an increase 
in the number of boutons that displayed a significantly reduced size and contained fewer 
vesicles (PENNETTA et al., 2002; CHAI et al., 2008). With respect to the total number of AZs Chai et 
al. (2008) did not observe any significant changes, while Ratnaparkhi et al. (2008) observed a 
decrease in the number of AZs. The study of Ratnaparkhi et al. suggests that VAP proteins 
might control the structural remodelling of AZs. However, up to date there not sufficient data 
connecting VAP proteins and AZ assembly in mammalian neurons.  
Besides the suggested role in protein transport and bouton formation, VAP proteins 
could be actively involved in AZ protein sorting in ER-Golgi as well (Fig. 5.2). Active zone 
proteins are processed in the soma of neurons in different ways. While Piccolo, Bassoon and 
ELKS share a common Golgi-derived transport vesicle, Munc13 exits the soma on a distinct 
Golgi-derived vesicle. Surprisingly, RIM1α associates with transport vesicles in a post-Golgi 
compartment. However, to date the molecular mechanism governing this sorting is not well 
understood (MAAS et al., 2012). Thus, an intriguing question is the potential involvement of VAP 
proteins in sorting RIM1α in the ER-Golgi compartment. VAPA was shown to be involved
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Our biochemistry data suggests a strong preference of Copine VI for the C2B-domain 
of RIM1α, while binding to full-length RIM1α is Ca2+-dependent. Since RIM1α C2-domains 
lack the amino acids necessary to bind calcium ions (COPPOLA et al., 2001; GUAN et al., 2007), only 
the C2-domains of Copine VI  are able to bind these divalent ions.  
Because these C2-domains can form homo- or heterodimers, the MS data was 
analysed for increased occurrence of C2-domain containing proteins, such as Synaptotagmin1 
or other copines. Such proteins, associating with the C-terminal part of RIM1α, were scarcely 
present in our MS data. Moreover, other copines were not detected in the MS. Together these 
observations support the specificity of the interaction.  
Previous reports have suggested that Copine VI is enriched in the postsynaptic 
terminal (Alexander Kriz, 2010; urn: urn:nbn:ch:bel-bau-diss89692). However, our IF of endogenous 
Copine VI in primary cultured neurons also suggests a presynaptic localization, where it 
partially co-localizes with the presynaptic protein RIM1α. Therefore, Copine VI might be 
present on both pre- and postsynaptic terminals, mediating different cellular processes. 
Additionally, the study of Nakayama showed that Copine VI could be present in low amounts 
in some parts of axons as well (NAKAYAMA et al., 1999). Unpublished data of our collaborators 
attribute to Copine VI a presynaptic function as well, e.g. the regulation of SV fusion. 
In summary, identification of Copine VI, as a potential binding partner for RIM1α, 
may point to a possible link between the function of RIM1α and the calcium-dependent events 
in the presynaptic terminal. Future experiments will be performed in order to examine the 
relevance of this interaction in the presynaptic terminal. 
 
5.3 Identification of novel SV2A binding partners: new experimental approaches  
Because of the still enigmatic function of the synaptic vesicle protein 2A (SV2A) in synaptic 
transmission and neuronal network plasticity, identification of novel potential binding 
partners for SV2A could provide insights into its role at synapses. 
SV2A is 12-pass transmembrane protein with a high degree of posttranslational 
modifications that include a highly glycosylated intravesicular loop and a N-terminus 
containing at least ten phosphorylation sites (review: MENDOZA-TORREBLANCA et al., 2013). To date 
only a limited number of binding partners for SV2A have been identified, such as 
Synaptotagmin1 and clathrin adaptor proteins (review: MENDOZA-TORREBLANCA et al., 2013; YAO et 
al., 2010), whose functional relevance for the function of SV2A are still unclear.  
Since the previous strategies to purify and identify novel SV2A binding partners were 
based mainly on GST pull-down or yeast two-hybrid assays using only parts of SV2A and did 
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not take into the account the posttranslational modifications (SCHIVELL et al., 1996; YAO et al., 
2010), we attempted to analyse the binding partners of overexpressed SV2A using a tandem 
affinity purification method. By applying one- or two-step purifications we aimed at the 
identification of specific SV2A binding partners by maintaining at the same time the native 
SV2A protein conformation. Therefore, a FLAG/Strep sequence was tagged either in the N- 
or C-terminus of SV2A in order to detect any differences in SV2A binding affinities. 
Different approaches were tested in order to co-purify SV2A and its potential binding partners 
both from cortical neurons as well as from transduced mouse brain.    
Purification of overexpressed SV2A from brain by employing the tandem-affinity 
methodology proved to be inconsistent between different trials. The major problems that we 
encountered were: (1) the expression level of the recombinant protein did not give a good 
yield after purification because either the viral titer was not high enough or the virus did not 
express high levels of protein; (2) the purification methodology used to co-purify the tagged-
SV2A had an unsatisfactory efficiency. During different approaches of purification, in most 
of the cases, the recombinant protein was lost, especially when the Strep column was used, 
either because the column was not able to retain the applied material (technical problem) or 
the Strep sequence in the tag was masked by various protein contaminants. In the case of 
FLAG-beads, most of the captured SV2A could not be eluted from beads. In contrary to the 
poor yield of SV2A after purification from brain, sufficiently high amounts were obtained 
when mouse primary cultured neurons were used as starting material.  
It has been demonstrated that the number of SV2A molecules per SV is critical for its 
function (TAKAMORI et al., 2006; NOWACK et al., 2011). Therefore, to avoid high levels of 
overexpressed SV2A in addition to the endogenous one, neuronal primary cultures were 
prepared from SV2A+/- or SV2A -/- mice. Moreover, to fix transient and/or weak interactions 
between SV2A and other proteins, a series of cross-linkers were used. However, neither the 
cross-linkers nor the primary cultures prepared from KO treatment produced a visible 
enrichment in the co-purified proteins. Because we could not see an improvement, wild-type 
neuronal cultures were further used for the final experiment. Compared to heterozygous or 
knock-out neurons, WT neurons allowed for a higher amount of starting material. Preparation 
of neuronal cultures from heterozygous or knock-out mice was limited to the number of 
embryos available at a certain time-point, since KO SV2A mice cannot be breed (CROWDER et 
al., 1999). 
The analysis of protein complexes co-precipitated with SV2A by MS revealed several 
proteins previosly reported to associate with the N-terminal region of SV2A (YAO et al., 2010), 
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like: AP-1 complex, Transcriptional activator protein Pur-beta, Tubulin beta-2A chain, Syt1. 
Additionally, other proteins were identified by MS, e.g. Latrophilin, EHD1; however, none of 
these potential SV2A binding partners could be verified in binding assays.  
Overall, the attempt to identify novel potential interacting partners for SV2A has been 
unsuccessful. This might be due to the fact that interactions require the native structure of the 
12-transmembrane protein, a structure that in turn could have hampered the purifications of 
the SV2A proteome. Even though the detergent, used to solubilize SV2A under native 
conditions, was reported to maintain SV2A’s binding properties to Syt1 and Keppra (anti-
epileptic drug) (LAMBENG et al., 2006), it might not have preserved the native structure and 
therefore interactions might have been lost. According to various protein-protein databases8, 
also for other multi-pass membrane proteins, e.g. synaptophysin or SCAMP, fewer binding 
partners are known. 
Over the years different functions have been attributed to SV2A, like: neurotransmitter 
transport, gel matrix (the sugar moieties attached to the intravesicular loop may hold and 
release neurotransmitters) or modulator of exocytosis (review: MENDOZA-TORREBLANCA et al., 2013).  
Experimental data suggest that SV2A mediates SV fusion by regulating the action of Syt1. 
The N-terminal region of SV2A binds and keeps Syt1 inactive until the level of intracellular 
calcium rises. Once the calcium level is high the binding is disrupted and Syt1 interacts with 
the SNARE complex facilitating SV fusion. Additionally, during endocytosis SV2A binds 
Syt1 and prevents its diffusion. The recycling after SV fusion is mediated by clathrin adaptor 
proteins that bind both Syt1 and SV2A (review: MENDOZA-TORREBLANCA et al., 2013). The fact that 
these proteins, Syt1 and various adaptor proteins have been identified by our MS may suggest 
that SV2A, in order to fulfil its function, does not require a large number of interacting 
proteins. 
Because our attempt to purify and resolve the SV2A proteome was not successful, 
other novel approaches are needed to be developed, e.g. generation of a knock-in mouse 
model expressing a tagged SV2A. Such a model would give the opportunity to study more 
closely not only the potential binding partners of SV2A but also the function of this protein.       
 
 
 
 
                                                            
8 http://www.uniprot.org/uniprot/P07825 (synaptophysin, R.norvegicus) 
  http://www.uniprot.org/uniprot/P56603 (SCAMP, R.norvegicus) 
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6. Outlook 
Taken together, the results of this thesis identified four novel RIM1α binding partners: two 
kinases, a calcium binding protein and proteins involved in trafficking and bouton formation. 
The next step will be to investigate the functional relevance of these new RIM1α binding 
proteins. Therefore, the following three major questions will need to be addressed in future 
experiments: 
1. The role of SRPK2 and ULK1/2 in maintaining or/and controlling the AZ architecture and 
composition. In this regard, the role of these novel kinases in the presynaptic terminal should 
be investigated by using a specific SRPK2 inhibitor (SRPIN340) as well as shRNA-mediated 
knock-down in neuronal cultures. In addition, it will be necessary to examine the possible 
contribution of these kinases in controlling the release machinery, for example by measuring 
the SV exo- and endocytosis using the fluorescent FM-dyes. Moreover, electrophysiological 
recordings of neuronal cultures treated with either shRNA or SRPIN340 would be useful to 
reveal any changes that may occur during synaptic transmission when kinase function is 
blocked. Additionally, it will be necessary to examine whether RIM1α is a direct substrate of 
these kinases.  
2. The role of VAP proteins in modulating the  function or trafficking of RIM1α. It should be 
tested if VAP proteins play a role in trafficking presynaptic proteins to the boutons, in 
particular RIM1α. Analysing if the absence of VAPA and/or VAPB results in an impairment 
of RIM1α trafficking, could be tested by confocal live-imaging. Next, it should be examined 
the functional relevance of C2A-domain phosphorylation in respect to the function of VAPA. 
To evaluate whether VAP proteins may constitute a link between the core release machinery 
and RIM1α, electrophysiological recordings of neuronal cultures overexpressing WT or 
T812/814A RIM1α (point mutations in the C2A-domain that abolished the binding to VAPA) 
could be performed.  
3. The role of the interaction between the calcium-binding protein, Copine VI and RIM1α in 
presynaptic plasticity. To address the function of Copine VI, shRNAs targeting specifically 
Copine VI will be used to investigate whether this protein has any major impact on the 
function of RIM1α and on synaptic transmission.  
 
Because the amount of SV2A seems to be critical for its function, a knock-in mouse 
model could be generated by inserting a tag in SV2A locus. Expression of this new tagged 
protein could be analysed in the whole brain. Moreover, the tagged SV2A could be purified 
from either whole brain or specific brain area in order to identify novel interacting partners. 
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7. Summary 
Synaptic plasticity encompasses various cellular mechanisms, which confer synapses the 
ability to react and adapt to ongoing changes in network activity. Some of the suggested 
mechanisms include remodelling and/or assembly of active zones (AZ), and modulation of 
neurotransmitter release. At the molecular level posttranslational modifications of proteins, 
e.g. phosphorylation, have been reported to be associated with these events. Two components 
of the release machinery, RIM1α and synaptic vesicle protein 2A (SV2A) were shown to be 
actively involved in presynaptic plasticity. However, the impact of posttranslational 
modifications, like phosphorylation, on the function of these proteins is not well understood. 
Therefore, the goals of this thesis were:  
(1) To examine the impact of phosphorylation on the binding properties of RIM1α;  
(2) To identify and analyse novel binding partners for SV2A. 
We found that the distribution of RIM1α at synapses is altered after globally 
increasing the level of phosphorylation, while its total level remained unchanged, suggesting 
that the association of RIM1α with the CAZ is controlled by its phosphorylation status. 
Affinity purification and MS revealed that alterations in the phosphorylation status of RIM1α 
affected its affinity to specific binding partners. Out of the identified proteins, four candidates 
with a potential functional link were chosen to be further analysed in binding assays: two 
kinases (unc-51-like kinase 1/2, serine arginine protein kinase 2), one calcium-binding protein 
(Copine VI), and proteins involved in trafficking (vesicle-associated membrane protein 
(VAMP) associated-protein A/B). Interestingly, RIM1α may represent the first AZ substrate 
for ULKs and SRPK2, which in D.melanogaster have already been linked to the assembly of 
AZs. This may support the hypothesis that both ULKs and SRPK2 could be actively involved 
in controlling not only RIM1α’s function but also its association with the CAZ. VAP proteins, 
by specifically binding the C2A-domain of RIM1α, may contribute to control the trafficking 
of RIM1α to the synapse. Copine VI may regulate the function of RIM1α in a calcium-
dependent manner. Further analysis will reveal if these novel interactions may have any 
functional relevance for the function of RIM1α. In summary, we identified novel RIM1α 
binding partners, of which some interact with RIM1α in a phosphorylation-dependent manner. 
Further studies will have to examine if these are involved in mediating the association of 
RIM1α with the CAZ or its role in plasticity. 
The last part of the study was dedicated to another presynaptic protein, SV2A. To date 
the role played by SV2A in SV priming is not fully elucidated. Therefore, to gain insight into 
the enigmatic function of SV2A identification of novel binding partners was pursued. 
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Different affinity purification strategies coupled to MS were performed in order to identify the 
SV2A proteome. However, none of these approaches resulted in the identification of novel 
interacting proteins, which could be further verified in biochemical assays.  
Taken together, the findings of this thesis may form the basis for further functional 
studies in order to decipher the molecular mechanisms underlying the function of RIM1α and 
in consequence, the role of RIM1α in presynaptic plasticity. 
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8.2 cDNA and Protein sequences 
8.2.1 RIM1α cDNA sequence (R.norvegicus)- NCBI Ref. seq: NM_052829.1 
[atgtcctcggccgtggggccccgaggtcctcgcccacccacggtgcctccccctatgcaagaactgcccgacctgagccacctgaccgaggaggagaggaac
attatcatggcagtgatggaccggcagaaggaagaggaggaaaaagaagaggccatgctcaa]E1gtgtgttgtcagggacatggcgaagcctgctgcctgcaa
aacaccaagaaatgctgaaagccagccccatcaaccaccact]E2gaacattttcagatgtgtctgtgttcccagaaagccaagcagcgaagagggaggcccaga
aagagactg]E3gagattgcatcaacagtttgaaagctacaaggagcaagtgagaaaaatcggagaggaagcgaggcgttaccagggcgagcacaaggatgat
gccccgacgtgtggaatctgtcataagacaaagtttgctgatggatgtggccatctctgctcctattgtcgcaccaagttctgtgcacgctgcggaggccgtgtgtctc
tgcgatcgaacaatgaggacaaagtg]E4gttatgtgggtatgcaatttatgtcgaaagcaacaagaaatcttaacgaaatctggagcgtggttctttggaagtggccc
tcagcagcctagtcaagatgggactctgagtgacacggccacaggtgctggatctgaggtgccaagagaaaagaaagcaaggctccaagagcgatcaaggtctc
agacgcccttgagtacagcagctgtctcttcccaagacactgctacccccggtgcaccgttgcacaggaacaaaggggctgagccctcacagcaagccttgggtc
ctgaacagaagcaggcatcaagatcaagaagcgagccaccgagggaaag]E5gaagaaggctccagggctttcagagcagaatggcaagggaggccagaag
agcgagcgcaaacgtgtccccaagtctgtggtgcaacccggggaagggatcgcggatgagagggagaggaaagagaggcgggaaacccgcaggttggaga
aagggcgctcccaggactactcagaccggcctgagaaacgcgacaatggcagggtggcggaagaccagaagcagaggaaggaggaggagtaccagactag
gtaccgcagcgaccctaacctggctcgctacccggtgaaggcgccgccagaggagcagcagatgcgcatgcacgcccgggtgtcccgagcgaggcacgagc
ggcgccacagcgacgtggcgctcccgcacaccgaggcagctgccgccgcgccggctgaggccacggcgggcaagcgcgcgccggccaccgccagggtct
ctcccccggagtccccgcgcgcacgcgcggcggccgcccagcctcccaccgagcacgggccaccgccgccgcggccagccccgggtcccgcagagccac
ccgagccgcgcgtccccgagccgctccgtaagcagggccgcctggacccgggctcggccgtgcttctgcgcaaggccaagcgcgagaaggcggagagcatg
ctgcggaacgactcgctgagctccgatcagtccgagtccgtgcggccatccccgcccaagcctcaccggcccaagcggggaggcaagagacgtcagatgtcg
gtgagcagctcggaggaggagggcgtgtccacaccggagtacacgagctgcgaggacgtggagctggagagcgagagcgtgagcgagaaag]E6gtgactt
ggattactactggttggatcccgccacgtggcacagcagggaaacgtcgcctatcagttcg]E7catcctgtaacgtggcagccgtctaaagagggagatcgacta
atcggccgtgttattcttaacaaaagaacaaccatgcccaaagaatcaggtgcattattgggtctgaag]E8gtggttggaggaaaaatgacggacttagggcgcctt
ggtgctttcatcaccaaagtaaagaagggcagcctggcagacgtcgtcggacacctaagagcag]E9gggacgaagtcctagagtggaatggtaaacccctgcc
gggagcaacaaacgaagaagtttacaacattatcttagaatcaaaatcagaacctcaagttgagattattgtttcaaggcctattgg]E10tgacatccccaggatccct
gagagttcccatcctcccctggagtcca]E11gttcaagttcctttgaatctcagaaaatggaaaggccttctatttctgttatttctccaaccagccctggagctctgaaa
gatgccccacaagtcttaccagggcaactctca]E12gtgaagctatggtatgataaagtggggcaccagctgattgtaaatgttctacaagcaacagatctaccccct
agagtagatggccgtcccaggaatccctatgtaaaaatgtattttcttccagatagaag]E13cgacaaaagtaaaaggagaaccaaaacagtaaagaaacttctaga
gccaaaatggaaccagacatttgtctactcacacgtacatcgtagagattttcgagagcgaatgttagagattaccgtgtgggaccagccgagagtacaggacgaa
gagagtgaatttcttggagag]E14atcctcatagagttggaaacagcgcttttagatgatgagccccattggtataaactccagacacatgacgaatcttcactacctct
gcctcagccatcaccgttcatgcccaggcggcatattcatggagagagctccagcaaaaagctacaaa]E15gatctcagcgaatcagtgatagtgacatctcagatt
atgaggttgatgatggtattggagtagtgcctccag]E16tgggttatagagctagtgctagagagagtaaagcaaccacgttaacagtgccagagcaacaaagaac
tacacatcaccgctcacgttccgtgtctcctcatcgcggcgatgatcagggaaggcctcgttcacgtttaccaaatgtgccattacagag]E17gagcttagatgaaatt
catccaacacgaaggtcacgttctccaacccgacaccatgatgcctcccgaagcccggccgatcacagatccagacatgtggaaagtcaatattcgtcagagcca
gacag]E18tgagcttctcatgctgcccagagcaaaacgaggacgaagtgcagaaagcctacacatgaccaga]E19gaccttgttaggtactctaacacattacca
cccaagatgcctttattacaaaacgactaccgttggagcagcagt]E20gaactgcagccctctcttgacagggctaggagtgctagtaccaactgcttgagaccaga
tactagtttgcattcaccagaacgagaaag]E21gggtagatggtccccctccctagataggaggcgacctgctagccccaggattcaaatccagcatgcatctccg
gagaatgacag]E22gcactccagaaagtctgaaagatgtagcatccaaaaacagtctaggaaaggcacagcctctgatgcagacag]E23ggttctcccaccatg
cctttctagaaggggatacgcaaccccaagagcaaccgatcaaccggtcgttaggggaaagcatcccactcgttcacggtcgagcgagcactctagtgtcagaac
cctgtgttctatgcaccaccttgcccccggagggtcggcgccaccttctccacttctgacaag]E24aacgcaccgacaaggaagcccaacccagtctcctccagca
gacacatccttcggcagtcgccgtggaagacagctcccacaggtgccagttcgaagcggcagtatagaacaag]E25caagcttagtagtggaggagcgaacga
gacagatgaaagtgaaagttcaccgatttaagcagacaacagggtctgggtctagtcaagaacttgaccacgagcaatactccaag]E26tacaacatacataaaga
tcagtacagaagctgtgataacgcgtctgccaagtcttcagatagtgatgtcagtgatgtgtccgccatttccagagccagcagtacctcacgcctcagcagcacaa
gctttatgtcagagcagtctgagcgccccaggggtaggatcag]E27ttcatttacccccaaaatgcaaggcagacggatggggacttcaggaagagccatcatca
agagcaccagtgtaagtggagagatatatacactggaacgtaatgacggtagccagtcggacacggccgtaggtaccgtcggagccggtggaaagaaacgaag
atccagcctgagcgccaaagtggtagccattgtgtctcgaagaagcaggagcacgtcacagctcagccagacag]E28agtcgggccacaagaagttgaaaagc
accatccagaggagtacggaaacaggaatggcagctgaaatgcggaagatggtgagacagccgagccgggagtccacggatggcagcatcaacagttatagct
cggaaggaaa]E29cttgatatttcctggagttcgagtaggacccgacagtcagttcagtgatttccttgatgggttgggaccagcgcagctcgttggccgtcagacg
ctcgccaccccggccatgg]E30gcgatatccaaatcgggatggaggataagaagggtcagttggaggttgaggttatcagagcccggagccttacacaaaaacc
tggttccaaatctacacccg]E31ctccctatgtgaaagtatatcttttggaaaatggagcctgtattgccaaaaagaagacaagaattgcacggaaaactctcgatcctt
tgtatcagcagtccctggtttttgatgaaagtccacagggtaaagttcttcag]E32gtgattgtctggggtgactatggaagaatggaccacaaatgctttatgggtgtg
gctcaaatcttgttggaagaacttgatctatccagcatggtgattggatggtataaattgttccctccgtcctcactggtggatcccactctcgctcccctgacccgccg
ggcttcccaatcatctctggaaagttcgtccgggcctccctgcatccggtcatag]E33  
 
8.2.2 RIM1α protein sequence (R.norvegicus) 
MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKEEAMLKCVVRDMAKPAACKTPRNAESQ
PHQPPLNIFRCVCVPRKPSSEEGGPERDWRLHQQFESYKEQVRKIGEEARRYQGEHKDDAPTCGICHKTKFADGCG
HLCSYCRTKFCARCGGRVSLRSNNEDKVVMWVCNLCRKQQEILTKSGAWFFGSGPQQPSQDGTLSDTATGAGSEV
PREKKARLQERSRSQTPLSTAAVSSQDTATPGAPLHRNKGAEPSQQALGPEQKQASRSRSEPPRERKKAPGLSEQNG
KGGQKSERKRVPKSVVQPGEGIADERERKERRETRRLEKGRSQDYSDRPEKRDNGRVAEDQKQRKEEEYQTRYRS
DPNLARYPVKAPPEEQQMRMHARVSRARHERRHSDVALPHTEAAAAAPAEATAGKRAPATARVSPPESPRARAAA
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AQPPTEHGPPPPRPAPGPAEPPEPRVPEPLRKQGRLDPGSAVLLRKAKREKAESMLRNDSLSSDQSESVRPSPPKPHR
PKRGGKRRQMSVSSSEEEGVSTPEYTSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDR
LIGRVILNKRTTMPKESGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNE
EVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPGQLSVKLWYD
KVGHQLIVNVLQATDLPPRVDGRPRNPYVKMYFLPDRSDKSKRRTKTVKKLLEPKWNQTFVYSHVHRRDFRERML
EITVWDQPRVQDEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDS
DISDYEVDDGIGVVPPVGYRASARESKATTLTVPEQQRTTHHRSRSVSPHRGDDQGRPRSRLPNVPLQRSLDEIHPTR
RSRSPTRHHDASRSPADHRSRHVESQYSSEPDSELLMLPRAKRGRSAESLHMTRDLVRYSNTLPPKMPLLQNDYRW
SSSELQPSLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPASPRIQIQHASPENDRHSRKSERCSIQKQSRKGT
ASDADRVLPPCLSRRGYATPRATDQPVVRGKHPTRSRSSEHSSVRTLCSMHHLAPGGSAPPSPLLTRTHRQGSPTQS
PPADTSFGSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKVKVHRFKQTTGSGSSQELDHEQYSKYNIHKDQYRSC
DNASAKSSDSDVSDVSAISRASSTSRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRAIIKSTSVSGEIYTLERND
GSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRE
STDGSINSYSSEGNLIFPGVRVGPDSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQK
PGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQI
LLEELDLSSMVIGWYKLFPPSSLVDPTLAPLTRRASQSSLESSSGPPCIRS*  
 
8.2.3 ULK1 cDNA and Protein sequence (M.musculus)- Clone ID:6406755/GenBank: 
BC059835   
ATGGAGCCGGGCCGCGGCGGCGTCGAGACCGTGGGCAAGTTCGAGTTCTCTCGCAAGGACCTGATTGGACACGGCGCCTT  
 M  E  P  G  R  G  G  V  E  T  V  G  K  F  E  F  S  R  K  D  L  I  G  H  G  A  F 
CGCGGTGGTCTTCAAGGGTCGACACCGCGAGAAGCACGACCTGGAGGTGGCCGTCAAATGCATTAACAAGAAGAACCTTG  
  A  V  V  F  K  G  R  H  R  E  K  H  D  L  E  V  A  V  K  C  I  N  K  K  N  L  
CCAAGTCCCAAACACTGCTGGGAAAGGAAATCAAAATCCTGAAGGAACTAAAGCACGAAAACATCGTGGCGCTGTATGAC  
A  K  S  Q  T  L  L  G  K  E  I  K  I  L  K  E  L  K  H  E  N  I  V  A  L  Y  D  
TTCCAGGAAATGGCTAATTCTGTCTACCTGGTCATGGAGTATTGTAATGGTGGAGACCTGGCTGACTACCTGCACACTAT  
 F  Q  E  M  A  N  S  V  Y  L  V  M  E  Y  C  N  G  G  D  L  A  D  Y  L  H  T  M  
GCGCACACTGAGTGAAGACACTGTCAGGCTTTTCCTACAGCAGATCGCTGGCGCCATGCGGCTGCTGCACAGCAAGGGCA  
  R  T  L  S  E  D  T  V  R  L  F  L  Q  Q  I  A  G  A  M  R  L  L  H  S  K  G  
TCATCCACCGGGACCTGAAGCCCCAAAACATCCTGCTGTCCAACCCTGGGGGCCGCCGGGCCAACCCCAGCAACATCCGA  
I  I  H  R  D  L  K  P  Q  N  I  L  L  S  N  P  G  G  R  R  A  N  P  S  N  I  R  
GTCAAGATTGCTGACTTTGGATTCGCTCGGTACCTCCAGAGCAACATGATGGCGGCCACACTCTGTGGTTCTCCTATGTA  
 V  K  I  A  D  F  G  F  A  R  Y  L  Q  S  N  M  M  A  A  T  L  C  G  S  P  M  Y  
CATGGCTCCTGAGGTCATTATGTCCCAGCACTACGATGGAAAGGCTGACCTGTGGAGCATTGGCACCATTGTCTACCAGT  
  M  A  P  E  V  I  M  S  Q  H  Y  D  G  K  A  D  L  W  S  I  G  T  I  V  Y  Q  
GTCTGACAGGGAAGGCCCCTTTTCAGGCCAGCAGCCCTCAGGATTTGCGCCTGTTTTATGAGAAGAACAAGACACTAGTT  
C  L  T  G  K  A  P  F  Q  A  S  S  P  Q  D  L  R  L  F  Y  E  K  N  K  T  L  V  
CCTGCCATCCCCCGGGAGACATCAGCTCCCCTGCGGCAGCTGCTCCTGGCTCTGTTGCAGCGGAACCACAAGGACCGCAT  
 P  A  I  P  R  E  T  S  A  P  L  R  Q  L  L  L  A  L  L  Q  R  N  H  K  D  R  M  
GGACTTTGATGAATTTTTCCACCACCCTTTCTTGGATGCCAGCACCCCCATCAAGAAATCCCCACCTGTGCCTGTGCCCT  
  D  F  D  E  F  F  H  H  P  F  L  D  A  S  T  P  I  K  K  S  P  P  V  P  V  P  
CATATCCAAGCTCAGGGTCTGGCAGCAGCTCCAGCAGCAGCTCTGCCTCCCACCTGGCCTCTCCACCGTCCCTGGGGGAG  
S  Y  P  S  S  G  S  G  S  S  S  S  S  S  S  A  S  H  L  A  S  P  P  S  L  G  E  
ATGCCACAGCTACAGAAGACCCTTACCTCCCCAGCCGATGCTGCTGGCTTTCTTCAGGGCTCCCGGGACTCTGGTGGCAG  
 M  P  Q  L  Q  K  T  L  T  S  P  A  D  A  A  G  F  L  Q  G  S  R  D  S  G  G  S  
CAGCAAAGACTCCTGTGACACAGATGACTTTGTCATGGTCCCAGCCCAGTTTCCAGGTGATCTAGTTGCTGAGGCAGCCA  
  S  K  D  S  C  D  T  D  D  F  V  M  V  P  A  Q  F  P  G  D  L  V  A  E  A  A  
GTGCCAAGCCCCCACCTGATAGCCTGCTGTGTAGTGGGAGCTCATTGGTGGCCTCTGCTGGCCTAGAGAGCCACGGCCGT  
S  A  K  P  P  P  D  S  L  L  C  S  G  S  S  L  V  A  S  A  G  L  E  S  H  G  R  
ACCCCCTCTCCCTCTCCGACCTGCAGCAGCTCTCCCAGCCCCTCTGGCCGGCCTGGCCCCTTCTCCAGCAACAGGTACGG  
 T  P  S  P  S  P  T  C  S  S  S  P  S  P  S  G  R  P  G  P  F  S  S  N  R  Y  G  
TGCCTCGGTCCCCATTCCTGTCCCCACTCAGGTGCACAATTACCAGCGCATCGAGCAAAACCTGCAATCGCCCACTCAAC  
  A  S  V  P  I  P  V  P  T  Q  V  H  N  Y  Q  R  I  E  Q  N  L  Q  S  P  T  Q  
AGCAGACAGCCAGGTCCTCTGCCATCCGAAGGTCAGGGAGCACCAGCCCCCTGGGCTTTGGCCGGGCCAGCCCATCACCC  
Q  Q  T  A  R  S  S  A  I  R  R  S  G  S  T  S  P  L  G  F  G  R  A  S  P  S  P  
CCCTCCCACACCGATGGAGCCATGCTGGCCAGGAAGCTGTCACTTGGAGGTGGCCGTCCCTACACACCTTCTCCCCAAGT  
 P  S  H  T  D  G  A  M  L  A  R  K  L  S  L  G  G  G  R  P  Y  T  P  S  P  Q  V  
GGGAACCATCCCAGAGCGACCCAGCTGGAGCAGAGTGCCCTCCCCACAAGGAGCTGATGTGCGGGTTGGCAGGTCACCAC  
  G  T  I  P  E  R  P  S  W  S  R  V  P  S  P  Q  G  A  D  V  R  V  G  R  S  P  
GACCCGGTTCCTCTGTGCCTGAGCACTCTCCAAGAACCACTGGGCTGGGCTGCCGCCTGCACAGTGCCCCTAACCTGTCC  
R  P  G  S  S  V  P  E  H  S  P  R  T  T  G  L  G  C  R  L  H  S  A  P  N  L  S  
GACTTCCATGTTGTGCGTCCCAAGCTGCCTAAGCCCCCAACAGACCCACTGGGAGCCACCTTTAGCCCACCCCAGACCAG  
 D  F  H  V  V  R  P  K  L  P  K  P  P  T  D  P  L  G  A  T  F  S  P  P  Q  T  S  
CGCACCCCAGCCATGCCCAGGGCTACAGTCTTGCCGGCCACTGCGTGGCTCACCTAAGCTGCCTGACTTCCTACAGCGGA  
  A  P  Q  P  C  P  G  L  Q  S  C  R  P  L  R  G  S  P  K  L  P  D  F  L  Q  R  
GTCCCCTACCCCCCATCCTAGGCTCTCCTACCAAGGCCGGGCCCTCCTTTGACTTCCCCAAAACCCCCAGCTCTCAGAAT  
S  P  L  P  P  I  L  G  S  P  T  K  A  G  P  S  F  D  F  P  K  T  P  S  S  Q  N 
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TTGCTGACCCTGTTGGCTAGGCAGGGGGTAGTAATGACACCACCTCGGAACCGTACACTGCCTGACCTCTCCGAGGCCAG  
 L  L  T  L  L  A  R  Q  G  V  V  M  T  P  P  R  N  R  T  L  P  D  L  S  E  A  S  
TCCTTTCCATGGCCAGCAGCTGGGCTCTGGCCTTCGGCCCGCTGAAGACACCCGGGGTCCCTTTGGACGGTCCTTCAGCA  
  P  F  H  G  Q  Q  L  G  S  G  L  R  P  A  E  D  T  R  G  P  F  G  R  S  F  S  
CCAGCCGCATTACGGACCTGCTGCTTAAGGCTGCATTTGGGACTCAGGCCTCTGACTCAGGCAGCACAGACAGCCTACAG  
T  S  R  I  T  D  L  L  L  K  A  A  F  G  T  Q  A  S  D  S  G  S  T  D  S  L  Q  
GAGAAACCTATGGAGATTGCTCCCTCTGCTGGCTTTGGAGGGACTCTGCATCCAGGAGCTCGTGGTGGAGGGGCCAGCAG  
 E  K  P  M  E  I  A  P  S  A  G  F  G  G  T  L  H  P  G  A  R  G  G  G  A  S  S  
CCCAGCACCTGTGGTATTTACTGTAGGCTCCCCACCCAGTGGTGCCACCCCACCCCAGAGTACCCGTACCAGAATGTTCT  
  P  A  P  V  V  F  T  V  G  S  P  P  S  G  A  T  P  P  Q  S  T  R  T  R  M  F  
CAGTGGGCTCTTCCAGCTCCCTGGGCTCTACTGGCTCCTCCTCTGCCCGCCACTTAGTGCCTGGGGCCTGTGGAGAGGCC  
S  V  G  S  S  S  S  L  G  S  T  G  S  S  S  A  R  H  L  V  P  G  A  C  G  E  A  
CCGGAGCTTTCTGCCCCAGGCCACTGCTGTAGCCTTGCTGACCCCCTTGCTGCCAACTTGGAGGGGGCTGTGACCTTCGA  
 P  E  L  S  A  P  G  H  C  C  S  L  A  D  P  L  A  A  N  L  E  G  A  V  T  F  E  
GGCTCCTGACCTCCCAGAGGAGACCCTCATGGAGCAAGAGCACACGGAAACCCTACACAGTCTGCGCTTCACACTAGCGT  
  A  P  D  L  P  E  E  T  L  M  E  Q  E  H  T  E  T  L  H  S  L  R  F  T  L  A  
TTGCACAGCAAGTTCTGGAGATTGCAGCCCTGAAGGGAAGTGCCAGTGAGGCCGCCGGTGGCCCTGAGTACCAGCTCCAG  
F  A  Q  Q  V  L  E  I  A  A  L  K  G  S  A  S  E  A  A  G  G  P  E  Y  Q  L  Q  
GAAAGTGTGGTGGCTGACCAGATCAGTCAGTTGAGCCGAGAGTGGGGCTTTGCAGAGCAACTGGTTCTGTACTTGAAGGT  
 E  S  V  V  A  D  Q  I  S  Q  L  S  R  E  W  G  F  A  E  Q  L  V  L  Y  L  K  V  
GGCTGAGCTGCTGTCCTCAGGCCTACAGACTGCCATTGACCAGATTCGAGCTGGCAAACTCTGCCTTTCATCTACTGTGA  
  A  E  L  L  S  S  G  L  Q  T  A  I  D  Q  I  R  A  G  K  L  C  L  S  S  T  V  
AGCAGGTGGTACGCAGACTAAATGAGCTGTACAAGGCCAGCGTGGTATCCTGCCAGGGCCTCAGCTTGCGACTTCAGCGC  
K  Q  V  V  R  R  L  N  E  L  Y  K  A  S  V  V  S  C  Q  G  L  S  L  R  L  Q  R  
TTCTTTCTGGACAAACAACGGCTGCTGGACGGGATCCATGGTGTCACTGCAGAGCGGCTCATCCTCAGCCATGCTGTGCA  
 F  F  L  D  K  Q  R  L  L  D  G  I  H  G  V  T  A  E  R  L  I  L  S  H  A  V  Q  
AATGGTACAATCAGCTGCCCTTGATGAGATGTTCCAGCACCGAGAGGGCTGTGTACCGAGATATCACAAAGCCCTGCTAT  
  M  V  Q  S  A  A  L  D  E  M  F  Q  H  R  E  G  C  V  P  R  Y  H  K  A  L  L  
TGCTGGAGGGGTTGCAGCACACTCTCACGGACCAGGCAGACATTGAGAACATTGCCAAATGCAAGCTGTGCATTGAGAGG  
L  L  E  G  L  Q  H  T  L  T  D  Q  A  D  I  E  N  I  A  K  C  K  L  C  I  E  R  
AGACTCTCGGCCCTGCTGAGTGGTGTCTATGCCTGA  
 R  L  S  A  L  L  S  G  V  Y  A  * 
 
8.2.4 ULK2 cDNA and Protein sequence (M.musculus)- Clone ID:5709559/GenBank: 
BC046778   
ATGGAGGTGGTGGGCGACTTCGAGTACTGCAAGCGGGACCTCGTGGGACACGGGGCCTTCGCTGTGGTCTTCCGGGGGCG  
 M  E  V  V  G  D  F  E  Y  C  K  R  D  L  V  G  H  G  A  F  A  V  V  F  R  G  R  
GCACCGCCAGAAAACTGATTGGGAGGTGGCTATTAAAAGTATTAATAAAAAGAACTTGTCAAAATCACAAATTCTGCTTG  
  H  R  Q  K  T  D  W  E  V  A  I  K  S  I  N  K  K  N  L  S  K  S  Q  I  L  L  
GAAAGGAAATAAAAATCTTAAAGGAGCTTCAGCATGAAAACATCGTAGCGCTCTATGATGTTCAGGAATTGCCCAACTCT  
G  K  E  I  K  I  L  K  E  L  Q  H  E  N  I  V  A  L  Y  D  V  Q  E  L  P  N  S  
GTCTTTCTGGTGATGGAGTATTGCAATGGTGGAGACCTGGCAGATTATTTGCAAGCTAAAGGAACTCTGAGTGAAGATAC  
 V  F  L  V  M  E  Y  C  N  G  G  D  L  A  D  Y  L  Q  A  K  G  T  L  S  E  D  T  
TATCAGAGTGTTTCTCCATCAGATTGCGGCAGCCATGCGAATCCTGCACAGCAAAGGGATAATCCACAGGGATCTCAAAC  
  I  R  V  F  L  H  Q  I  A  A  A  M  R  I  L  H  S  K  G  I  I  H  R  D  L  K  
CACAGAATATCCTGTTGTCTTATGCCAATCGAAGGAAGTCGAATGTCAGTGGTATTCGTATTAAAATAGCTGATTTTGGT  
P  Q  N  I  L  L  S  Y  A  N  R  R  K  S  N  V  S  G  I  R  I  K  I  A  D  F  G  
TTCGCACGGTACCTACATAGTAACACAATGGCAGCGACACTGTGTGGATCCCCAATGTACATGGCTCCCGAGGTTATTAT  
 F  A  R  Y  L  H  S  N  T  M  A  A  T  L  C  G  S  P  M  Y  M  A  P  E  V  I  M  
GTCTCAACATTATGATGCTAAGGCAGATTTATGGAGCATAGGAACAGTGATCTATCAATGCCTAGTTGGAAAACCACCTT  
  S  Q  H  Y  D  A  K  A  D  L  W  S  I  G  T  V  I  Y  Q  C  L  V  G  K  P  P  
TTCAGGCTAATAGTCCTCAGGACCTAAGGATGTTTTATGAAAAAAACAGGAGCTTAATGCCTAGTATTCCCAGAGAAACA  
F  Q  A  N  S  P  Q  D  L  R  M  F  Y  E  K  N  R  S  L  M  P  S  I  P  R  E  T  
TCACCTTACTTGGCTAATCTCCTTTTGGGTTTGCTTCAGAGAAATCAAAAGGATAGAATGGACTTTGAAGCATTTTTCAG  
 S  P  Y  L  A  N  L  L  L  G  L  L  Q  R  N  Q  K  D  R  M  D  F  E  A  F  F  S  
CCATCCTTTCCTTGAGCAAGTTCCAGTTAAAAAATCTTGCCCAGTCCCAGTGCCTGTGTATTCTGGCCCTGTCCCTGGAA  
  H  P  F  L  E  Q  V  P  V  K  K  S  C  P  V  P  V  P  V  Y  S  G  P  V  P  G  
GCTCCTGCAGCAGCTCACCATCTTGTCGCTTTGCTTCTCCACCATCCCTTCCAGATATGCAGCATATTCAGGAAGAAAAC  
S  S  C  S  S  S  P  S  C  R  F  A  S  P  P  S  L  P  D  M  Q  H  I  Q  E  E  N  
TTATCCTCCCCACCGTTGGGTCCTCCCAACTATCTACAGGTGTCCAAAGACTCTGCGAGTAATAGTAGCAAGAACTCTTC  
 L  S  S  P  P  L  G  P  P  N  Y  L  Q  V  S  K  D  S  A  S  N  S  S  K  N  S  S  
TTGTGACACGGATGACTTTGTTTTGGTTCCACACAACATCTCGTCAGACCACTCATATGACATGCCAATGGGGACTACGG  
  C  D  T  D  D  F  V  L  V  P  H  N  I  S  S  D  H  S  Y  D  M  P  M  G  T  T  
CCAGACGTGCTTCAAATGAATTCTTTATGTGTGGAGGGCAGTGTCAACCTACTGTGTCACCTCACAGCGAAACAGCCCCA  
A  R  R  A  S  N  E  F  F  M  C  G  G  Q  C  Q  P  T  V  S  P  H  S  E  T  A  P  
ATTCCAGTTCCTACTCAAGTAAGGAATTATCAGCGCATAGAACAGAATCTTATATCCACTGCCAGCTCTGGCACAAACCC  
 I  P  V  P  T  Q  V  R  N  Y  Q  R  I  E  Q  N  L  I  S  T  A  S  S  G  T  N  P 
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ACATGGTTCTCCAAGATCTGCAGTAGTACGAAGGTCTAATACCAGCCCCATGGGCTTCCTCCGGGTTGGGTCCTGCTCCC  
  H  G  S  P  R  S  A  V  V  R  R  S  N  T  S  P  M  G  F  L  R  V  G  S  C  S  
CTGTACCAGGAGACACAGTGCAGACAGGAGGACGAAGACTCTCTACTGGCTCTTCCAGGCCTTACTCACCATCCCCTTTG  
P  V  P  G  D  T  V  Q  T  G  G  R  R  L  S  T  G  S  S  R  P  Y  S  P  S  P  L  
GTTGGTACCATTCCTGAACAGTTTAGTCAGTGCTGCTGTGGACATCCTCAGGGCCATGAAGCCAGGAGTAGGCACTCCTC  
 V  G  T  I  P  E  Q  F  S  Q  C  C  C  G  H  P  Q  G  H  E  A  R  S  R  H  S  S  
AGGTTCTCCAGTGCCACAGACCCAGGCACCACAGTCACTCTTACTGGGTGCTAGACTGCAGAGTGCACCCACCCTCACCG  
  G  S  P  V  P  Q  T  Q  A  P  Q  S  L  L  L  G  A  R  L  Q  S  A  P  T  L  T  
ATATCTATCAGAACAAGCAGAAGCTCAGAAAGCAGCACTCTGACCCTGTGTGTCCGTCCCATGCTGGAGCTGGGTATAGT  
D  I  Y  Q  N  K  Q  K  L  R  K  Q  H  S  D  P  V  C  P  S  H  A  G  A  G  Y  S  
TACTCACCTCAGCCTAGTCGGCCTGGCAGCCTTGGGACCTCTCCCACCAAGCACACGGGGTCCTCTCCACGGAATTCTGA  
 Y  S  P  Q  P  S  R  P  G  S  L  G  T  S  P  T  K  H  T  G  S  S  P  R  N  S  D  
CTGGTTCTTTAAAACTCCTTTACCAACAATCATTGGCTCTCCTACTAAGACTACAGCTCCTTTCAAAATCCCTAAAACAC  
  W  F  F  K  T  P  L  P  T  I  I  G  S  P  T  K  T  T  A  P  F  K  I  P  K  T  
AAGCATCTTCTAACCTGTTAGCCTTGGTTACTCGTCATGGGCCTGCTGAAAGCCAGTCCAAAGATGGGAATGACCCTCGT  
Q  A  S  S  N  L  L  A  L  V  T  R  H  G  P  A  E  S  Q  S  K  D  G  N  D  P  R  
GAGTGTTCCCACTGCCTCTCAGTACAAGGAAGCGAGAGGCATCGATCTGAGCAGCAGCAGAGCAAGGCAGTGTTTGGCAG  
 E  C  S  H  C  L  S  V  Q  G  S  E  R  H  R  S  E  Q  Q  Q  S  K  A  V  F  G  R  
ATCTGTCAGTACTGGGAAGTTATCAGAACAACAAGTAAAGGCACCTTTAGGTGGACACCAGGGCAGCACGGATAGTTTAA  
  S  V  S  T  G  K  L  S  E  Q  Q  V  K  A  P  L  G  G  H  Q  G  S  T  D  S  L  
ACACAGAACGACCAATGGATGTAGCTCCTGCAGGAGCCTGTGGTGTTATGCTGGCATTGCCAGCAGGAACAGCAGCAAGC  
N  T  E  R  P  M  D  V  A  P  A  G  A  C  G  V  M  L  A  L  P  A  G  T  A  A  S  
GCCAGAGCTGTCCTCTTCACCGTGGGGTCTCCTCCACACAGTGCCACAGCCCCCACTTGTACTCATATGGTCCTTCGAAC  
 A  R  A  V  L  F  T  V  G  S  P  P  H  S  A  T  A  P  T  C  T  H  M  V  L  R  T  
AAGAACCACCTCAGTGGGGTCCAGCAGCTCAGGAGGTTCCTTGTGTTCTGCAAGTGGCCGAGTATGTGTGGGCTCCCCTC  
  R  T  T  S  V  G  S  S  S  S  G  G  S  L  C  S  A  S  G  R  V  C  V  G  S  P  
CTGGACCAGGGTTGGGCTCTTCCCCACCAGGAGCAGAGGGAGCTCCCAGCCTAAGATACGTGCCTTATGGTGCTTCACCA  
P  G  P  G  L  G  S  S  P  P  G  A  E  G  A  P  S  L  R  Y  V  P  Y  G  A  S  P  
CCCAGCCTAGAGGGTCTCATCACCTTTGAAGCCCCTGAACTACCAGAGGAGACACTGATGGAGCGAGAGCACACAGACAC  
 P  S  L  E  G  L  I  T  F  E  A  P  E  L  P  E  E  T  L  M  E  R  E  H  T  D  T  
CTTACGCCATCTGAACATGATGTTAATGTTTACTGAGTGTGTGCTGGACCTGACGGCAGTGAGGGGTGGGAACCCTGAGC  
  L  R  H  L  N  M  M  L  M  F  T  E  C  V  L  D  L  T  A  V  R  G  G  N  P  E  
TGTGCACATCTGCTGTGTCCTTGTACCAGATTCAGGAGAGTGTAGTTGTGGACCAGATCAGCCAGCTAAGCAAAGATTGG  
L  C  T  S  A  V  S  L  Y  Q  I  Q  E  S  V  V  V  D  Q  I  S  Q  L  S  K  D  W  
GGGCGGGTGGAGCAGCTGGTGTTGTACATGAAGGCAGCACAGCTGCTGGCGGCTTCCCTGCATCTCGCCAAAGCTCAGGT  
 G  R  V  E  Q  L  V  L  Y  M  K  A  A  Q  L  L  A  A  S  L  H  L  A  K  A  Q  V  
CAAGTCTGGGAAGCTGAGCCCATCCATGGCTGTGAAACAAGTTGTTAAAAATCTGAATGAAAGATACAAATTCTGCATCA  
  K  S  G  K  L  S  P  S  M  A  V  K  Q  V  V  K  N  L  N  E  R  Y  K  F  C  I  
CCATGTGCAAGAAACTTACAGAAAAGCTGAATCGCTTCTTCTCCGATAAACAGAGATTTATTGATGAAATCAACAGTGTG  
T  M  C  K  K  L  T  E  K  L  N  R  F  F  S  D  K  Q  R  F  I  D  E  I  N  S  V  
ACTGCAGAGAAACTCATCTATAATTGTGCTGTGGAAATGGTTCAATCTGCAGCCCTGGATGAGATGTTTCAGCAGACTGA  
 T  A  E  K  L  I  Y  N  C  A  V  E  M  V  Q  S  A  A  L  D  E  M  F  Q  Q  T  E  
AGACATCGTTTATCGCTACCACAAGGCAGCCCTTCTTTTGGAAGGCTTAAGTAAGATCCTGCAGGACCCTACAGATGTTG  
  D  I  V  Y  R  Y  H  K  A  A  L  L  L  E  G  L  S  K  I  L  Q  D  P  T  D  V  
AAAATGTGCATAAGTATAAATGTAGTATTGAAAGAAGATTGTCAGCACTCTGCTGTAGCACTGCAACTGTGTGA  
E  N  V  H  K  Y  K  C  S  I  E  R  R  L  S  A  L  C  C  S  T  A  T  V  *  
 
Kinase domain of ULK1/2 is depicted in blue, serine proline rich domain in black and C-
terminal domain in orange. 
 
8.2.5 VAPA cDNA sequence (M.musculus)- Clone ID:3490082/GenBank:BC003866 
 
ATGGCGTCCGCCTCCGGGGCCATGGCGAAGCACGAGCAGATCCTGgTCCTCGACCCTCCTTCAGACCTCAAATT
CAAAGGCCCCTTCACAGATGTAGTCACTACAAATCTTAAATTGCAAAATCCATCGGATAGAAAAGTGTGTTTC
AAAGTGAAGACTACAGCACCTCGCCGGTACTGTGTGCGGCCCAACAGTGGGATTATTGACCCGGGGTCAATTG
TGACTGTTTCAGTAATGCTGCAACCCTTTGATTATGATCCGAATGAAAAGAGTAAACATAAGTTCATGGTACAG
ACAATTTTTGCTCCACCAAACATTTCAGATATGGAAGCTGTGTGGAAAGAAGCAAAACCTGATGAATTAATGG
ATTCTAAATTGAGATGTGTGTTTGAAATGCCGAATGAAAATGATAAGCTGAATGATATGGAACCTAGCAAAGC
TGTTCCACTGAATGCATCCAAACAAGACGGACCCCTGCCAAAACCAcACAGTGTTTCACTCaATGATACGGAAA
CAAGGAAACTGATGGAAGAGTGCAAGCGACTCCAGGGAGAAATGATGAAGCTCTCAGAAGAAAACCGACACC
TGAGAGATGAAGGCCTAAGGCTCAGAAAGGTAGCACATTCGGATAAACCTGGATCCACCTCAGCCGTGTCCTT
CAGAGATAATGTCACCAGTCCTCTTCCTTCTCTTCTGGTTGTAATTGCAGCCATTTTCATTGGATTCTTTCTAGG
GAAATTCATCTTG 
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8.2.6 VAPA Protein sequence (M.musculus)  
 
MASASGAMAKHEQILVLDPPSDLKFKGPFTDVVTTNLKLQNPSDRKVCFKVKTTAPRRYCVRPNSGIIDPGSIVTVS
VMLQPFDYDPNEKSKHKFMVQTIFAPPNISDMEAVWKEAKPDELMDSKLRCVFEMPNENDKLNDMEPSKAVPLNA
SKQDGPLPKPHSVSLNDTETRKLMEECKRLQGEMMKLSEENRHLRDEGLRLRKVAHSDKPGSTSAVSFRDNVTSPL
PSLLVVIAAIFIGFFLGKFIL  
 
8.2.7 VAPB cDNA sequence (M.musculus)- NCBI Ref. seq: NM_019806.5 
 
ATGGCGAAGGTGGAACAGGTCCTGAGCCTCGAGCCACAACACGAGCTCAAGTTCCGAGGTCCCTTCACTGATG
TTGTCACCACCAACCTAAAGCTTGGCAACCCAACAGACCGAAATGTGTGTTTTAAAGTGAAGACCACAGCACC
TCGCAGGTACTGCGTGCGGCCCAACAGTGGGGTCATTGATGCCGGGGCCTCTCTCAATGTGTCTGTGATGTTAC
AGCCTTTCGATTATGATCCCAATGAGAAAAGTAAACACAAGTTTATGGTTCAGTCTATGTTTGCTCCGCCTGAC
ACTTCTGATATGGAGGCAGTATGGAAGGAGGCAAAACCGGAAGACCTTATGGATTCAAAACTTAGATGTGTGT
TTGAATTGCCAGCAGAAAATGCTAAACCACATGATGTAGAAATAAATAAAATCATACCTACGAGTGCATCCAA
GACAGAAGCACCGGCAGCCGCAAAGTCCCTGACATCGCCCCTCGATGACACAGAAGTAAAGAAGGTGATGGA
AGAGTGCAGGCGGCTGCAGGGGGAGGTGCAGAGGCTTCGGGAGGAGAGCAGGCAGCTCAAGGAAGAAGACG
GACTTCGGGTGAGGAAGGCGATGCCGAGCAACAGCCCCGTGGCGGCTCTGGCGGCCACTGGGAAGGAGGAGG
GCCTGAGCGCCCGGCTGCTGGCCCTGGTGGTTCTGTTCTTTATCGTTGGTGTCATTATAGGGAAGATTGCCTTG 
 
8.2.8 VAPB Protein sequence (M.musculus)  
 
MAKVEQVLSLEPQHELKFRGPFTDVVTTNLKLGNPTDRNVCFKVKTTAPRRYCVRPNSGVIDAGASLNVSVMLQPF
DYDPNEKSKHKFMVQSMFAPPDTSDMEAVWKEAKPEDLMDSKLRCVFELPAENAKPHDVEINKIIPTSASKTEAPA
AAKSLTSPLDDTEVKKVMEECRRLQGEVQRLREESRQLKEEDGLRVRKAMPSNSPVAALAATGKEEGLSARLLAL
VVLFFIVGVIIGKIAL  
 
8.2.9 Copine VI  cDNA sequence (M.musculus)- Clone ID:6591063/GenBank:BC050766 
 
atgtcggacccagagatgggatgggtgcctgagcccccggccatgaccctgggagcctctcgagtggagctgcgggtgtcctgccatggcctgctggaccgag
acacgctcacaaagccgcatccatgtgtgctgctcaaactctactcggatgagcagtgggtggaggtggaacgcacggaggtgcttcgctcctgttcaagcccagt
cttctcccgggtgctggccattgaatacttttttgaagagaagcagcctttgcagttccacgtgttcgatgccgaggatggagccaccagccccagcagcgacacctt
cctcgggtctacggagtgcaccttgggccagattgtgtcacaaaccaaggtcactaagccattactgctgaagaatgggaagacggcgggcaagtctactatcacg
attgtggctgaggaggtatcaggtaccaacgactatgtgcaacttaccttcagagcccacaagctggataacaaggatctgttcagcaagtctgaccccttcatggag
atttataagaccaatggagaccagagtgaccaactggtctggaggactgaggtggtgaaaaacaacctgaaccccagctgggagccattccgcctgtccttgcatt
ctttgtgcagctgtgacatccacaggccgctcaagttcctggtatatgactatgactccagtggaaagcacgacttcatcggcgagttcaccagcacattccaggaaa
tgcaagaggggaccgcaaaccctgggcaggagatgcagtgggactgtatcaaccccaagtaccgagacaagaagaagaattacaagagctcagggacagtcgt
gctggcccagtgcaccgtggaaaaagtccacaccttcctggattatatcatgggtggctgccagatcagcttcacggtggctatcgacttcactgcctccaatgggg
acccaaggagcagccagtctctgcactgcctcagcccccgacagcccaaccactacctgcaggccttgcgcacagtgggcggtatctgccaggactatgacagt
gataagcggttcccagcttttggcttcggagctcgaatccccccaaactttgaggtctcccatgactttgctatcaactttgacccagaaaatcctgaatgtgaagagat
ctcaggggtcatagcctcctaccgccgctgcttgcctcagatccagctctatggtcctaccaacgtggcccctatcatcaaccgtgtggctgaaccagcccagcgag
agcagagcaccggccaagccacgaagtattcagtactgctggtgctcactgacggtgtggtgagtgatatggcagagacccgaacagccattgtgcgagcctccc
gcctgcccatgtcaatcatcatcgtgggtgtgggcaacgctgacttctctgacatgaggctactggacggagatgatggtcccctgcgttgcccaaagggggtacct
gcagcccgtgacattgtccagtttgtgcccttcagggacttcaaggacgctgccccctctgcactagctaagtgtgtcctggcagaggtgccacggcaggtggtag
agtactatgccagccaaggtatcagtcccggggctcccaggccctccacgccagctatgactcccagccctagccca 
 
8.2.10 Copine VI  Protein sequence (M.musculus)  
 
MSDPEMGWVPEPPAMTLGASRVELRVSCHGLLDRDTLTKPHPCVLLKLYSDEQWVEVERTEVLRSCSSPVFSRVLA
IEYFFEEKQPLQFHVFDAEDGATSPSSDTFLGSTECTLGQIVSQTKVTKPLLLKNGKTAGKSTITIVAEEVSGTNDYVQ
LTFRAHKLDNKDLFSKSDPFMEIYKTNGDQSDQLVWRTEVVKNNLNPSWEPFRLSLHSLCSCDIHRPLKFLVYDYD
SSGKHDFIGEFTSTFQEMQEGTANPGQEMQWDCINPKYRDKKKNYKSSGTVVLAQCTVEKVHTFLDYIMGGCQISF
TVAIDFTASNGDPRSSQSLHCLSPRQPNHYLQALRTVGGICQDYDSDKRFPAFGFGARIPPNFEVSHDFAINFDPENPE
CEEISGVIASYRRCLPQIQLYGPTNVAPIINRVAEPAQREQSTGQATKYSVLLVLTDGVVSDMAETRTAIVRASRLPM
SIIIVGVGNADFSDMRLLDGDDGPLRCPKGVPAARDIVQFVPFRDFKDAAPSALAKCVLAEVPRQVVEYYASQGISP
GAPRPSTPAMTPSPSP 
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8.2.11 SRPK2 cDNA sequence (M.musculus)-Clone ID: 4507346/GenBank:BC020178 
 
ATGTCAGTTAACTCTGAGAAGTCGTCCTCTTCAGAAAGGCCGGAGCCTCAACAGAAAGCTCCTTTAGTTCCTCC
TCCTCCACCACCACCACCGCCACCACCACTGCCAGACCCCGCACCCCCAGAGCCAGAGGAGGAGATTCTGGGG
TCAGATGATGAGGAGCAGGAGGACCCCGCAGATTACTGCAAAGGTGGCTATCATCCAGTGAAAATTGGAGATC
TCTTCAATGGTCGATATCATGTCATTAGAAAGCTAGGATGGGGGCACTTTTCTACTGTATGGCTGTGCTGGGAT
ATGCAAGGGAAAAGATTTGTTGCAATGAAAGTTGTAAAAAGTGCCCAGCATTATACAGAGACAGCCTTGGATG
AAATTAAACTACTCAAATGCGTTCGAGAAAGTGACCCCAGTGACCCAAACAAAGACATGGTAGTTCAGCTAAT
TGATGACTTCAAGATCTCAGGCATGAATGGGATACATGTCTGCATGGTCTTTGAAGTACTTGGTCACCATCTCC
TCAAATGGATCATCAAATCCAACTATCAAGGCCTCCCAGTACGTTGTGTGAAGAGTATCATTCGACAGGTCCTT
CAAGGGTTAGATTATCTACACAGTAAGTGCAAGATAATTCACACCGACATAAAGCCGGAAAACATCTTGATGT
GTGTGGATGACGCTTACGTGAGAAGAATGGCAGCCGAAGCCACGGAGTGGCAGAAAGCAGGTGCTCCTCCTCC
CTCTGGGTCTGCAGTGAGTACGGCTCCACAGCAAAAACCTATAGGAAAAATATCTAAAAACAAAAAGAAAAA
GCTGAAAAAGAAACAGAAGAGACAGGCTGAGTTGCTGGAGAAACGCCTACAGGAGATTGAGGAATTGGAGCG
AGAAGCCGAAAGGAAAATCCTAGAGGAGAACATCACCTCTGCAGAAGCTTCCGGGGAGCAGCAGGATGGAGA
GTACCAGCCGGAGGTGACACTGAAAGCAGCCGACTTAGAGGACACAACTGAGGAAGAGACAGCAAAGGATAA
TGGTGAAGTTGAAGACCAGGAAGAGAAAGAAGATGCAGAGAAGGAGAACGCGGAGAAGGATGAAGATGATG
TTGAACAGGAACTTGCAAACTTAGACCCTACCTGGGTGGAGTCCCCGAAAGCCAATGGCCATATTGAAAATGG
CCCGTTCTCACTGGAGCAGCAGCTGGAGGATGAAGAGGACGATGAAGATGACTGTGCAAATCCCGAGGAGTA
TAACCTCGATGAGCCAAATGCAGAGAGTGATTACACGTATAGCAGCTCCTATGAACAATTCAATGGTGAATTG
CCAAATGGACAACATAAGACTTCAGAGTTTCCCACACCGTTGTTTTCTGGGCCCTTAGAACCTGTGGCCTGTGG
CTCTGTGATTTCAGAGGGATCGCCACTTACCGAGCAGGAGGAAAGCAGTCCCTCCCATGACAGAAGCAGGACA
GTTTCAGCCTCTAGTACTGGAGATTTGCCAAAAACAAAAACCCGGGCGGCTGACCTGTTGGTGAACCCTCTGG
ATCCACGGAATGCAGATAAAATTAGAGTAAAAATTGCTGACCTGGGAAATGCTTGTTGGGTGCATAAACATTT
CACAGAGGATATCCAGACACGTCAGTATAGGTCCATAGAGGTTTTAATAGGAGCAGGCTACAGCACACCTGCA
GACATTTGGAGTACAGCTTGCATGGCATTTGAGCTCGCCACAGGAGACTATTTGTTCGAACCGCATTCTGGGGA
AGACTATTCCAGAGATGAAGACCACATAGCCCACATCATAGAGCTGCTAGGCAGTATCCCAAGGCACTTTGCT
CTGTCTGGAAAATATTCTCGGGAATTCTTCAATCGCAGAGGAGAACTGCGGCACATCACCAAGCTGAAGCCCT
GGAGCCTCTTTGATGTACTTGTGGAAAAGTATGGCTGGCCCCATGAAGATGCTGCACAATTTACAGATTTCCTG
ATCCCAATGTTAGAGATGGTTCCAGAAAAACGAGCCTCAGCTGGCGAATGCCTTCGACATCCTTGGTTGAATTC
T 
 
8.2.12 SRPK2 Protein sequence (M.musculus) 
 
MSVNSEKSSSSERPEPQQKAPLVPPPPPPPPPPPLPDPAPPEPEEEILGSDDEEQEDPADYCKGGYHPVKIGDLFNGRY
HVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKIS
GMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRM
AAEATEWQKAGAPPPSGSAVSTAPQQKPIGKISKNKKKKLKKKQKRQAELLEKRLQEIEELEREAERKILEENITSAE
ASGEQQDGEYQPEVTLKAADLEDTTEEETAKDNGEVEDQEEKEDAEKENAEKDEDDVEQELANLDPTWVESPKA
NGHIENGPFSLEQQLEDEEDDEDDCANPEEYNLDEPNAESDYTYSSSYEQFNGELPNGQHKTSEFPTPLFSGPLEPVA
CGSVISEGSPLTEQEESSPSHDRSRTVSASSTGDLPKTKTRAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTE
DIQTRQYRSIEVLIGAGYSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREF
FNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWLNS  
 
8.2.13 SV2A (R.norvegicus)-NCBI Ref. seq: NM_057210.2 
 
atggaagaaggctttcgagaccgagcagcgttcatccgtggggccaaagacattgccaaggaagttaagaagcacgcggccaagaaggtggtgaagggtctcg
acagagtccaggatgaatattcccgaaggtcctactcccgctttgaggaggaggaggatgatgatgacttccctgcccctgctgacggctattaccgcggagaagg
ggcccaggatgaggaggaaggtggcgcttccagtgatgccactgagggccacgatgaggatgatgagatctacgagggagaatatcagggcatcccccgggc
agagtctgggggcaaaggcgaacggatggcagatggggcacccctggctggagtgagagggggcttaagtgatggggagggtccccctgggggtcgcgggg
aggcgcagcggcgtaaagatcgggaagaattggctcagcagtatgagaccatcctccgggagtgcggccatggtcgcttccagtggacactctacttcgtgctgg
gtctggcgctgatggccgatggtgtagaggtctttgtggtgggctttgtgctgcccagtgctgagaaagatatgtgcctgtcggactccaacaaaggcatgctaggc
ctcattgtgtacctgggcatgatggtgggggccttcctctggggaggcctggctgatcggctgggtcggagacagtgtctgctcatctcgctctcagtcaacagcgt
cttcgctttcttctcatccttcgtccagggttatggcaccttccttttctgccgcctcctttctggggttgggattggtggttccatccccattgtcttctcctatttttcggagtt
tctggcccaggagaaacgtggggagcatttgagctggctctgtatgttctggatgattggtggcgtgtatgcagctgcaatggcctgggccatcatcccccactatgg
gtggagtttccagatgggctctgcttaccagttccacagctggagggtctttgtcctcgtctgtgcctttccctctgtgtttgccatcggggctctgactacgcagccgg
agagtccccgcttcttcttagagaatgggaagcacgatgaggcctggatggtgctgaagcaggttcatgacaccaacatgcgagccaagggccatcctgagcgag
tcttctcagtaacccacattaaaacgattcatcaggaggatgaattgattgagatccagtcagacacaggaacctggtaccagcgctggggagtgcgggctttgagc
ctggggggtcaggtttgggggaacttcctctcctgcttcagtccagagtaccggcgcatcactctgatgatgatgggggtatggttcaccatgtccttcagctactacg
gtttgactgtctggtttcccgacatgatccgccatctccaggctgtggactatgcagcccgaaccaaagtgttcccaggggagcgcgtggagcacgtgacatttaact
tcacactggagaatcagatccaccgagggggacagtacttcaatgacaagttcatcgggctgcgtctgaagtcagtgtcctttgaggattccctgtttgaggaatgtta
ctttgaagatgtcacatccagcaacacattcttccgcaactgcacattcatcaacaccgtgttctacaacacggacctgtttgagtacaagttcgtgaacagccgcctg
gtgaacagcacattcctgcacaataaggaaggttgcccactagatgtgacagggacgggcgaaggtgcctacatggtgtactttgtcagcttcttggggacactgg
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ctgtgctccctggaaatattgtgtctgctctgctcatggacaagattggcaggctcagaatgcttgctggttccagtgtgttgtcctgtgtttcctgcttcttcctgtcttttg
ggaacagtgagtcagccatgatcgctctgctctgcctttttgggggagtcagtattgcatcctggaacgcgctggacgtgctgactgttgaactctacccttccgacaa
gaggacgacggccttcggcttcctgaatgccctgtgtaagctggcagctgtactgggcatcagcatcttcacgtcctttgtgggaatcaccaaggccgctcccatcct
cttcgcctcagctgcgcttgcccttggtagctctctggctctgaagctgcctgagacccggggacaggtgctgcag 
 
8.2.14 SV2A  Protein sequence (R. norvegicus)  
 
MEEGFRDRAAFIRGAKDIAKEVKKHAAKKVVKGLDRVQDEYSRRSYSRFEEEEDDDDFPAPADGYYRGEGAQDEE
EGGASSDATEGHDEDDEIYEGEYQGIPRAESGGKGERMADGAPLAGVRGGLSDGEGPPGGRGEAQRRKDREELAQ
QYETILRECGHGRFQWTLYFVLGLALMADGVEVFVVGFVLPSAEKDMCLSDSNKGMLGLIVYLGMMVGAFLWGG
LADRLGRRQCLLISLSVNSVFAFFSSFVQGYGTFLFCRLLSGVGIGGSIPIVFSYFSEFLAQEKRGEHLSWLCMFWMIG
GVYAAAMAWAIIPHYGWSFQMGSAYQFHSWRVFVLVCAFPSVFAIGALTTQPESPRFFLENGKHDEAWMVLKQV
HDTNMRAKGHPERVFSVTHIKTIHQEDELIEIQSDTGTWYQRWGVRALSLGGQVWGNFLSCFSPEYRRITLMMMG
VWFTMSFSYYGLTVWFPDMIRHLQAVDYAARTKVFPGERVEHVTFNFTLENQIHRGGQYFNDKFIGLRLKSVSFED
SLFEECYFEDVTSSNTFFRNCTFINTVFYNTDLFEYKFVNSRLVNSTFLHNKEGCPLDVTGTGEGAYMVYFVSFLGTL
AVLPGNIVSALLMDKIGRLRMLAGSSVLSCVSCFFLSFGNSESAMIALLCLFGGVSIASWNALDVLTVELYPSDKRTT
AFGFLNALCKLAAVLGISIFTSFVGITKAAPILFASAALALGSSLALKLPETRGQVLQ  
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9. Abbreviations 
 
A  EM Electron microscopy  
AAV Adeno associated virus ER Endoplasmic reticulum 
AC Adenylyl cyclase ERK2 Extracellular signal-regulated kinase2 
ADBE Activity-dependent bulk endocytosis ES Elution steps 
APS Ammonium peroxodisulphate F  
ATP  Adenosine tri-phosphate FCS Fetal calf serum 
AZ  
 
Active Zone 
 
FM  Name after Fei Mao, who synthetized for 
the first time these dyes 
B  Fw  Forward 
BDNF Brain-derived neurotrophic factor G  
BES N,N, Bis-(2-hydroxyethyl)-2-amino-
ethansulfonic acid 
G 
GFP 
Gravitational 
Green fluorescent protein 
BME  Basal Medium Eagle GPCR G-protein coupled receptor 
Brp  Bruchpilot GSH Glutathione 
BSA  Bovine serum albumin GST  Glutathione S-transferase 
β-ME Beta mercaptoethanol GTP Guanosintriphosphate 
C  H  
Ca2+ Calcium ions h  Hour 
CaCl2 
CaMKII 
Calcium chloride 
Ca2+/calmodulin-dependent protein kinase 
II 
HA  
HBS 
HBSS 
Human influenza hemaglutinin 
HEPES buffered saline 
Hanks buffered salt solution 
cAMP 
CASK 
 
CAZ 
CC 
Cyclic adenosine-3,5-monophosphate 
Calcium/calmodulin-dependent serine 
protein kinase 
Cytomatrix at the active zone 
Coiled-coil domain 
HEK 
293T 
HEPES 
Human embryonic kidney cell line 293T 
 
2-[4-(2-hydroxyethyl)piperazin-1-
yl]ethanesulfonic acid 
CCB Coomassie Colloidal Blue I  
cDNA Complementary DNA IAA  Iodamidacetate 
Cdk5 Cyclin-dependent kinase 5 IB Immunoblotting 
CMV Cytomegalovirus IC50 Half inhibitory concentration 
CNS Central nervous system IF Immunofluorescence 
CO2  Carbon dioxide IgG Immunoglobulin G 
Co-IP Co-immunoprecipitation IHC Immunohistochemistry 
CTD  C-terminal domain IMDM Iscove’s Modified Dulbecco’s Medium 
C-
terminus  
Carboxyl terminus IP 
IPTG 
Immunoprecipitation 
Isopropyl-β-D-thiogalactoside 
D  IRDye  InfraRed Dye 
DAPI 4’,6-diamidin-2-phenylindol K  
DDM n-dodecyl-β-maltoside kb  Kilo base 
dH2O Distillate water KCl Potassium chloride 
DIV  Day in vitro KD Kinase domain 
DMEM Dulbecco's Modified Eagle's Medium kDa Kilo Dalton 
DMSO  Dimethyl sulfoxide KH2PO4 Potasium dihydrogenphosphate 
DNA   Deoxyribonucleic acid KO  Knock-out 
dNTP  Deoxyribonucleotide triphosphate L  
DSP Dithiobis (succinimidylpropionate) LAR Leukocyte common antigen related 
DTBP Dimethyl 3,3’-dithiobispropionimidate-
2HCl 
LB-
medium  
Luria broth medium 
DTT Ditiothreitol LC-MS Liquid chromatography- mass spectrometry 
E  LTD Long-term depression 
E18,5 Embryo at day 18.5 after fertilization LTP  Long-term potentiation 
EDTA  Ethylenediaminetetraacetic acid   
ELKS Name stems from the proteins high content 
in glutamate (E), leucine (L), lysine (K), and 
serine (S) 
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M  RIM-BPs  RIM-binding proteins 
M Molar RNA  Ribonucleic acid 
MCS   Multiple cloning site rpm  Rotation per minute 
MEM  Minimal essential medium RRP Readily releasable pool 
MF Mossy fibres RS Arginine/serine dipeptides 
mg  Miligram RT  Room temperature 
MgCl2 Magnesium chloride RT-PCR  Reverse transcription PCR 
MgSO4 Magnesium sulphate S  
min  Minute S1 Supernatant 1 
ml  Millilitre sec Seconds 
mM  Milimolar SEM  Standard error of the mean 
mRNA  Messenger RNA shRNA Short hairpin RNA 
MS Mass spectrometry SDS  Sodium dodecyl sulfate 
MSP Major sperm protein domain SNAP25   Synaptosomal-associated protein 25 
MW  
MWCO 
Molecular weight 
Molecular weight cut off 
SNARE  
 
Soluble N-ethylmaleimide-sensitive factor 
(NSF) attachment protein receptors 
Μg Microgram SPRD Serine proline rich domain 
μl Microliter SRPK  Serine arginine protein kinase 
µm Micromolar SS Splice site 
N  SV  Synaptic vesicle 
NaCl Sodium chloride SV2A  Synaptic vesicle protein 2 A 
NAD Nicotinamide adenine dinucleotide Syt1 Synaptotagmin1 
NaHCO3 Sodium carbonate T  
Na2HPO4 Disodiumhydrogenphosphat TAP   Tandem affinity purification 
NaOH Sodium hydroxide TBS Tris buffered saline 
NCBI National Center for Biotechnology 
Information 
TEMED 
Tm 
N,N,N',N'-Tetramethylethylendiamin 
Melting temperature   
ng  Nanogram TMD Transmembrane domain 
NGS  Normal goat serum TMR Transmembrane region 
nm Nanometer U  
nM Nanomolar U Units 
NMJ Neuromuscular junction ULK Unc51-like kinase 
N-
terminus  
Amino-terminus UF 
UNC 
Unbound fraction 
Uncoordinated 
O  UPS Ubiquitin-proteasome system 
OD  Optical density V  
OE 
ON 
Over expression 
Over night 
VAPA/VAP
B 
Vesicle-associated membrane protein (VAMP) 
associated protein A/B  
P  VAMP-2 Vesicle associated membrane protein 2 
P2 Pellet 2- crude synaptosomes VGCG Voltage gated calcium channels 
PAGE Polyacrylamide gel electrophoresis vWA Von Willebrand factor type A  
PBS Phosphate buffered saline W  
PCR Polymerase chain reaction WB  Western blot 
PDZ Post synaptic density; Drosophila disc 
large tumour suppressor; zonula 
occludens-1 protein 
WS 
WT 
Washing steps 
Wild-type 
Pen/Strep  Penicillin/Streptomycin Z  
PFA Paraformaldehyde ZF Zinc finger domain 
PKA  Protein kinase A   
PKC Protein kinase C   
PP1 Protein phosphatase 1   
PP2A Protein phosphatase 2A   
R    
Rev Reverse    
RIM  Rab3 interacting molecule   
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